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Bayesian modeling of unknown causes of events is an important and pervasive problem. 
However, it has received relatively little research attention. In general, an intelligent agent (or 
system) has only limited causal knowledge of the world. Therefore, the agent may well be 
experiencing the influences of causes outside its model. For example, a clinician may be seeing a 
patient with a virus that is new to humans; the HIV virus was at one time such an example. It is 
important that clinicians be able to recognize that a patient is presenting with an unknown 
disease. In general, intelligent agents (or systems) need to recognize under uncertainty when they 
are likely to be experiencing influences outside their realm of knowledge. This dissertation 
investigates Bayesian modeling of unknown causes of events in the context of disease-outbreak 
detection. 
The dissertation introduces a Bayesian approach that models and detects (1) known 
diseases (e.g., influenza and anthrax) by using informative prior probabilities, (2) unknown 
diseases (e.g., a new, highly contagious respiratory virus that has never been seen before) by 
using relatively non-informative prior probabilities and (3) partially-known diseases (e.g., a 
disease that has characteristics of an influenza-like illness) by using semi-informative prior 
probabilities. I report the results of simulation experiments which support that this modeling 
method can improve the detection of new disease outbreaks in a population.  
BAYESIAN MODELING OF ANOMALIES  
DUE TO KNOWN AND UNKNOWN CAUSES 
Yanna Shen, PhD 
University of Pittsburgh, 2009
 
 v 
A key contribution of this dissertation is that it introduces a Bayesian approach for jointly 
modeling both known and unknown causes of events. Such modeling has broad applicability in 
artificial intelligence in general and biomedical informatics applications in particular, where the 
space of known causes of outcomes of interest is seldom complete. 
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1.0  INTRODUCTION 
Anomaly detection refers to the problem of finding anomalous patterns in data that do not 
conform to expected behavior. These non-conforming patterns are often referred to as anomalies, 
outliers, discordant observations, aberrations or contaminants in different application domains. 
Of these, anomalies and outliers are two terms used most commonly in the context of anomaly 
detection. Detecting anomalies or outliers in data has been studied in the statistics community as 
early as the 19th century (Edgeworth 1887). Chandola, et al. (Chandola 2009) provide a 
comprehensive overview of the research on anomaly detection. 
Anomaly detection has some important applications in domains such as disease outbreak 
detection (Wong 2004), fraud detection (Fawcett 1997), and electronic intrusion detection 
(Warrender 1999).  In a typical scenario, a monitoring system examines a sequence of data to 
determine if any recent activity can be considered a deviation relative to historical baseline 
behavior. The causes of anomalies can be divided into two types – those that we can anticipate 
and those that we cannot. As a result, algorithms within these monitoring systems can be 
classified into two categories – those that detect anomalies we can anticipate and those that 
detect anomalies we cannot. In this study I refer to these as specific detection algorithms and 
non-specific detection algorithms, respectively. 
A specific detection algorithm looks for a pre-defined anomalous pattern in the data. For 
example, in the context of disease outbreak detection, a specific detection approach would 
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examine health-care data for the onset of a specific disease such as inhalational anthrax. A large-
scale airborne release of inhalational anthrax has anticipated spatio-temporal characteristics, such 
as a specific incubation time and a plume-like spatial distribution (Hogan 2004). As a result, 
when monitoring for such an outbreak, a detection algorithm should be vigilant in watching for 
these characteristics. BARD (Hogan 2007) is an example of a specific detection algorithm. It 
models the effects of an outdoor airborne anthrax release using the Gaussian plume model of 
atmospheric dispersion and a model of inhalational anthrax. 
In contrast, a non-specific detection approach tries to detect any anomalous events, 
relative to some baseline of “normal” behavior. It searches for any statistically significant 
anomalous patterns in the data, not just those that fit known causes of anomalies. The WSARE 
algorithm is an example of a non-specific detection algorithm (Wong 2004). It works by 
searching for any significant changes in the ratios of different subgroups of the data between a 
recent period and a period in the more distant past. A non-specific detection algorithm can detect 
a wide range of anomaly types, but usually at the expense of being less effective at detecting any 
particular type. Commonly used non-specific detection algorithms are usually implemented 
using frequentist methods that are based on deriving a p-value from recent data. Examples of 
these approaches include Shewhart’s control charts, CUSUM, and EWMA (Montgomery 1991).  
Frequentist approaches are useful tools for anomaly detection and are commonly used in 
the public health community for detection of disease outbreaks. However, compared with 
Bayesian approaches, it is difficult to incorporate any prior information that we may have, as for 
example our prior beliefs about the size, location, or temporal progression of a potential 
outbreak. Bayesian outbreak detection algorithms have another advantage in that they can be 
readily used in a decision-analytic framework to compute the expected utility of a decision. For 
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example, the algorithm may calculate the posterior probability that there is a SARS outbreak as 
0.80, which strongly suggests that some action is in order. Alternatively, the algorithm may 
compute the probability as 10-12, and then, no action would be required. 
The objective of this dissertation is to develop an anomaly-detection algorithm that is 
able to capture anomalies due to both known and unknown causes. As described in this section, 
both specific and non-specific detection algorithms have their advantages and disadvantages in 
detecting anomalies due to known or unknown causes. Therefore, I propose a hybrid detection 
algorithm that combines specific and non-specific detectors in order to capture anomalous events 
due to both known and unknown causes. I propose a Bayesian method to develop this algorithm 
because we can (1) incorporate any prior knowledge we may have about the anomalies due to 
known causes, (2) develop our own non-informative and semi-informative priors to model 
anomalies due to unknown causes, and (3) readily apply the algorithm in a decision-analytic 
framework to compute the expected utility of a decision.  
Bayesian anomaly detection essentially performs Bayesian inference on anomalous 
events by combining prior beliefs about model parameters with evidence from data using Bayes’ 
theorem. Two challenges of Bayesian inference are that it can be difficult to specify the prior 
distribution and that the required computations are difficult.  
In this dissertation, I describe a Bayesian anomaly-detection algorithm in the context of 
disease outbreak detection and describe methods to develop my own algorithm to address these 
two challenges. Because the fundamental ideas are general, they could be used to develop richer 
Bayesian detection models and detection algorithms than those that currently exist. 
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1.1 OVERVIEW OF THE PROPOSED METHODOLOGY 
The question of how to specify a prior distribution turns out to be a disease-modeling problem in 
the context of disease-outbreak detection. Modeling non-outbreak diseases (i.e., all the diseases 
that people can have in the absence of any infectious disease outbreak in the population) is 
relatively straightforward, at least conceptually. Given the large amount of electronically 
available data, such as emergency department visits, over-the-counter medication sales, and 
ambulatory care visit records, we can apply traditional machine-learning techniques to learn the 
parameters of the non-outbreak disease model. However, due to the lack of actual outbreaks of 
diseases under surveillance, for many diseases it is difficult to learn the outbreak models using 
machine-learning techniques. Even though some outbreak disease-specific models could be 
learned, such as influenza outbreaks for which we have ample training data, there are many 
outbreak diseases for which we have little or no training data. Also, an outbreak could be due to 
a new infectious disease for which we obviously would not have a specific model. I define such a 
disease as an unknown outbreak disease since it is the one that we do not yet know about. There 
are some diseases that are known to us but not explicitly modeled, as for example Brucellosis. I 
define unknown outbreak diseases and unmodeled (but known) outbreak diseases as non-specific 
outbreak diseases 1
The disease-modeling problem in this dissertation describes how to model the probability 
of a symptom in a disease, as for example the probability that a patient will have a cough given 
that he or she has respiratory anthrax. Common disease-modeling problems model this parameter 
. Therefore, non-specific outbreak disease modeling is an important and 
significant challenge. 
                                                 
1 For convenience, I will assume that a non-specific outbreak disease is an unknown disease, unless stated 
otherwise.  
 5 
(probability) as a known probability value (Cooper 2006), as for example based on expert 
assessment. In contrast, this dissertation models the distributions of parameters that represent 
frequencies of the population, as for example the frequency of cough in the individuals with 
anthrax, whereas the true parameters (frequencies) are unknown. Figure 1.1 shows an example of 
modeling the distribution of a parameter and a point value of the parameter, where the parameter 
represents the frequency of cough in the individuals with early stage anthrax. Modeling the 
distributions of parameters allows us to express our ignorance about how diseases will present 
themselves and to develop disease models that flexibly fit a variety of symptom patterns in the 
population. 
Figure 1.1 An example that shows modeling of the distribution of a parameter and a point value of the parameter. 
The curve shows the distribution of a parameter that represents the frequency of cough in the individuals with early 
stage anthrax; the dot on the X-axis shows the mean of the distribution, which represents the point value of this 
parameter. 
0 0.2 0.4 0.6 0.8 1
0
0.5
1
1.5
2
2.5
3
3.5
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5
point value
↓
P(cough | early stage anthrax)
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In this dissertation I explore the problem of modeling unknown outbreak diseases. In 
particular, I will consider disease modeling as a continuous modeling space, from disease-
specific to partially-known-disease to unknown-disease modeling (see Figure 1.2). I will explore 
key areas of this modeling space with an outbreak-detection system (Cooper 2006) that uses 
Bayesian methods for detecting CDC Category A outbreak diseases (CDC).   
 
A disease-specific model (DSM) models a disease we are aware of and want to detect. It 
incorporates our prior knowledge of this disease, such as prior beliefs about the incubation time 
of the disease. An example of such a disease is influenza, since it is a disease we know about and 
care to detect early. Other examples are the CDC Category A diseases, which include anthrax, 
botulism, plague, smallpox, tularemia, and viral hemorrhagic fevers. 
In contrast, an unknown-disease model (UDM) models a disease about which we have 
almost no knowledge. Hence, I propose a non-informative prior for modeling unknown outbreak 
diseases. I anticipate that the use of non-informative priors will enable the UDMs to capture 
disease outbreaks due to diseases that are unanticipated or unmodeled. 
A partially-known-disease model (PDM), on the other hand, models an anticipated but 
partially-known disease, as for example a disease that has characteristics of a respiratory-like 
illness. In this dissertation, I propose a semi-informative prior for modeling partially-known 
Unknown outbreak 
diseases 
 (e.g., a dramatically 
new outbreak disease 
due to a recently 
mutated virus) 
 
Partially-known 
outbreak diseases 
 (e.g., a respiratory-
like illness) 
 
Known outbreak 
diseases 
 (e.g., influenza) 
 
Figure 1.2 Diagram showing the continuous disease-modeling space. 
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diseases. In particular, a mixture of priors is proposed in order to model outbreak diseases that 
may have disease characteristics similar to several known outbreak diseases. For example, a 
mixture of priors that has components of several known respiratory diseases, such as anthrax, 
plague, and inhalation tularemia, could be used for modeling a respiratory-like illness.  
In addition, there is a fourth category of disease model that represents an outbreak disease 
we know about but do not care to detect. If we want specifically to have a system that detects 
inhalational anthrax, then we do not want the detection system to send out alerts on other 
diseases that manifest similar patient symptoms, such as influenza. In this case, we would model 
influenza in order to avoid having the detection system alert on it. 
This dissertation addresses the disease modeling problem of the first three categories of 
models just described and introduces a Bayesian detection algorithm that is able to incorporate 
all three types of models. I call the proposed Bayesian hybrid detection algorithm the BH 
algorithm. 
1.2 THE DISSERTATION HYPOTHESIS  
In this dissertation research, I develop a hybrid detection system that combines models of known 
and unknown outbreak diseases together in order to capture outbreaks due to known diseases and 
due to unanticipated or unknown diseases. In most real-world problems, we do not know the 
underlying outbreak disease that is causing the ongoing disease outbreak. Since modeling both 
known and unknown outbreak diseases allows us to represent a wide range of disease 
presentations than modeling known outbreak diseases only, the hypothesis of this dissertation is 
that 
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Modeling both known and unknown outbreak diseases in a hybrid system can lead 
to better expected disease outbreak detection performance than modeling known 
outbreak diseases only.  
The dissertation makes this general statement more precise, so that it can be tested, as I did. 
Two scenarios occur in the real world when there is an outbreak occurring due to some 
disease d. One scenario is that disease d is known to us and has been modeled as a DSM disease. 
Then one might conjecture that incorporating UDM or PDM in the detection system (which 
model the possibility of unknown or partially-known disease, respectively) would detract the 
system from detecting disease d. Another scenario is that disease d is unexpected and not 
explicitly modeled in DSM. Then one could conjecture that incorporating UDM or PDM models 
in the detection system might help in the detection of disease d, relative to not modeling d in 
DSM. This dissertation will describe how I constructed these two scenarios in order to test the 
above hypothesis. 
Note that there are numerous ways of modeling unknown outbreak diseases or partially-
known outbreak diseases in UDMs or PDMs. This dissertation focuses on a basic way of 
modeling unknown diseases in order to investigate whether incorporating UDMs or PDMs in a 
detection system can improve the system’s detection performance relative to a system that only 
incorporates DSMs. 
1.3 GUIDE FOR THE READER 
The dissertation is organized as follows. Chapter 2 contains the background of the dissertation 
research. Since the proposed algorithm is a Bayesian hybrid detection algorithm that combines 
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specific and non-specific detectors, I first provide a Bayesian framework that combines the 
results of these detectors. Then I provide an overview of some commonly used specific and non-
specific detection algorithms and their evaluation methods. Additionally, I review some 
representative research on prior distributions and some previous research on modeling unknown 
objects. Finally, entity-relationship methods are briefly reviewed, because this dissertation builds 
on a previously developed outbreak disease detection system that uses an entity relationship 
method. 
Chapter 3 first introduces notation used for the remainder of the dissertation. It then 
introduces the experimental domain of the proposed Bayesian hybrid detection algorithm (the 
BH algorithm), the MD-PANDA model. In addition, this chapter provides a brief overview of 
how the MD-PANDA detection system monitors and detects CDC Category A diseases. 
Chapter 4 describes the main issues of the proposed BH algorithm, which includes a 
univariate version and a multivariate version. In particular, the BH algorithm extends MD-
PANDA to (1) model unknown and partially-known outbreak diseases, and (2) model the 
distributions over the probabilities of a person’s symptoms, given different diseases that a person 
could have. Additionally, Chapter 4 includes methods for performing Bayesian inference.  
Chapter 5 presents the experimental methods for evaluating the univariate and 
multivariate versions of the BH algorithm. In particular, I construct two experimental scenarios 
when there is an outbreak occurring due to some disease d, as described in Section 1.2. In 
addition, experimental results are presented and discussed for the univariate and multivariate 
versions of the algorithm. This chapter also provides statistical analyses and sensitivity analyses 
of the experimental results and performs decision analysis regarding whether and in what 
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situations it would be beneficial to model an unknown disease in the detection system. Finally, 
Chapter 6 contains conclusions and suggestions for future research.  
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2.0  BACKGROUND 
This chapter provides background knowledge that relates to the proposed dissertation research. 
The proposed Bayesian hybrid outbreak-detection algorithm (the BH algorithm) is a Bayesian 
approach that combines disease-specific and non-disease-specific detectors. I thus begin in 
Section 2.1 by describing a basic Bayesian framework of outbreak detection that combines the 
results of a suite of specific and non-specific detectors. Section 2.2 provides a brief overview of 
some commonly used outbreak detection algorithms, including both disease-specific detection 
algorithms and non-disease-specific detection algorithms, and Section 2.3 provides a brief 
overview of the evaluation methods of the outbreak detection algorithms. Section 2.4 provides 
background on choice of prior distributions in Bayesian inference, where I particularly review 
previous work on non-informative prior distributions. Since unknown-disease modeling will be 
explored in this dissertation, Section 2.5 includes some prior research on languages for 
representing unknown objects. Finally, Section 2.6 provides a brief overview about entity-
relationship models as background for introducing the disease domain in which the BH 
algorithm is evaluated. 
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2.1 BAYESIAN FRAMEWORK 
Let H be a hypothesis and E denote some available evidence. We are often interested in knowing 
the posterior probability of H in light of E, that is P(H | E). Assume we can estimate the 
likelihood P(E | H). Frequently such likelihoods are derived from a model that represents the 
probability that H generates E. A Bayesian approach requires the specification of a prior 
probability of H, namely P(H), which is our belief in H before seeing evidence E. Equation 2.1 
shows the well-known use of the Bayes’ rule to derive P(H | E). 
,
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where the sum is taken over all hypotheses H’ in a mutually exclusive and presumed exhaustive 
set S of hypotheses that are each modeled as having a non-zero prior probability. 
The hypotheses in S can be at different levels of abstraction. Consider an anomaly 
detection application in which we are monitoring population evidence E for new outbreaks of 
disease. Such evidence might include the symptoms of patients who have recently visited 
emergency departments in a given region. Suppose S includes some set of disease-specific 
disease outbreaks (e.g., outbreaks due to inhalational anthrax, SARS, and West Nile virus). 
Another hypothesis in S represents the absence of any disease outbreak in the population. 
Traditionally a Bayesian diagnostic system contains only hypotheses for specific disease 
outbreaks and for the non-outbreak condition. However, I propose to also represent all the 
diseases (known and unknown) that are not being modeled by a given set of disease-specific 
disease outbreaks. For example, such an outbreak disease could be smallpox, if smallpox is not 
modeled in the set of disease-specific disease outbreaks. As another example, such a disease 
could be a new infectious disease that has never been seen before. 
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In other words, then, the hypotheses in S are a union of the hypotheses for specific 
disease outbreaks, for the non-outbreak condition, and for unknown disease outbreaks. As 
unseen diseases are so numerous and sometimes imponderable that it is not practical (or even 
possible) to try to represent them explicitly, a primary purpose for including a model of unknown 
diseases in S is to identify patterns of evidence E that are not similar to those associated with 
non-outbreak diseases or any of the specific outbreak diseases that we are modeling.  
2.2 OVERVIEW OF OUTBREAK-DETECTION ALGORITHMS 
This dissertation describes the Bayesian anomaly-detection algorithm in the context of disease-
outbreak detection. Disease-outbreak detection is an important application domain in anomaly 
detection, which is also referred to as “biosurveillance”. The term “biosurveillance” denotes 
disease surveillance practiced by public health organizations and many other organizations that 
monitor for disease, such as hospitals, agribusinesses, and zoos (Wagner 2006). Electronic 
biosurveillance refers to the systematic collection and automated analysis of electronically 
available data with the intent of detecting outbreaks of disease rapidly (Mandl 2004). These 
electronic data come from emergency department (ED) visits, over-the-counter medication sales, 
ambulatory care visit records, and other sources. The goal of disease outbreak-detection 
algorithms is to detect outbreaks early while exhibiting few false alerts.  
This section provides a brief overview of some commonly used outbreak-detection 
algorithms, which include both specific and non-specific detection approaches. Each detection 
approach is categorized as either a frequentist method or a Bayesian method. I focus in more 
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detail on reviewing Bayesian methods, since the anomaly-detection algorithm I developed uses a 
Bayesian approach. 
Existing disease outbreak-detection algorithms can be further categorized as temporal 
detection algorithms, spatial detection algorithms, and spatio-temporal detection algorithms. 
Temporal methods operate on aggregate data that are measured only with respect to time in order 
to detect unusual temporal patterns. Spatial methods involve accumulating data over some time 
interval, removing the time information, and then searching for areas of unusually high 
incidences of events. Spatio-temporal methods use spatial and temporal data to look for areas of 
unusually high incidences of events. Because the detection algorithm in my dissertation research 
is a temporal method, in this section I only review temporal detection algorithms. Examples of 
the spatial and the spatial-temporal detection algorithms include the spatial scan statistic 
(Kulldorff 1997) and the spatio-temporal scan statistic (Kulldorff 2001). Sonesson et al. 
(Sonesson 2003) and Buckeridge (Buckeridge 2005; Buckeridge 2007) provide good reviews of 
these types of methods. 
2.2.1 Non-disease-specific detection methods 
This section provides an overview of commonly used non-disease-specific detection methods. 
2.2.1.1 Frequentist approaches Many non-specific detection algorithms use frequentist 
statistical techniques. Most of these algorithms operate on a univariate time series of aggregate 
counts of some event. That is, data only contain one piece of information per time step, as for 
example the number of patients with respiratory symptoms appearing at an emergency 
department per day. The majority of univariate algorithms model non-outbreak background 
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activity first and then detect outbreaks by examining marked deviations from that background 
activity. 
The frequentist univariate algorithms include methods from statistical quality control 
(Hutwagner 2003), regression (Serfling 1963), time series models (Reis 2003), and wavelets 
(Goldenberg 2002; Zhang 2003). These methods are reviewed in (Wong 2004) and (Moore 
2003). Some univariate detection methods described in the following sections, such as EWMA 
(Lowry 1992) and CUSUM (Crosier 1988), could be extended to multivariate versions. 
1) Statistical quality control  
Statistical quality control is an effective method of monitoring a process through some 
statistic of a production process. Many of these techniques have been used in the field of disease 
surveillance. 
A Control Chart is one of the simplest and the most commonly used statistical quality 
control methods for surveillance (Lawson 2005). The observations in the background activity are 
assumed to follow a normal distribution. The control chart consists of a center line, which is 
drawn as the process mean, and it also includes upper and lower control limits that indicate the 
threshold at which the process output is considered statistically unlikely (Banks 1989). If any 
point falls outside either the upper or the lower control limits, the process is considered to be out 
of control. Technically, the control chart method is not a temporal algorithm, because it only uses 
the information about the process contained in the current observation and the decision depends 
solely on the current observation. It has been shown that the control chart method performs 
relatively poorly for small and moderate shifts. 
CUSUM works by maintaining a cumulative sum of deviations from the mean of a 
univariate count. If the cumulative sum exceeds a threshold, the process is considered to be out 
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of control and an alert is raised. It has been shown to be more effective than a control chart at 
detecting small shifts from the mean of a process. For large shifts, Frisén and Wessman (Frisen 
1999) showed that the CUSUM method converges to the control chart method. 
EWMA (Exponentially Weighted Moving Average) utilizes all information contained in 
every observation in the process. It is an average of all the observations that have multiplying 
factors, which decrease exponentially to give different weights to different data points. 
Specifically, the weighting of each older data point decreases exponentially, giving more 
importance to recent observations while still not discarding older observations entirely. If the 
moving average exceeds some upper control limit, the process is considered to be out of control. 
According to (Montgomery 1991), EWMA is better at detecting small shifts in a process than the 
control chart method, and it has a performance similar to the CUSUM algorithm. It is also highly 
insensitive to the normality assumption. 
2) Regression 
Regression is a technique that is applied widely in biosurveillance to model background 
activity while accounting for seasonal trends and day-of-week effects. It forecasts the value for 
the current day. If the observed value is significantly different from the forecast value, then an 
alert is raised. 
The Serfling method is a cyclical (often annual) linear regression method to model 
temporal patterns of disease (Serfling 1963). The model parameters are obtained through 
regression on a training set of non-outbreak periods using the standard least squares method. 
The generalized linear mixed model (GLMM) extends the original logistic regression 
model by including random effects in the predictors (Lazarus 2002). Logistic regression is a 
regression model for binomially-distributed dependent variables (Hosmer 1989). Lazarus et al. 
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developed a system for monitoring ambulatory-care encounter records, and they used a general 
linear mixed model to estimate the daily counts for each census tract for each syndrome. In 
developing GLMM, Lazarus first estimated the model parameters from historical data. Then, the 
GLMM was applied to data of ambulatory-care encounter records from the current day in order 
to calculate the probability pit of an encounter with a diagnosis in the syndrome monitored for 
that census tract i and day t. Once pit is determined, the expectation of the number of ambulatory-
care encounters for census tract i and day t can be calculated. The method calculates the 
probability of seeing an extreme number of counts on day t assuming that the number of the 
observed counts on day t is binomially distributed. 
3) Time series models  
The regression models assume independence over the sequence of observations, thereby 
making it difficult to model observations that are correlated to each other in time. Techniques in 
time series analysis have been developed to handle data with correlation between data points in 
time, seasonality, cyclic components, and non-stationarity, which makes time series models 
applicable to the task of disease surveillance. 
ARIMA (AutoRegressive Integrated Moving Average) was first introduced by Box and 
Jenkins (Box 1976). It makes no assumption of independent data and it is able to describe 
historical visit rates and account for temporal dependency, secular trends and seasonal effects. 
An ARIMA(p, d, q) process is obtained by integrating an ARMA(p, q) model, where d is a 
positive integer that controls the level of differencing (if d = 0, this model is equivalent to an 
ARMA model) and d is also called the order of integration. The ARMA(p, q) model consists of 
two parts: an autoregressive part of order p, and a moving average part of order q. Reis and 
Mandl provide a review of the ARIMA model for biosurveillance in (Reis 2003). 
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4) Wavelets  
Wavelets are a popular pre-processing approach to smooth time series data. Wavelet 
transforms preserve both the temporal and the frequency information of the signal. In the context 
of disease surveillance, real datasets exhibit features such as noisiness, periodic variations, and 
long-term trends that do not vary periodically. Wavelets are excellent tools for modeling such 
time series (Goldenberg 2002). They work by forecasting the current data value (e.g., the 
expected emergency department visits) from historical data and then comparing the forecast with 
the actual value. Zhang (Zhang 2003) applied a multiresolution-based predictor in order to 
forecast the current data value, i.e., independently forecasting by predictors from other 
resolutions. The expected value for the current value is obtained by summing all the predictions 
from all resolutions. Some common prediction models, such as the autoregressive model 
(Goldenberg 2002), can be applied to each individual resolution for prediction. 
5) Change-point statistics  
The change-point statistics method (Carlstein 1988) is a popular tool in the statistics 
literature for detecting when an underlying process changes in terms of the mean or other 
measures of location. This technique considers a sequence of independent random variables {Xi: 
1 ≤ i ≤ n} having cdf F for i ≤ θn and cdf G otherwise, that is, a time series of signals in which 
each observation is generated independently from some fixed but unknown distribution F until a 
certain unknown time T = θn, after which they are instead generated independently from some 
fixed but unknown distribution G. The objective is to estimate the change-point ( )1,0∈θ . 
2.2.1.2 Bayesian approaches Bayesian non-disease-specific approaches for anomaly detection 
include hidden Markov models (Rabiner 1989), Kalman filters (Hamilton 1994), Bayes 
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sequential change-point techniques (Shiryaev 1978), dynamic linear models (West 1989), and 
Bayesian clustering (Banfield 1993). 
Hidden Markov models (HMMs) represent a sequence of observations that emanate from 
a chain of unobserved discrete variables (Rabiner 1989). LeStrat and Carrat (LeStrat 1999) 
applied HMMs to detect an influenza-like illness (ILI) from a univariate time series of ILI data. 
They proposed to detect outbreak and non-outbreak phases of influenza by modeling the 
incidence rates of influenza-like illnesses with HMMs using a mixture of Gaussian distributions. 
Rath et al. (Rath 2003) analyzed the same dataset and showed that better detection accuracy can 
be achieved by modeling the epidemic rates with a Gaussian distribution and the non-epidemic 
rates with an exponential distribution. They both used the EM algorithm (Dempster 1977) on 
historical data to obtain the maximum likelihood estimates for the model parameters. 
Kalman filter (Harvey 1981) is similar to the HMM approach, but in this method the 
hidden state is a continuous variable. According to (Buckeridge 2005), adaptive Kalman filters 
have been used to predict expected values of sales of over-the-counter pharmaceuticals for each 
day. It has also been applied for monitoring AIDS surveillance data (Stroup 1995). 
Bayes sequential change-point technique Shiryaev (Shiryaev 1978) formulated the 
problem of optimal sequential detection of the change point in a Bayesian framework by putting 
a geometric prior distribution on the unknown change point. Baron (Baron 2002) proposed a 
hierarchical Bayesian change-point model for influenza outbreaks. Non-outbreak and outbreak 
phases of influenza are modeled as Gaussian distributions with different parameters. These 
parameters were estimated from historical data. Prior probabilities of a change point depend on 
(random) factors that affect the spread of influenza. 
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Dynamic linear models (DLMs) are implemented by updating priors to obtain posteriors 
using a sequential approach for forecasting. To start a DLM modeling process, it is necessary to 
specify the initial priors before arrival of the first observation of the time series. Nobre et al. 
(Nobre 2001) modeled the stochastic trend and the seasonal effect of a time series of reported 
number of cases of hepatitis A and malaria for the United States using the linear growth models 
described in (West 1989). They used a non-informative prior, a normal distribution with mean 
zero and a large variance, as the initial prior for the vector of model parameters that are related to 
the seasonal trend and the stochastic trend. Palomo (Palomo 2005) described a similar method 
but using initial priors specified by experts. 
Bayesian clustering considers probability models for partitions of a set of m elements, 
that is, it determines the component membership of these elements. Models are specified in terms 
of the conditional probability of either joining an already existing cluster or forming a new one. 
The model-based clustering (MBC) approach (Dasgupta 1998) is an example of the Bayesian 
clustering method. The MBC method was originally proposed by Banfield and Raftery (Banfield 
1993) for clustering of d-dimensional data based on a mixture of Gaussian distributions. 
Dasgupta and Raftery (Dasgupta 1998) later extended this approach and used the EM algorithm 
for estimating parameters. In model-based clustering, clusters are formed based on the posterior 
probability of component membership for each data point. Given independent observations X1, 
X2, …, Xm, the likelihood for a mixture model with K components is 
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The MBC method based on multivariate Gaussian mixture models has been used in 
applications such as identification of flaws in textiles from images (Campbell 1997; Campbell 
1999), detection of minefields and seismic faults (Dasgupta 1998), and classification of 
astronomical data (Mukherjee 1998). 
2.2.2 Disease-specific detection methods 
This section provides an overview of commonly used disease-specific detection methods. 
2.2.2.1 Frequentist approaches To my knowledge, there is no frequentist detection algorithm 
designed to monitor for a specific disease, such as inhalational tularemia, although frequentist 
algorithms have been applied to detect particular syndromes, such as respiratory illness. 
2.2.2.2 Bayesian approaches In the context of disease outbreak detection, disease-specific 
detection algorithms are designed to look for anticipated anomalous patterns in data with the 
purpose of monitoring for a particular disease outbreak. This section provides a brief overview of 
two disease-specific detection algorithms: BARD (Hogan 2007) and PANDA (Cooper 2004), 
which were both designed to monitor an outbreak of inhalational anthrax due to aerosol releases 
of B. anthracis spores. 
BARD (Bayesian Aerosol Release Detector) analyzes both medical surveillance data and 
meteorological data for early detection and characterization of outdoor releases of B. anthracis. 
The approach is general and could be applied to outbreaks due to other biological agents that can 
be disseminated by outdoor aerosol release. BARD performs a combined analysis of 
meteorological data and medical surveillance data using models of both. The system computes 
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the posterior probability of a release given these data. It also computes a posterior distribution 
over the release location, quantity, and time. In addition, BARD is used for simulating outbreaks 
due to inhalational anthrax. Simulated anthrax cases generated by BARD were used in (Cooper 
2004). 
PANDA (Population-wide ANomaly Detection and Assessment) uses a multivariate 
Bayesian approach to biosurveillance. In particular, a causal Bayesian network is used to model 
an outbreak due to the windborne spread of anthrax. Unlike BARD, however, PANDA does not 
contain a meteorological model. Each person in the population being monitored for an outbreak 
is explicitly modeled using a subnetwork. Specifically, each person in the population is 
represented using a six-node network structure that includes disease status, patient symptoms, 
and other personal information, while avoiding any information that could personally identify the 
individual (e.g., name, social security number, and home street address). The primary clinical 
information about each person is whether he or she presented to the ED with a respiratory chief 
complaint (e.g., a cough). The subnetworks are connected through a common set of nodes that 
represent the disease outbreak conditions, such as the hypothesized location and time of release 
of anthrax spores. 
Given current data about individuals in the population, inferences are performed on a 
Bayesian network to derive the posterior probabilities of outbreak diseases in the population. 
Since the resulting Bayesian network requires millions of nodes to model a medium-sized U.S. 
metropolitan population, PANDA uses several optimization methods to keep the model size 
manageable and the inference time tractable. In particular, if the subnetworks representing one or 
more individuals are identical in structure and parameters, they are modeled using a single 
subpopulation subnetwork, which is called an equivalence class. Furthermore, PANDA uses an 
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incremental updating method that only updates the network state based on new information 
about an individual in the population. 
Cooper et al. (Cooper 2006) further extended PANDA and developed an outbreak 
detection system called MD-PANDA (Multiple-Disease PANDA) that was applied to monitor 
for outbreaks of CDC Category A diseases (anthrax, botulism, plague, small pox, tularemia, and 
viral hemorrhagic fevers) and several other diseases, namely, influenza, cryptosporidiosis, 
hepatitis A and asthma. MD-PANDA takes as input a time series of 54 possible emergency 
department chief complaints, and each hour it outputs the posterior probability of the outbreak 
diseases mentioned above.  
According to the Bayesian non-disease-specific and disease-specific methods described 
above, choices of prior distributions can generally be divided into three categories: (1) estimating 
the prior from historical data such as hidden Markov models, Bayes sequential change-point 
techniques, and Bayesian clustering techniques, (2) using non-informative priors, then 
sequentially updating the priors when new data becomes available, as in dynamic linear models, 
and (3) assessing the priors using expert knowledge such as PANDA and BARD detection 
methods.  
2.2.3 Methods combining disease-specific and non-disease-specific detectors 
As described in Chapter 1, a disease-specific detection method and a non-disease-specific 
detection method each has its own advantages and disadvantages in detecting different patterns 
of anomalous events. 
A specific detection method is designed to monitor for a specific type of disease 
outbreak, thus making it better at detecting that specific type of outbreak or a similar one. 
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Specific detection methods are readily implemented using Bayesian methods (e.g., the specific 
detection algorithms described in Section 2.2.2.2), which allow us to incorporate expert 
assessments and any prior knowledge we may have. The probabilistic outputs of the specific 
detection algorithms can be further used in the public health community to guide the response 
and actions of the public health officers. However, specific detection methods, as the name 
implies, may not be as effective at detecting an outbreak disease that is unanticipated or 
unknown. 
Non-specific detection methods are designed for monitoring a wide range of anomalous 
patterns in data, but they may be less effective at detecting any particular disease, relative to 
explicitly modeling that disease. Most non-specific detection algorithms are implemented using 
frequentist approaches, as described in Section 2.2.1.1. Bayesian approaches have been 
developed that can also be applied to perform non-specific anomaly detection as described in 
Section 2.2.1.2. 
To my knowledge, there is no detection system that combines specific and non-specific 
detectors. The proposed BH algorithm is a Bayesian approach that combines specific and non-
specific detectors such that the algorithm is vigilant in watching for anomalous events due to 
both known and unknown causes. This dissertation describes the BH algorithm in the context of 
disease-outbreak detection. 
2.3 EVALUATION OF OUTBREAK-DETECTION ALGORITHMS 
Outbreak detection algorithms are designed to detect outbreaks rapidly by monitoring routinely 
collected data and raising an alert upon discovery of any significant deviations from the norm. 
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These algorithms are intended to exhibit few false alerts and to detect outbreaks early. Therefore, 
evaluations on the effectiveness and timeliness of the algorithms are important. Many metrics 
have been used to evaluate the performances of outbreak detection algorithms (Table 2.1). 
Table 2.1 Evaluation methods used for outbreak detection algorithms 
Evaluation 
methods Description 
ARL0 The expected time until the first false alarm 
ARL1 The expected delay before detecting an outbreak when there is an outbreak at the initiation of surveillance 
CED(t) The expected delay before detecting an outbreak when the outbreak occurs at time point t 
PSD(d,t) The probability that the outbreak is detected with a delay no longer than d 
PV(t) The probability that the outbreak occurs when an alarm is triggered 
Sensitivity The probability of an alarm given that an outbreak occurs 
False positive 
rate The probability of an alarm given that an outbreak does not occur 
ROC curve The curve defined by plotting sensitivity versus false positive rate 
AMOC curve The curve defined by plotting the expected time to detection (since the outbreak began) versus false positive rate 
FROC curve The curve defined by plotting the fraction of outbreak locations detected versus false positive rate 
 
There are a group of quality assurance measures that have been used to characterize the 
behavior of outbreak detection algorithms (Sonesson 2003). Evaluation studies of change-point 
detection algorithms tend to employ these metrics. 
• The average in-control run length (ARL0) measures the expected time until the 
first false alarm, which, in another way, estimates false positive alerts per time. 
However, this measure is only a method for estimating in-control performance 
and does not address the effectiveness of the algorithm after an outbreak occurs.  
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• The average out-of-control run length (ARL1) measures the expected delay before 
detecting an outbreak when there is an outbreak at the initiation of surveillance.  
• The conditional expected delay as a function of the change point (CED(t)), which 
measures the expected delay before detecting an outbreak when the outbreak 
occurs at time point t.  
All the three methods evaluate the timeliness of an outbreak-detection algorithm, but do 
not measure the accuracy of an outbreak-detection algorithm. 
• The probability of successful detection (PSD(d,t)) as a function of a limited delay 
time d and a change point t, which is the probability that the outbreak is detected 
with a delay no longer than d. In the applications of disease outbreak detection, 
especially of an infectious disease where only a limited delay time can be 
tolerated, this measure is particularly useful. 
• The predictive value of an alarm (PV(t)), as a function of the time of the alarm t, 
is the probability that an outbreak occurs when an alarm is triggered. If an alarm 
is triggered, various preventive actions should be taken. This measure allows us to 
be able to choose what actions to take by estimating how much trust to put in an 
alarm. 
Both methods above do not evaluate the probabilities that an outbreak detection 
algorithm raises a false alert under the non-outbreak condition. 
Other common performance measures include the direct reporting of sensitivity and false 
positive rates (fpr). Sensitivity (true positive rate) is the probability of an alarm given an 
outbreak, and it estimates the chance that a future outbreak will ever be detected. False positive 
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rate is the probability of an alarm given that there is no outbreak, which calculates the expected 
number of false alerts of an outbreak per unit time.  
When calculated over a range of parameter settings for an algorithm, the set of 
sensitivity/false positive rate values can be plotted to determine the receiver operating 
characteristic (ROC) curve (Burkom 2003). The ROC curves are commonly used summaries for 
assessing the tradeoff between sensitivity and fpr. 
The ability to detect outbreaks in a timely manner is an issue of central importance 
(Mostashari 2003). While the sensitivity, fpr and ROC curves summarize the ability of an 
algorithm to detect outbreaks, they do not evaluate the timeliness of detection. The Activity 
Monitoring Operating Characteristic (AMOC) curve (Fawcett 1999), which is adopted from the 
area of financial transaction, plots the expected time to detection (since the outbreak began) 
versus the false positive rate. Outbreaks have different lengths and could be undetected by the 
algorithm. Therefore sometimes median time to detection is used instead of mean time for 
robustness (Siegrist 2004). One possible approach for missed detections is to use the duration of 
the outbreak, or the interval between the beginning of the outbreak and likely detection by 
another means, such as reporting by clinicians or public health officers. 
A limitation of all above metrics is that they do not evaluate the ability of an algorithm to 
identify the geographic location of an outbreak. Free Response Operating Characteristic (FROC) 
curve (Chakraborty 2002) is a method to evaluate the spatial accuracy of an algorithm, which is 
defined by plotting the fraction of outbreak locations detected against false positive rate. But this 
approach does not evaluate the timeliness of detection either. 
Since this dissertation reports many of its experimental results using AMOC curves, 
which were mentioned above, I provide additional detail about them in the remainder of this 
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section. Activity monitoring involves monitoring the behavior of a large population of entities 
for interesting events requiring action. As mentioned, the AMOC curve plots the expected time 
to detection (since the outbreak began) versus the false alert rate. I use the phrase false alert or 
alarm rate, instead of the false positive rate in the context of disease outbreak detection, to 
differentiate the former from measures used in the evaluation of traditional classification 
problems, in which false positive rate is calculated as the proportion of negative instances that 
were erroneously reported as being positive. In the application of disease outbreak detection, 
false alert rate is calculated as the expected number of false alerts per unit time. See (Fawcett 
1999) for details regarding how to plot AMOC curves. 
2.4 CHOICE OF A PRIOR DISTRIBUTION 
Modeling an unknown disease using Bayesian methods involves specifying the prior distribution 
of some characteristics that the disease manifests, as for example the visit rates of patients to the 
ED with the symptom fever. The prior distribution described here is a parameter prior 
distribution, which will be further used to derive the posterior probability of an outbreak due to 
the unknown disease. 
According to (Castillo 2007), three common choices of priors are conjugate priors, non-
conjugate priors, and non-informative priors, in which non-informative priors are usually non-
conjugate as well. 
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2.4.1 Conjugate priors  
Conjugate priors result in posteriors that have the same type of distribution (with different 
parameters) as the prior distribution, so conjugacy is a closure property which can simplify 
computations. For example, the Beta distribution is a conjugate prior to the Binomial likelihood, 
which yields a closed-form posterior of the Beta distribution with updated parameter values. For 
a large collection of conjugate priors, see (Gelman 1995). In some applications, “tuning” a 
conjugate prior to reflect the knowledge of the user is a difficult problem, and even when tuning 
is done, the conjugate priors might not be able to reflect the user’s knowledge well. 
2.4.2 Non-conjugate priors  
Non-conjugate priors result in posteriors that have a different parametric form than the priors, 
which does not satisfy the closure property. For example, suppose that y1, …, yn are independent 
samples from a Cauchy distribution with unknown center θ and known scale 1: p(yi | θ) ∝  1 / (1 
+ (yi - θ)2). Suppose the prior distribution for θ is uniform on [0, 1]. Then the posterior 
probability P(θ | y1, …, yn) is calculated as follows: 
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Solving the integral shown in Equation 2.2 can be difficult and may require approximation 
methods such as Markov chain Monte Carlo (MCMC) methods (Andrieu 2003). 
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2.4.3 Non-informative priors  
Non-informative priors are sometimes called “objective priors”, and the resulting analysis is 
called objective Bayesian analysis. We use these priors to reflect a situation where there is a 
relative lack of knowledge about a parameter. Non-informative priors are also called “reference 
priors” in the sense of being a default choice that is used in a situation when one knows little 
about a parameter. This section provides an overview of non-informative prior distributions 
because my dissertation research involves unknown-disease modeling using non-informative 
priors. 
According to (Castillo 2007), a uniform distribution over a subrange of a parameter is 
informative. Such a prior is non-informative only if the parameter has a range that overlaps with 
that of the uniform distribution. For example, a uniform distribution on the interval [0,1] for the 
Binomial proportion parameter p is non-informative, since parameter p is defined on the range 
[0,1] that coincides with the range of the uniform distribution on the interval [0,1]. 
Proper and improper prior distributions 
One practical problem associated with non-informative priors is the requirement that the 
posterior distribution be proper. According to (Gelman 1995), a prior distribution ( )θπ  is proper 
if it does not depend on data and integrates to 1. Often non-informative priors on continuous, 
unbounded variables are improper (Lawson 2009). That is, the integration of the prior 
distribution of the random variable θ over its range (Ω) is not finite: 
( ) ∞=∫Ω θθπ d . 
Nonetheless, under the right conditions, improper prior distributions can still lead to proper 
posterior distributions (Gelman 1995), which is the most critical issue. 
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This dissertation research uses a non-informative prior (a uniform distribution) to model 
the parameter, namely the probability of a symptom in a disease, and this parameter has a 
bounded range on the interval [0,1]. Thus, this non-informative prior is proper.  
In most cases, non-informative priors in the medical domain are proper, because the 
parameters to be modeled in the domain are often bounded in particular ranges due to patients’ 
physical limits, as for example a patient’s temperature.  
Some methods for constructing non-informative priors are briefly reviewed as follows: 
1) Laplace and the principle of insufficient reason 
Laplace introduced the principle of insufficient reason, in which he suggested using a 
uniform prior to assign equal probability to each point in the parameter space if the parameter 
space is finite. When the parameter space is continuous, it is natural to apply the principle of 
insufficient reason to obtain a flat prior, that is, a prior that is equal to a positive constant. 
2) Jeffreys’ invariance principle 
Jeffreys (Jeffreys 1961) initiated the idea of using a formal rule to define a non-
informative prior. He used the concept of invariance as a formal rule. If ( )θπ  is a non-
informative prior for θ that is derived using some rule, then the same rule should lead to 
( ) ( )
ϕ
θ
θπϕπ
d
d
=  
as a non-informative prior for φ, where φ = h(θ) is a one-to-one transformation. Jeffreys’ general 
principle is that any rule for determining the prior distribution ( )θπ  should lead to an equivalent 
result if applied to the transformed parameter; that is, posterior inferences based on ( )ϕπ  will be 
the same as those based on ( )θπ . Jeffreys also described a non-informative prior that meets the 
invariance principle, which is 
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( ) ( ) 21θθπ I∝ ,                                                          (2.3) 
where I(θ) is Fisher’s information for the parameter θ if observing y = (y1, …, yn) of iid 
observations. I(θ) is represented as follows: 
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3) Maximum entropy 
If Θ = {θ1, …, θn} is finite and π is a probability mass function on Θ, then the entropy of 
π, which is meant to capture the amount of uncertainty implied by π, is defined by 
( ) ( ) ( )iiE πππ log∑−= . Jaynes (Jaynes 1957; Jaynes 1968) is the main developer of entropy-
based methods. Priors with larger entropy are regarded as being less informative, and the method 
of maximum entropy involves selecting the prior that maximizes the entropy Ε(π). If the problem 
has no further constraints, then the prior with maximum entropy is the uniform prior. 
4) The Berger-Bernardo method 
Bernardo (Bernardo 1979) proposed a method for constructing priors based on the notion 
of missing information. Let X1n = (X1, …, Xn) be a vector of n iid random variables and let  
( ) ( )( )θπθπ ,| 1nn xK  be the Kullback-Leibler distance between the posterior density and the prior 
density, where ( ) ( )( ) ( ) ( ) ( )( )∫= θθπθπθπθπθπ dxxxK nnnn 111 |log|,| .  
Let ( ) ( )( )( )θπθππ ,| 1nnn xKEK =  be the expected gain in information. Bernardo’s idea 
was to think of  for a large n as a measure of the missing information in the experiment. 
Loosely, this is the gain in information provided by the experiment. He suggested constructing a 
prior that maximizes ππ nn KK ∞→∞ = lim . However, K∞
π is usually infinite. Bernardo found the 
prior πn that maximizes Knπ to circumvent this problem. He then computed the limit of the 
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corresponding sequence of posteriors and defined the Berger-Bernardo prior as the prior that 
produces the limiting posterior via Bayes’ theorem. When there are no nuisance parameters and 
certain regularity conditions are satisfied, this prior turns out to be the prior shown in Equation 
2.3 for continuous parameter spaces and the uniform prior for finite parameter spaces. 
Kass and Wasserman (Kass 1996) provide an excellent review of all the above methods 
for establishing non-informative priors. Besides the above methods, they also discussed methods 
based on data-translated likelihoods (Box 1973), coverage matching methods (Welch 1963), 
Zellner’s method (Zellner 1977), and decision-theoretic methods (Hartigan 1965), as well as 
others. They have found that several of the methods rely specifically on asymptotic theory when 
sample sizes are very large (relative to the number of parameters being estimated). For example, 
Jeffreys’ invariance principle, the Berger-Bernardo rule, and coverage matching methods are all 
built from asymptotic theory. They concluded that these methods all lead to Jeffreys’ invariance 
principle or some modification of it. 
2.4.4 Why use the Beta distribution as a prior belief? 
The Beta distribution is a continuous probability distribution that is parameterized by two 
positive shape parameters (α and β). The Beta distribution has been used for a wide variety of 
applications because it can flexibly specify a range of forms of distributions from peaked  (α, β > 
1) to uniform (α = β = 1) and from U-shaped (0 < α, β < 1) to skewed or either monotonically 
decreasing or increasing (Gelman 1995).  
The Beta distribution can be used to represent the uncertainty or random variation of a 
rate or proportion. In particular, the Beta distribution is a conjugate prior of the Binomial 
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likelihood function and, as such, it is often used to describe the uncertainty about a Binomial 
probability parameter, as I do in this dissertation. 
There is a long history of using the Beta distribution to represent belief about a relative 
frequency. In the 19th century G.F. Hardy (Hardy 1889) and W.A. Whitworth (Whitworth 1897) 
proposed quantifying prior beliefs with Beta distributions. 
Neapolitan (Neapolitan 2003) presented two arguments for why we should use Beta 
distributions. First, consider the two concepts of a relative frequency and an updated density 
function. Neapolitan used the term relative frequency, as opposed to the term probability, to 
represent the propensity that an event happens, while the term probability is used to refer to a 
subjective probability (degree of belief). Given a sample, the density function of the relative 
frequency conditional on data is called the updated density function of the relative frequency. 
The first argument that Neapolitan presented is that if we initially consider all numbers in 
[0, 1] equally likely to be the value of a relative frequency and therefore use the uniform 
distribution to represent our prior beliefs, it is a mathematical consequence of the theory that the 
updated density function is Beta (Casella 2002). 
The second argument is a theorem proved by Zabell (Zabell 1982), which states that if 
the assumptions of exchangeability and Johnson’s sufficientness postulate hold, then that 
individual must use the Beta distribution to quantify any prior beliefs about a relative frequency. 
Zabell’s theorem actually is concerning the Dirichlet distribution, which is a generalization of the 
Beta distribution. 
I now present the formal definition of exchangeability in terms of a finite and infinite 
sequence of random variables, respectively, and Johnson’s sufficientness postulate, as below: 
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Let D = {X1, X2, …, XM} be an ordered set (sequence) of random variables, each 
with the same r alternatives 1, 2, …, r. If for every two sets of values d’ and d” 
such that each alternative occurs the same number of times in d’ and d”, we have 
P(D = d’) = P(D = d”), the sequence is said to be finite exchangeable. 
 
Let X1, X2, … be an infinite sequence of random variables, each with the same r 
alternatives 1, 2, … r. If for every M, the sequence of the first M variables is finite 
exchangeable, the sequence if said to infinite exchangeable. 
 
Let X1, …, XM, XM+1 be a sequence of random variables, each with the same r 
alternatives 1, 2, …, r, and let D = {X1, X2, …, XM}. Suppose for every set of 
values d of the variables in D, we have  
P(XM+1 = k | D = d) = gk (sk, M), 
where sk is the number of times k occurs in d. That is, the probability the next 
variable is equal to k is a function gk only of how many times k occurs in d and the 
number of variables in D. Then Johnson’s sufficientness postulate is said to hold 
for the sequence. 
 
Note that the use of the Dirichlet distribution to quantify our prior beliefs on relative 
frequencies concerns only the case in which we know the number of values of the variable in 
advance. For example, we know a die can land six ways, and we know a patient either does or 
does not have anthrax. In this dissertation research, expert judgments are used to quantify the 
prior beliefs on the relative frequency of incidence of a disease symptom for an outbreak disease, 
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as for example the relative frequency of cough in anthrax, which is modeled as a binary variable. 
Thus, the Beta distribution, which is a special case of the Dirichlet distribution, can be used in 
this dissertation research to quantify the prior beliefs. 
Using the Beta distribution as a prior for the Binomial likelihood, Tuyl et al. also suggest 
using the Bayes-Laplace Beta(1, 1) as the natural representation of the prior ignorance (Tuyl 
2009). They argued that the posterior predictive distribution resulting from Beta-Binomial (or 
multinomial) models, when viewed via a hypergeometric-like representation (Weisstein 2009), 
suggests the uniform prior (Beta(1, 1)) on the proportion parameter for these models. Let P(y | m, 
x, n) be the posterior probability of y successes in m trials given x successes in n trials, and let 
P(x | n, y, m) be defined analogously. They further expressed P(y | m, x, n) using a 
hypergeometric-like representation, which suggests the uniform prior Beta (1, 1), leading to 
symmetry in y and x. That is, Beta(1, 1) prior reflects the fact that y and x have m + 1 and n + 1 
possible values, respectively, and the ratio of P(y | m, x, n) and P(x | n, y, m) is 1 when m = n so 
that P(y | m, x, n) equals P(x | n, y, m). These facts seem reasonable, but follows from the Beta(1, 
1) prior only. 
2.4.5 Empirical Bayes methods  
A prior distribution for an unknown parameter θ, π(θ), has its own parameters, usually referred to 
as hyperparameters. The hyperparameters can be obtained, for example, by assessing expert 
opinions. According to (Castillo 2007), hyperparameters can also be assumed to be “random 
variables that themselves have a prior distribution in an additional level of a hierarchy of 
parameters and prior distributions that can be repeated at several levels up to the highest level in 
the hierarchy in which all parameters are assumed known”. Empirical Bayes methods use data to 
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estimate the hyperparameters by applying techniques such as maximum likelihood (Lehmann 
1998) or the method of moments (Gelman 1995). Many Bayesian detection algorithms reviewed 
in Section 2.2.1.2, such as the hidden Markov models, Kalman filters, and the model-based 
clustering method, use empirical Bayes methods to estimate the hyperparameters. 
2.4.6 Mixture priors  
A finite M-component mixture prior (Murdoch 2001) is defined as ( ) ( )∑ =∝
M
i ii1
θπτθπ , where 
iτ  is the mixing parameter, ( )θπ i  is the prior distribution for the ith component, and 11 =∑ =
M
i i
τ . 
Gajewski and Mayo (Gajewski 2006) use a mixture of informative prior distributions, which 
come from several sources of information, for example, from two (or more) clinicians. In 
particular, they used a mixture of Beta distributions. Because the Beta distribution is a conjugate 
prior for the Binomial likelihood, it is easy to show that a Binomial likelihood with a prior of a 
mixture of Beta distributions has a posterior distribution that is also a mixture of Beta 
distributions. As described in the section on conjugate priors, this conjugacy results in a closed-
form posterior, which simplifies computation. 
In this dissertation research, I have used a non-informative prior to model unknown 
diseases and a mixture of priors to model partially-known diseases. The mixture of priors 
consists of priors that are informative for known (modeled) diseases and non-informative for 
conditions we know little about. I thus call this mixture of priors a semi-informative prior. 
As described in Chapter 1, the disease modeling problem is essentially a problem of 
choosing a prior. Accordingly, this dissertation explores the disease modeling space spanning 
from using non-informative priors to semi-informative priors to informative priors. 
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2.5 UNKNOWN-OBJECT REPRESENTATION 
As this dissertation research involves unknown-disease modeling, this section provides a brief 
review of some prior research related to unknown objects and unknown-object modeling. In 
particular, several methods are reviewed in this section, including probabilistic graphical models, 
first-order probabilistic languages (FOPLs), Bayesian Logic (BLOG), and Nonparameteric 
Bayesian Logic (NP-BLOG). 
A general problem in AI is that intelligent systems must represent and reason about 
objects, but those objects may not be known a priori and may not be directly and uniquely 
identified by a perceptual process. Many AI applications must deal with unknown objects.  
One such application is population estimation, as for example estimating the population 
of a certain animal species in an area by marking animals that are caught in one sweep through 
the area and looking at the fraction of marked animals in a subsequent sweep (Borchers 2002). 
The goal of this application is to estimate the number of unknown objects (Milch 2006).  
Another application is solving a multiple-target tracking problem. One central problem in 
multiple-target tracking is data association, i.e., the problem of determining the correct 
correspondence between measurements and existing tracked objects, as for example radar blips 
and hypothesized aircrafts (Bar-Shalom 1988). This application differs from the population 
estimation problem in that one is no longer interested in the number of individual objects; 
instead, tracking individual objects is the goal. 
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2.5.1 Probabilistic graphical models 
A graph comprises nodes connected by arcs (or edges). Probabilistic graphical models are graphs 
in which nodes represent random variables, and the arcs represent probabilistic relationships 
between these variables. Hence, they provide a compact representation of joint probability 
distributions over all of the random variables (Bishop 2006). 
Uncertainty in data association has been addressed using probabilistic graphical models 
since the 1960s (Sittler 1964). Consider probabilistic models used for multiple-target tracking. 
They represent targets moving over time and model dependency between observations and the 
true target positions. If we observe the positions of blips on a radar screen over several time 
steps, we can use such a model to compute the probability that two particular blips came from 
the same aircraft. However, as the number of observations increase, performing such 
computations becomes computationally intractable, because we need to consider all possible 
mappings between observations and underlying objects. 
Standard graphical models are propositional rather than first-order. That is, they do not 
support quantification over objects. For example, if we want to reason about the disease status of 
N people in the population, we need to repeat the portions of the graph that deal with one person 
N times. 
2.5.2 First-order probabilistic languages (FOPLs) 
There has also been significant work on first-order probabilistic languages (FOPLs) that can 
represent multiple objects and the relations between them (Gilks 1994; Koller 1998). These 
languages allow us to define indexed families of random variables. For example, if we want to 
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define the disease status of person i on day t, we can use disease_status(i, t). However, most 
FOPLs assume that the only objects that exist are the ones explicitly defined. This assumption 
restricts FOPLs to be used in multiple-target tracking applications, where we might want to 
reason about objects that are not observed at all. 
2.5.3 Bayesian logic (BLOG) 
Milch, et al. (Milch 2007) developed a representation language called Bayesian LOGic (BLOG) 
that defines probability distributions over outcomes with varying sets of objects and unknown 
objects. BLOG defines generative models that create first-order model structures by adding 
objects and setting function values. A model structure corresponds to a possible world, which is 
constructed by adding objects iteratively and even recursively via generating functions. This 
generative process allows a BLOG model to define a varying and unbounded number of objects.  
The unknown object that a BLOG model defines involves number uncertainty, existence 
uncertainty, and identity uncertainty. I describe these types of uncertainty using examples of a 
simplified version of the multi-target tracking problem and a citation-matching problem. See 
(Milch 2007) for a detailed description of these examples. 
Example 2.1: An unknown number of aircraft exist in some volume of airspace. An aircraft’s 
state (position and velocity) at each time step depends on its state at the previous time step. We 
observe the area with radar: aircraft may appear as identical blips on a radar screen. Each blip 
gives the approximate position of the aircraft that generated it. However, some blips may be 
false detections, and some aircraft may not be detected. Which aircraft exists, and what are their 
trajectories? Are there any aircraft that are not observed? 
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Number uncertainty involves dealing with an unknown number of objects. In Example 
2.1, the number of aircrafts may vary in possible worlds. In the generative process, number 
uncertainty corresponds to a number statement with a single generating function, such as the 
statement #Aircraft ~ NumAircraftPrior() (on line 3 of Figure 2.1) that represents sampling the 
number of aircrafts in the area.  
 
Existence uncertainty is modeled with generating functions. The generative process 
constructs a world by adding objects whose existence and properties depend on those of objects 
already created. In such a process, the existence of objects may be determined by many random 
variables, not just a single population-sized variable. Lines 1-2 of Figure 2.1 represent origin 
function declarations. An origin function must take a single argument of some type (namely Blip 
in the example). Generative steps that add objects to the world are described by number 
statements, such as line 7 of Figure 2.1: 
#Blip(Source = a, Time = t) ~ DetectionCPD(State(a, t)); 
01 type Author; type Pulication; type Citation; 
02 #Author ~ NumAuthorsPrior(); 
03 #Publications(Author = a) ~ NumPubsPrior(); 
04 Name(a) ~ NamePrior(); 
05 Title(p) ~ TitlePrior(); 
 
06 PubCited(c) ~ Uniform({Publication p}); 
 
07 Text(c) ~ NoisyCitationGrammar(Title(PubCited(c)), 
           Name(Author(PubCited(c)))); 
Figure 2.2 BLOG model for the citation-matching problem. 
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This statement says that for each aircraft a and time step t, the process adds some number of 
blips, and each of these added blips b has the property that Source(b) = a and Time(b) = t. 
 Identity uncertainty is the most relevant to the uncertainty that is addressed in this 
dissertation. The citation-matching problem described in (Pasula 2003) involves this type of 
uncertainty. As for each citation, we would like to recover its true title and authors. For example, 
the following citations from the CiteSeer database probably refer to the same paper: 
Kozierok, Robin, and Maes, Pattie, A Learning Interface Agent for Meeting 
Scheduling, Proceedings of the 1993 International Workshop on Intelligent user 
Interfaces, ACM Press, NY. 
R. Kozierok and P. Maes. A learning interface agent for scheduling meetings. In 
W. D. Gray, W. E. Heey, and D. Murray, editors, Proc. of the International 
Workshop on Intelligent User Interfaces, Orlando FL, New York, 1993. ACM 
Press. 
The BLOG model for this citation-matching problem is shown in Figure 2.2 with the 
function declaration statements omitted. BLOG resolves the identity uncertainty by first 
sampling the total number of authors from some distribution (line 2); then for each author a, 
sample the number of publications by that author (line 3), using the number statements described 
above. Then it samples author names and publication titles using their respective prior 
distributions, e.g., Name(a) ~ NamePrior() and Title(p) ~ TitleDist() in line 4 and 5. Next, for each 
citation, sample the publication cited by choosing uniformly at random from the set of 
publications. Finally, generate the citation text using a noisy formatting distribution that allows 
for errors and abbreviations in the title and author names. See (Milch 2007) for a detailed 
description of this process. 
 
BLOG is a representational language for defining probability models over objects in the 
world – it just provides a framework for the generative process that constructs the world. 
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However, it does not specify explicitly how to estimate the prior distributions for objects of 
various types, for example, the publication titles and author names in the above citation-
matching problem.  
The BH algorithm described in this dissertation uses the MD-PANDA model as an 
experimental domain to construct a “world” for monitoring the disease-outbreak status in the 
population. It uses a non-informative prior distribution for modeling an unknown outbreak 
disease that we have almost no knowledge of and a mixture prior distribution for modeling a 
partially-known outbreak disease that might manifest some disease symptoms, wherein a mixture 
component is based on the properties of a known disease. The proposed prior distributions 
described in the dissertation could be used together with BLOG-like representations or with 
graphical models (e.g., Bayesian networks) to model under uncertainty the unknown causes of 
events. In this dissertation, I use Bayesian networks. 
In addition, compared with the developed inference methods in probabilistic models (e.g., 
Bayesian networks), much work remains to be done on BLOG. Besides rejection sampling and 
likelihood weighting algorithms, BLOG needs more efficient and practical inference methods to 
perform inference on real-world problems. 
2.5.4 Nonparametric Bayesian logic (NP-BLOG) 
As an alternative to explicitly defining a prior distribution over some unknown object, one could 
use the nonparametric version of BLOG proposed by Carbonetto et al. (Carbonetto 2005), which 
incorporates Dirichlet process mixture models.  
As for the citation-matching problem described in Section 2.4.3, the NP-BLOG model 
follows a similar generative approach as the BLOG model, the key difference being that it 
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samples collections of unknown objects from Dirichlet processes, and it allows for uncertainty in 
the order of authors in publications. See (Carbonetto 2005) for a detailed description of the NP-
BLOG model for the citation-matching problem. 
However, Carbonetto et al. did not specify explicitly how to estimate the prior 
distributions for objects, such as NamePrior and TitlePrior in Figure 2.2. They postponed the 
parameterizations to future work.  
Both BLOG models and NP-BLOG models have left out one piece of puzzle: how to 
specify the prior distributions for objects of various types. For the citation-matching problem, 
Pasula et al. (Pasula 2003) obtained state-of-the-art accuracy using reasonably simple prior 
distributions for publication titles and author names, estimated from BibTeX files and U.S. 
Census data. For the prior distributions for the numbers of objects, such as the numbers of 
authors and publications, Pasula et al. (Pasula 2003) simply used a log-normal distribution, 
which has a very large variance. 
However, in the disease outbreak detection domain, it is sometimes unreasonable for the 
user to obtain “outbreak data” to estimate the prior distribution of the outbreak diseases due to 
the lack of actual outbreaks of diseases under surveillance. Thus in the absence of training data 
on which to base the estimate of prior distributions, a user still needs to model known, partially-
known, and unknown diseases. 
2.6 ENTITY-BASED MODELS FOR RELATIONAL DATA 
The proposed BH algorithm uses an experimental domain called MD-PANDA, which is 
represented using a Bayesian network model (Pearl 2000) in this dissertation. MD-PANDA takes 
 45 
as input relational datasets (Codd 1970) and can also be represented using entity-based models, 
such as entity-relationship (ER) models, probabilistic entity-relationship (PER) models 
(Heckerman 2004), and plate models (Buntine 1994). This section provides a brief summary of 
these models for a relational dataset2
2.6.1 Relational dataset 
. 
Before 1970, there were only “flat” databases, in which information was stored in one long text 
file. Each entry contained multiple pieces of information (fields) about a particular object that 
were grouped together as a record.  
The relational database (Codd 1970) was born in 1970. Since then, relational databases 
have grown in popularity to become a standard. A relational database allows one to easily find 
specific information. It also allows one readily to sort based on any field and generate reports 
that contain only certain fields from each record. Relational databases use tables to store 
information. The standard fields and records are represented as columns (fields) and rows 
(records) in a table. 
The dataset in Table 2.1 represents an example relational dataset that MD-PANDA takes 
as input, where you can quickly group patients with a specific disease symptom, such as cough, 
because of the arrangement of data in columns.  
 
 
                                                 
2 In what follows, I make no distinction between a database and a dataset. 
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Table 2.2 An example dataset that MD-PANDA monitors 
Person ID Hospital ID Admission date Gender Chief complaint [More fields…] 
12345 1 01/01/2004 F Cough … 
67890 3 01/01/2004 M Abdominal pain … 
… … … … … … 
2.6.2 Entity-relationship models 
There is a language called the Entity-Relationship (ER) model, which is commonly used to 
represent a relational database structure (Ullman 1997).  
When building ER models, we distinguish between entities, relationships, and attributes. 
According to (Heckerman 2004), an entity corresponds to a thing or object that is or may be 
stored in a database; a relationship corresponds to a specific interaction among entities; and an 
attribute corresponds to a variable describing some property of an entity or relationship. In the 
example dataset shown in Table 2.1, the set of individuals contains a sequence of entities (e.g., 
{person 12345, person 67890, …}). A reference to a set of entities is called an entity class. 
Similarly, attribute class refers to an unspecified collection of like attributes. In this example 
dataset, Person has an attribute class Person.Chief_complaint. 
MD-PANDA models the chief complaint state of every person in the population in order 
to monitor for a possible disease outbreak, and each individual’s chief complaint state is 
observable. It also models an individual’s disease state, which is a latent variable that is not 
observable (from Table 2.1) but needs to be inferred from other observed variables. A high-level 
Bayesian network model used by MD-PANDA is shown in Figure 2.2, where subnetwork E is an 
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entity-based model that models an individual’s disease state and his or her chief complaint state 
in the population. Thus, MD-PANDA can be considered as an entity-based model. 
 
However, individual’s disease state and chief complaint state can also be explicitly 
modeled as an entity-relationship pair using an ER model, as shown in Figure 2.3, where we can 
think of individuals in the population as entities and their chief complaint states as attributes, and 
individual’s disease as an entity class and his or her disease state as an attribute of this entity 
E 
G 
Person 1's  
Chief complaint 
Person 1's 
disease state 
Person N's  
Chief complaint 
Person N's 
disease state 
… 
… 
… 
Figure 2.1 A high-level Bayesian network representation showing the MD-PANDA model, where the dashed 
rectangular shapes represent subnetworks: subnetwork G contains nodes that represent global features common to 
all people in the population being monitored, and subnetwork E represents an entity-based model that contains every 
entity (Person) in the population; the bolded arrow between subnetworks shows the direction in which the Bayesian-
network arcs are oriented between subnetworks, and the arrows between nodes in subnetwork E show probabilistic 
dependencies between nodes. 
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class3
 
. For example, a possible relationship is the pair (person 12345, disease cryptosporidiosis), 
meaning that person 12345 had disease cryptosporidiosis.  
A relationship class refers to a set of like relationships among entities. In this example, 
we have the relationship class Has. A relationship class also can have attributes. For example, a 
relationship class Takes that represents the relationship between entity Student and entity Course 
can have the attribute Grade. In our example shown in Figure 2.3, the database structure shown 
                                                 
3 In practice, a user typically models an individual’s disease state, such as the stage of one’s infection, using 
a temporal model. However, this dissertation uses a non-temporal model as an experimental domain. Thus, in what 
follows, I make no distinction between an individual’s disease and his or her disease state. 
Disease 
Person 
Has 
Chief 
complaint 
Disease 
state 
Figure 2.2 An entity-relationship (ER) model depicting the structure of the relational dataset for Table 2.1. The 
entity classes (Person and Disease) are shown as rectangular nodes; the relationship class (Has) is shown as a 
diamond-shaped node; and the attribute classes (Disease.Disease_state, Person.Chief_complaint) are shown as oval 
nodes. Dashed edges are used for connecting attribute classes to their corresponding entity classes and the 
relationship class to its associated entity classes. 
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in Table 2.1 does not contain attributes for the relationship class Has4
It is important to know that an ER model is a representation of a database structure, such 
as the database structure shown in Table 2.1, not of a particular database that contains data. That 
is, an ER model can be built prior to the collection of any data. In contrast, each entity-
relationship pair associated with the data has to be explicitly represented in a Bayesian network 
model. That is, the instantiation of subnetwork E can only be developed once we know the exact 
number of entities (persons) in the database. 
, therefore the relationship 
class Has shown in Figure 2.3 is used to easily convey the relationship between entities. 
Similarly, there is a relationship class Has between entity Person and entity Chief complaint. For 
simplicity, this relationship is ignored in this figure. 
2.6.3 Probabilistic entity-relationship model 
The Probabilistic Entity-Relationship (PER) model is an extension of the ER model as it adds a 
probabilistic entity-relationship. A specific type of PER model is the directed acyclic 
probabilistic entity-relationship (DAPER) model (Heckerman 2004), which is an ER model with 
directed arcs among the attribute classes that represent probabilistic dependencies among 
corresponding attributes.  
Figure 2.4 shows a DAPER model for the example entity and relationship classes of the 
ER model described above. The DAPER model extends the ER model in Figure 2.3 with the 
                                                 
4 In practice, the relationship class Has can have the attribute that indicates the time that a person got 
infected with the disease denoted by the entity Disease. Since this dissertation uses a non-temporal model as an 
experimental domain, as described above, it is assumed that the relationship class Has does not have attributes. 
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addition of a solid arc from attribute Disease.Disease_state to attribute Person.Chief_complaint, 
which represents a probabilistic dependency between the two attributes. 
 
Note that the DAPER model shown in Figure 2.4 shows the relationship (conditional 
independence) between attributes (Disease.Disease_state and Person.Chief_complaint), whereas 
the ER model shown in Figure 2.3 does not represent the relationship between these two 
attributes because an ER model is an abstract representation of database structure and this ER 
model represents the entity-relationship pair based on the database structure shown in Table 2.1. 
2.6.4 Plate model 
A Plate model (Buntine 1994) is a language for compactly representing graphical models in 
which there are repeated measures. In a plate model, a plate is represented as a large rectangle 
for labeling an entity class.  
Disease 
Person 
Has 
Chief 
complaint 
Disease 
state 
Figure 2.3 A directed acyclic probabilistic entity-relationship (DAPER) model showing that a person’s chief 
complaint depends on the person’s disease state. 
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Figure 2.5 depicts plate notation of the high-level Bayesian network model shown in 
Figure 2.2. Instead of drawing each repeated variable (Person’s disease state and Person’s chief 
complaint state) individually, a plate or rectangle (shown as bolded rectangle) is used to group 
variables into a subgraph that repeat together, and a number N is drawn on the plate to represent 
the number of repetitions of the subgraph in the plate, where N represents the number of people 
in the population being monitored. In a plate model, any links that cross a plate boundary are 
replicated once for each subgraph repetition. 
 
Unlike in a directed acyclic graph (DAG) model (such as the Bayesian network model 
shown in Figure 2.2), where an entity-relation pair has to be explicitly modeled, each entity-
relation pair in a plate model does not need to be represented explicitly. 
Another type of entity-based model is a Probabilistic Relational Model (PRMs) (Getoor 
2002) that also can be used for representing the entity-relationship encoded in the MD-PANDA 
Figure 2.4 Plate notation for the high-level Bayesian network model used by MD-PANDA. 
 
 
 
 
N 
G 
Person's  
Chief complaint 
Person's 
Disease state 
… 
 52 
model. See (Heckerman 2004) for a detailed review and comparison of PRMs and the models 
already described above. 
Beyond a relational representation, the issue of probabilistic inference in relational 
representations is also important. Koller and Pfeffer (Koller 1997) have done some preliminary 
work on performing probabilistic inference using DAPER models. Since a plate model is 
essentially a Bayesian network model with a different representation notation, inference 
techniques used by a Bayesian network model can be directly applied on a plate model. Since 
techniques of probabilistic inference are more developed in a Bayesian network model, this 
dissertation represents MD-PANDA using a Bayesian network model in what follows. 
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3.0  THE EXPERIMENTAL DOMAIN 
The experimental domain for my dissertation research is the disease model used by MD-
PANDA. MD-PANDA is a Bayesian detection algorithm that operates on a time series of 
emergency department (ED) chief complaints for detecting CDC Category A diseases (CDC) 
(anthrax, botulism, plague, smallpox, tularemia, and viral hemorrhagic fevers) and several other 
diseases (influenza, cryptosporidiosis, hepatitis A, and asthma). Among these diseases, of which 
there are ten, anthrax, plague, and viral hemorrhagic fevers each is modeled using its early stage 
and its late stage, making a total of 13 outbreak diseases. I call these 13 diseases CDC-A+ 
diseases. Section 3.1 introduces the notation used for the remainder of this dissertation. Section 
3.2 provides an introduction to MD-PANDA. 
3.1 NOTATION 
This section introduces the notation used for the remainder of this dissertation. The term ED 
refers to one or more emergency departments in the region being monitored. If there is more than 
one, then the total patient cases across all EDs are treated as a single pool. 
Let D0 represent all the diseases that ED patients can have in the absence of any disease 
outbreak in the population, and let d0 represent an arbitrary member of D0 (e.g., acute 
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appendicitis would be one such non-outbreak disease). I will call these diseases non-outbreak 
diseases.  
Let DK represent all the outbreak diseases that we know about and have modeled. 
Assume that there are K types of such known outbreak diseases, as for example anthrax, 
botulism, and plague. Let dk represent a specific outbreak disease in DK, where 1 ≤ k ≤ K.  
Let D* represent all the outbreak diseases that are unknown or unmodeled. Let d* 
represent an arbitrary member of D*. For example, d* might be a newly mutated type of virus 
that previously was innocuous to human health, but now is potentially lethal.  
Let the total number of individuals in the population being monitored in a given region be 
N.  
Let i, 1 ≤ i ≤ N, represent the index of a specific person in the population. 
Let j, 1 ≤ j ≤ J, represent the index of a specific disease symptom, where J is the total 
number of symptoms that are modeled. Note that in the MD-PANDA model, j represents the 
index of chief complaints. For example, j = 4 might represent the binary symptom cough that can 
serve as a chief complaint. MD-PANDA takes as input ED chief complaints (one per patient), 
while the BH algorithm for my dissertation research takes as input patient disease symptoms, of 
which there can be more than one per patient. 
Let OB represent the state of an outbreak existing during the most recent 24-hour period 
in the region being monitored, and let NOB represent the absence of any disease outbreak during 
that period. Note that OB and NOB are mutually exclusive and exhaustive, and thus, 
P(disease_outbreak_status = OB) + P(disease_outbreak_status = NOB) = 1. 
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3.2 MD-PANDA 
MD-PANDA, which is shown in Figure 3.1, is an entity-based Bayesian network model that 
represents all the people in a given population (not just the ED patients).5
                                                 
5  The particular version of MD-PANDA that models CDC category A diseases has also been called 
PANDA-CDCA, or PC for short in (Jiang 2008).  
 Recall from Section 
2.6.4 that MD-PANDA can also be considered as a plate model. Figure 3.2 shows the plate 
notation of MD-PANDA model. For a detailed description of the nodes and the conditional 
probability tables, see the following two sections. 
disease outbreak status 
(O) 
outbreak disease in population 
(OD) 
fraction 
(F) 
person_1 disease 
(PD1) 
person_2 disease 
(PD2) 
person_N disease 
(PDN) 
person_1 evidence 
(E1) 
person_2 evidence 
(E2) 
person_N evidence 
(EN) 
… 
… 
Figure 3.1 The Bayesian network structure for the MD-PANDA model. See the text next for a description of the 
nodes and the conditional probability tables. 
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MD-PANDA describes a general modeling framework for multiple diseases. In this 
dissertation, I will be discussing and using the CDCA version (PC) of MD-PANDA, and thus, 
will only mention PC further.  
PC, as described in (Cooper 2006), only examines ED chief complaint data for the most 
recent 24 hours and does not take into account temporal or spatial information. While temporal 
and spatial extensions of PC have been developed (Jiang 2008), the algorithm developed in this 
dissertation research employs the non-temporal non-spatial version of PC as an experimental 
domain. By doing so, the dissertation can focus more clearly on fundamental issues of modeling 
both known and unknown diseases, without the added complexity of spatial and temporal 
Figure 3.2 Plate notation of the MD-PANDA model. The subgraph in the plate (bolded box) repeats N times, where 
N is the number of individuals in the population being monitored, and any links that cross a plate boundary are 
replicated once for each subgraph repetition. 
 
 
 
 
N 
disease outbreak status 
(O) 
outbreak disease in population 
(OD) 
fraction 
(F) 
person_i disease 
(PDi) 
person_i evidence 
(Ei) 
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modeling, which can be investigated later as extensions. Thus, in this section, I only provide an 
overview of this version of PC. 
3.2.1 The nodes 
The node disease outbreak status represents the outbreak status in the population being 
monitored during the most recent 24-hour period. Let O represent this node, where O = OB or 
NOB. If an outbreak occurred in the population at any time during the most recent 24-hour 
period, then O = OB, where the ongoing outbreak is due to the outbreak disease denoted by OD, 
otherwise, O = NOB. 
The node outbreak disease in population represents the state of there being an outbreak 
disease in the population. Let OD denote this node. OD can have the value dk for k > 1 (outbreak 
of known disease dk) or the value none, which represents that there is no outbreak disease in the 
population, among those being modeled.6
1. early stage anthrax 
 The outbreak diseases dk that PC models are the CDC 
category A outbreak diseases listed as follows: 
2. late stage anthrax  
3. early stage plague  
4. late stage plague  
5. smallpox 
6. tularemia 
7. botulism 
8. early stage marburg hemorrhagic fever 
9. late stage marburg hemorrhagic fever 
                                                 
6 PC assumes that different disease outbreaks would not occur simultaneously; however, the model could 
be extended to allow for multiple disease outbreaks. 
 58 
The additional diseases modeled in PC are as follows: 
1. influenza 
2. cryptosporidium 
3. hepatitis A 
4. asthma 
 
The node fraction in Figure 3.1 represents the hypothesized fraction of the total 
population who has outbreak disease dk and has visited the ED in the last 24 hours. Let F denote 
this node. Let f denote an arbitrary value of F. For example, f might be 10-4 or 2 × 10-5 or any of 
a wide range of fractions. As in PC, we model F as a discrete variable for computational 
convenience. 
The node person_i disease represents the possible diseases that person i can have, given 
outbreak disease OD in the population. Let PDi denote the person_i disease node. Although we 
index over all people in the population, the data we use is de-identified, and thus, we do not 
know the actual identity of a given person i. We use the assignment PDi = noED to represent that 
person i did not come to the ED during the most recent 24-hour period. For the patients who 
came to the ED, a specific patient among them could have a non-outbreak disease d0 or a specific 
outbreak disease dk for 1 ≤ k ≤ K. That is, PDi is a random variable that can take on values d0, d1, 
…, dK. 
Given the disease state of person i, the person_i evidence node is used to model the 
evidence state of that person, such as the patient’s chief complaint. Let Ei represent this node for 
a specific person i. PC currently models 53 possible patient chief complaints. For ED patients 
who do not have one of those 53 chief complaints, their chief complaints are assumed to have the 
“catch all” value other. For people who did not visit the ED, our convention is to give their chief 
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complaints the value unknown. Therefore, Ei = unknown and PDi = noED are assigned when a 
person i did not visit the ED during the previous 24-hour period. 
As mentioned, PC currently models 13 possible outbreak diseases; thus K = 13. In 
practice, some other disease outbreak might occur, such as a new infectious disease that has 
never been seen before. Recall from Section 3.1 that we denote an unmodeled or unknown 
outbreak disease as d*. However, PC is not able to represent such diseases. Chapter 4 describes 
how I extend PC to model such diseases. 
3.2.2 The conditional probability tables 
This section describes the conditional probability tables (CPTs) in the Bayesian network model 
in Figure 3.1.  
The prior probabilities of variable O are given by P(O = OB) = 0.05 and thus P(O = 
NOB) = 0.95. The prior probability of outbreak condition is high due to the incorporation of 
influenza into the CDC-A+ outbreak diseases being modeled and the frequent occurrence of 
influenza in any year.  
The conditional probabilities of P(OD = dk | O = OB) (for k ≥ 1) were assessed by an 
infectious disease expert, Dr. John Dowling at the University of Pittsburgh, based on the 
literature and his clinical beliefs, where dk is one of the 13 CDC-A+ diseases. When O = NOB, 
we have OD = none with probability 1, that is, P(OD = none | O = NOB) = 1. 
The values of F depend on the temporal progression of disease dk and the type of disease 
dk, because an outbreak disease in an earlier stage tends to affect a smaller fraction of population 
than that disease in a later stage, and some outbreak diseases tend to affect a larger fraction of 
population than other outbreak diseases. Since PC does not represent temporal progression in this 
 60 
model, there is uncertainty of the disease stage of a potential outbreak disease. Therefore, PC 
does not model a dependency between F and OD. However, in general the disease model in 
Figure 3.1 could be readily extended to represent a dependency between F and OD. 
The values of f of the fraction node F are derived as follows: Let μ0 denote the mean 
number of patients who came to the ED each day when there is no disease outbreak in the 
population, and let σ0 denote its standard deviation. Parameters μ0 and σ0 were estimated from 
real ED data that presumptively contains no disease outbreak. Let n be the number of outbreak 
cases who visited the ED when there is a disease outbreak in the population. We model the 
values of n as being the rounded values of 010
1
σ , 010
2
σ , 010
3
σ , 010
4
σ , 010
5
σ , σ0, 1.5σ0, 2σ0, 2.5σ0, 
3σ0, 3.5σ0, 4σ0, 4.5σ0, and 5σ0. The 15 values of f were calculated as n / N, where N is the total 
number of individuals in the population who could potentially visit the EDs that are covered in 
the region, which in this case is estimated to be 400,000. The fraction F is assumed to be 
uniformly distributed over these 15 discrete values. Thus, P(F = f) = 1/15 for all values of f7
If OD = none, a specific person i either has d0 or his (her) status is noED. Note that d0 
represents that an individual (1) went to the ED during a given 24-hour period and (2) has a non-
outbreak ED disease. The probability that the person has d0, which is denoted as θ, is estimated 
from past ED data during which it is assumed no outbreak was occurring. Then P(PDi = noED | 
OD = none, F = f) = 1 – θ. 
. 
When OD = dk (for 1 ≤ k ≤ K), a specific person i could have disease d0, dk, or noED. 
That person cannot have another outbreak disease, because in the current model it is assumed 
that there is at most one outbreak disease present in the population at any time. The probability 
                                                 
7 Note that since the interval spacing of the discrete values of F is not the same, assuming a uniform over 
the discrete version of P(F = f) actually assumes a non-uniform over the continuous probability density function of 
P(F = f). 
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of person i having dk is equal to the value of the fraction node, f, by the construction of that node. 
Thus, there is 1 - f fraction of the total population who do not have dk (who have d0 or noED). It 
is assumed that a fraction θ of these people have d0. The probability of person i having d0 in light 
of dk as an outbreak disease in the population is then equal to (1 – f)θ. Finally, P(PDi = noED | 
OD = dk, F = f) = 1 – f – (1 – f)θ = (1 – f)(1 – θ). 
Let puj represent the probability of a specific person having the jth chief complaint given 
that the person has disease du, namely P(Ej = ej | PDi = du), where 0 ≤ u ≤ 13 and ej is one of the 
53 possible observed chief complaints for person i. P(Ej = ej | PDi = d0) is estimated from past 
ED data that are assumed to contain no disease outbreaks. When person i has an outbreak 
disease, puj is assessed using expert knowledge for 1 ≤ j ≤ 53 and 1 ≤ u ≤ 13. In particular, Dr. 
John Dowling of the University of Pittsburgh, who is an infectious disease specialist, assessed puj 
based on the literature and his clinical beliefs (Cooper 2006).  
3.2.3 Inference 
Each hour, PC outputs the posterior probability of each CDC-A+ disease in a population. In order 
to compute these probabilities, we need to compute P(OD = none | E) and P(OD = dk | E) for 
each outbreak disease dk, where 1 ≤ k ≤ 13, and E denotes the observed chief complaint for each 
person in the population who came to the ED within the past 24 hours. PC performs exact 
inference to compute these probabilities. Since PC serves as the experimental domain for this 
dissertation research, and this dissertation research involves more complicated inferences than 
those in PC, I leave discussion of these issues to Chapter 4. 
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4.0  THE BAYESIAN HYBRID DETECTION ALGORITHM 
This chapter describes the main issues of the BH model and algorithm. The BH algorithm 
combines models of known and unknown outbreak diseases in order to capture outbreaks due to 
both categories of disease. As described in Chapter 3, PC only models known diseases (13 CDC-
A+ diseases) but does not model an unknown disease d*. The BH algorithm extends PC to (1) 
model an unknown outbreak disease d* and (2) model the distributions8
The BH algorithm has two versions: a univariate version, which I call the UBH 
algorithm, and a multivariate version, which I call the MBH algorithm. I begin this chapter by 
presenting the three categories of disease models in Section 4.1, which include a disease-specific 
model (DSM), an unknown-disease model (UDM), and a partially-known disease model (PDM). 
Section 4.2 describes the UBH algorithm, which takes as input a univariate symptom state for 
every person in the population for the last 24 hours. Section 4.2 describes the MBH algorithm, 
which takes as input multivariate symptom states for every person in the population. For each 
 over the probabilities of 
a person’s symptoms, given different diseases that a person could have. These extensions make 
exact inference in the Bayesian network model in Figure 3.1 computationally and conceptually 
more complicated. The current chapter describes how I performed inference efficiently under 
these extensions. 
                                                 
8 PC models point probabilities, but BH models distributions over those probabilities. Thus, BH models an 
additional level of uncertainty, relative to PC. 
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version of the BH algorithm, I describe how to use DSM, UDM, and PDM to model different 
types of outbreak diseases in the PC domain. I also describe how to perform inference on these 
Bayesian network models.  
4.1 DISEASE MODELING 
Common Bayesian networks model parameters (probabilities) as being known, and PC uses this 
approach. PC models the probability of a symptom in an outbreak disease as a known probability 
value using expert assessment, as for example the probability that a patient will have a cough 
given that he or she has respiratory anthrax. For the purpose of estimation and assessment in this 
section, the probability of a symptom in a disease can be viewed as the frequency in a large 
sample limit of patient cases with that disease. 
In contrasts, the BH algorithm models distributions over parameters that represent 
frequencies of the population, as for example the frequency of cough in the individuals with 
anthrax, whereas the true parameters (frequencies) are unknown. Modeling distributions of 
parameters allows us to represent uncertainty in how diseases express themselves and to express 
our own ignorance of how diseases will express themselves – both forms of uncertainty are 
important. 
This section describes how I modeled non-outbreak diseases, known outbreak diseases, 
unknown outbreak diseases, and partially-known outbreak diseases. In particular, I describe these 
disease models in terms of the jth disease symptom, assuming there are a total of J symptoms (1 
≤ j ≤ J) that are conditionally independent, and the symptom states of each symptom j are binary, 
as described below. Section 4.2 describes the univariate BH algorithm, where J = 1. Section 4.3 
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describes the multivariate BH algorithm, where J > 1, and presents disease models in terms of a 
total of J disease symptoms, each of which is assumed to be binary.  
4.1.1 The non-outbreak disease model 
As stated, this model represents that a person has a non-outbreak disease d0. Recall from Section 
3.2 that p0j represents the probability of having symptom j given a person having d0. I assume p0j 
is distributed according to a Beta distribution, namely, p0j ~ Beta(α0j, β0j). Next, I describe how 
BH models p0j from past ED data. 
Parameters α0j and β0j were estimated based on real ED data that are assumed to contain 
no disease outbreaks. Specifically, these parameters were estimated based on real ED reports 
from a large healthcare system in Pittsburgh from January to December 2002. Patient visit data 
to the ED were stored in a database since 1990, including dictated and transcribed ED reports 
and coded ICD-9 discharge diagnoses. Chapman, et al. previously identified a random sample of 
ED patient cases that either contained one or more respiratory symptoms or did not (Chapman 
2004; Chapman 2005; Chu 2007); these two sets were relevant to their study goals. We were 
able to use their two sets of cases to provide the α0j and β0j parameter estimates needed for this 
dissertation, as described in the remainder of this section. Chapman, et al. obtained 69 patient 
cases with respiratory symptoms and 151 cases without, yielding a total of 220 cases. By 
computing the fraction of respiratory patients in the real ED reports in 2002, they estimated that 
the fraction of respiratory patients who visit to the ED is approximately 0.08. Thus, for a specific 
symptom j, we can derive the mean probability of symptom j in disease d0 as follows: 
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where ( ) 08.0__| 0 === ddiseaseipersonpresentyrespiratorP . 
Consider the example of deriving P(cough = present | person_i_disease = d0). From the 
69 respiratory cases there were 10 patients with cough, and from the 151 non-respiratory cases 
there were no cases with a cough. We derived P(cough = present | person_i_disease = d0) as 
follows: 
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Therefore, we can approximate parameters α0j and β0j for the symptom cough as shown below, 
assuming symptom cough has a symptom index of j = 1: 
( )010 __| ddiseaseipersonpresentcoughPN ED ==⋅=α , 
1
0
1
0 αβ −= EDN , 
where NED represents the total number of expected ED patients for a year. I used one-year data of 
ED patients rather than multi-year data of ED patients to estimate NED because multi-year data 
might not capture recent trends in the estimated parameters (e.g., the frequency of cough might 
change over time), whereas one-year data is likely to capture recent trends and still constitutes a 
large sample size. 
The above method of estimating parameters α0j and β0j is applied to every symptom j of 
disease d0 that is modeled, where 1 ≤ j ≤ J, in order to construct a multivariate model for a non-
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outbreak disease. For a complete list of parameters, see Appendix A. In the current multivariate 
version of the BH algorithm (for J > 1), this dissertation research assumes that symptom states 
are conditionally independent given the disease state. 
4.1.2 The disease-specific model (DSM) 
DSM represents that a person has a specific outbreak disease dk (for 1 ≤ k ≤ K). Recall that pkj 
represents the probability of having symptom j given a person having dk. pkj is also assumed to 
have a Beta distribution, namely, pkj ~ Beta(αkj, βkj). Next, I describe how BH models pkj using 
informative priors. 
Recall that pkj may be viewed as a frequency in the large sample limit of patient cases 
with disease dk. I assessed parameters αkj and βkj based on expert judgments for 1 ≤ k ≤ K. The 
expert provided his expectation μkj of pkj and an interval assessment [akj, bkj] for which he stated a 
belief that there is a 90% chance that pkj is between akj and bkj. Parameters αkj and βkj were then 
estimated by solving Equations 4.1 and 4.2 in terms of the Beta density function Beta(pkj; αkj, 
βk
j).  
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The above method of estimating parameters αkj and βkj is applied to every symptom j of 
disease dk, where 1 ≤ j ≤ J, in order to construct a multivariate disease-specific model for an 
outbreak disease dk. For a complete list of parameters, see Appendix A. The multivariate 
symptom states are assumed to be conditionally independent given the disease state. 
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4.1.3 The unknown-disease model (UDM)          
UDM represents that a person has an unknown outbreak disease d*. I model p*j, which is the 
probability of symptom j of an unknown disease, using a non-informative prior, where 1 ≤ j ≤ J. 
Castillo et al., as well as many others, suggest a non-informative prior for parameters defined 
over a finite range to be uniform in that range (Castillo 2007). An example of this was proposed 
by Bayes himself (Press 2003), who used a uniform [0,1] on the Binomial proportion parameter 
p. Tuyl et al. also suggest using the uniform prior Beta(1, 1), called the Bayes-Laplace prior, on 
the Binomial proportion parameter p to represent ignorance (Tuyl 2009). I model p*j using a 
uniform distribution over [0,1], namely, p*j ~ Beta(1, 1).  
When multiple disease symptoms are being modeled, I define an unknown disease d* as a 
disease for which we almost completely lack knowledge regarding every disease symptom. Each 
symptom j is modeled using a non-informative prior described above. All the multiple disease 
symptoms are modeled as being conditionally independent given the person’s disease state. 
4.1.4 The partially-known disease model (PDM) 
PDM represents a partially-known outbreak disease that manifests some disease symptoms 
similar to one or more modeled known diseases. For example, a partially-known outbreak 
disease might be modeled as having a cough rate in the population that is similar to the cough 
rate of a known outbreak disease, such as influenza. Recall from Chapter 1 that this dissertation 
focuses on a basic way of modeling unknown and partially-known diseases. In particular, I will 
model a partially-known disease that results in a rate of some disease symptoms in the 
population that is similar to those of several known diseases that have been modeled. I thus will 
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use a mixture of priors of the known diseases to model a partially-known disease and will 
represent this partially-known disease with the notation d*p. 
As described in Section 2.4.5, a mixture of priors is composed of prior distributions that 
come from several sources of information. A mixture of Beta prior distributions has a closed-
form solution for a Beta-Binomial model, which results in a posterior distribution being a 
mixture of Beta distributions. As the definition of a partially-known disease described above 
suggests, I intend to use a mixture of priors to model a partially-known disease d*p. In particular, 
a mixture of priors consists of priors that are informative for known (modeled) diseases and non-
informative for conditions we know little about, as explained next. 
I now present how to model a partially-known disease d*p that has a disease symptom j 
whose incidence rate is similar in distribution to those of several known diseases. Assuming 
there are M known diseases being modeled, the method of mixture priors involves a finite 
mixture model of M + 1 components, with each of the M components representing a prior 
distribution for a known disease and an additional component representing a non-informative 
prior for conditions that we know little about. Equation 4.3 shows the derived prior distribution 
( )jjpf ** ;θ  of the jth disease symptom for a partially-known disease d*p. 
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kτ . 
In this Equation, when 1 ≤ k ≤ M, ( )jkjkk pf θ;  represents an informative prior distribution 
for the jth symptom of disease dk, and ( )jkjkk pf θ;   is assumed to have a Beta distribution as 
Beta(pkj; αkj, βkj), where parameters αkj and βkj are estimated using the method described in the 
disease-specific model in Section 4.1.2 above; when k = M + 1, ( )jMjMM pf 111 ; +++ θ  represents a 
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non-informative prior distribution, for which I use a uniform distribution on [0, 1]. τkj is the 
probability that measures the degree to which d*p is similar in distribution to dk with respect to 
the jth symptom.  
In this dissertation research, I assume that we know little about possible similarities in 
distribution between disease d*p and any disease of the M + 1 components. Thus, I assume τkj is 
uniformly distributed over the M + 1 components for 1 ≤ k ≤ M + 1, that is, τkj = 1 / (M + 1). If, in 
other applications, we have prior belief about how to weight the disease components (e.g., any 
partially known disease is expected to be much more like influenza than like any other modeled 
disease), we could weight the components differentially (e.g., more heavily for influenza). 
I now describe an example of modeling a partially-known disease d*p using the method of 
mixture priors. Suppose the observed evidence contains the status of the symptoms cough and 
fever for every person who came to the ED during the most recent 24 hours. Assume there are 
three known diseases we are modeling, namely, influenza, anthrax, and asthma, and their disease 
indices are k = 1, k = 2, and k = 3, respectively. The only prior knowledge we wish to model 
about d*p is that it is a respiratory-like illness that manifests a cough rate in the population that is 
similar in distribution to those of several diseases, such as influenza, anthrax, and asthma. 
Moreover, we believe it possible (although not inevitable) that disease d*p could have a rate of 
cough that is quite different from all of influenza, anthrax, and asthma. Hence, a fourth 
component is incorporated in the mixture of priors to represent this condition. Assuming cough 
and fever have the symptom indices, j = 1 and j = 2, respectively, we can derive a prior 
distribution of the probability of cough for d*p as follows: 
( ) ( ) ( )14144
3
1
111
*
1
* ;4
1;
4
1; θθθ pfpfpf
k
kkk ⋅+= ∑
=
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where ( )jkjkk pf θ;  represents an informative prior derived for the kth disease and ( )14144 ;θpf  
represents a non-informative prior, namely Beta(1, 1). 
If we have no reason to believe that the fever rate of disease d*p is similar to known 
disease we are modeling, then we could model the prior distribution of the probability of fever 
for d*p using a uniform distribution on [0, 1], as described in Section 4.1.3. 
4.2 THE UNIVARIATE BAYESIAN HYBRID DETECTION ALGORITHM 
The univariate Bayesian hybrid detection algorithm (UBH), which I have developed and 
investigated, uses the PC model, and combines specific and non-specific detectors. It takes as 
input the total count over the most recent 24 hours of a single emergency department patient 
symptom, such as cough (Shen 2007). This section describes an example of this algorithm in 
terms of aggregate counts of the binary symptoms, cough vs. no cough. 
4.2.1 The univariate entity-based disease model 
Recall from Section 3.2.1, Ei represents the person_i evidence node in Figure 3.1. In the UBH 
algorithm, I represent Ei as a binary symptom (cough vs. no cough) of person i, where 1 ≤ i ≤ N.9
                                                 
9  See Section 4.3 for a multivariate version of the Bayesian hybrid algorithm that models multiple 
symptoms of person i. 
 
For people who came to the ED during the past 24 hours, their evidence states are cough or no 
cough. For people who did not visit the ED, our convention is to give their evidence state the 
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value unknown. Figure 4.1 shows the Bayesian network model used for the example UBH 
algorithm. 
4.2.2 The conditional probability tables 
As described in Section 3.2.1, the disease outbreak status node represents the outbreak status in 
the population during the most recent 24-hour period. The node is represented as O, where O = 
OB or NOB. The prior probability of variable O is specified as in PC10
                                                 
10 The current version of UBH actually derives the likelihood ratio LR = P(E = e | O = OB) / P(E = e | O = 
NOB), instead of the posterior probability P(O = OB | E = e), as described in Section 4.2.3, in order to remove the 
need to specify this difficult prior probability. In any event, the evaluation measures that we use are not sensitive to 
the prior probability. 
, that is, P(O = OB) = 
0.05, and thus P(O = NOB) = 0.95. 
disease outbreak status 
(O) 
outbreak disease in population 
(OD) 
fraction 
(F) 
person_1 disease 
(PD1) 
person_2 disease 
(PD2) 
person_N disease 
(PDN) 
person_1 cough state 
(E1) 
person_2 cough state 
(E2) 
person_N cough state 
(EN) 
… 
… 
Figure 4.1 A Bayesian network showing the UBH entity-based disease model. 
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If O = NOB, the model represents that there is no disease outbreak occurring in the 
population in the last 24 hours, i.e., P(OD = none | O = NOB) = 1. If O = OB, the model 
represents that some outbreak due to disease du (for { },*,,1 Ku ∈ ) is occurring in the 
population. I use expert assessments to determine the probability of P(OD = du | O = OB), as 
described in Section 3.2.2. However, the BH algorithm models an unknown outbreak disease d*, 
and the probability P(OD = d* | O = OB) is difficult to estimate using the literature or expert 
assessments. Thus, I will perform a sensitivity analysis over various values for P(OD = du | O = 
OB. See Chapter 5 for a detailed description of specifying these probabilities. 
In this chapter I do not describe in detail every node in Figure 4.1, but rather focus on 
deriving the conditional probability tables of the Bayesian network model in that figure, which is 
different from the PC model. For a detailed description of the nodes in Figure 4.1, see Section 
3.2.1. 
If OD = none or OD = dk (for 1 ≤ k ≤ K), then we can derive P(PDi | OD = none, F = f) or 
P(PDi | OD = dk, F = f) in the same fashion as in PC: 
 P(PDi = d0 | OD = none, F = f) = θ, 
P(PDi = noED | OD = none, F = f) = 1 – θ, 
P(PDi = dk | OD = dk, F = f) = f, 
P(PDi = d0 | OD = dk, F = f) = (1 – f)θ, and 
P(PDi = noED | OD = dk, F = f) = (1 – f)(1 – θ). 
When OD = d*, we can similarly derive  
P(PDi = d* | OD = d*, F = f) = f,  
P(PDi = d0 | OD = d*, F = f) = (1 – f)θ, and  
P(PDi = noED | OD = d*, F = f) = (1 – f)(1 – θ). 
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Recall that we model the state of a binary symptom Ei for every person in the population 
using a Bernoulli distribution. Because the univariate version of the BH algorithm only models a 
single disease symptom, for simplicity, I ignore the superscript that defines the index of a disease 
symptom that appears in Section 3.2.2. Recall that for the people who came to the ED in the last 
24 hours, their evidence states are cough or no cough, and for people who did not visit the ED, 
our convention is to give their evidence state the value unknown. I define P(Ei = cough | PDi = 
d0) = p0, P(Ei = cough | PDi = dk) = pk and P(Ei = cough | PDi = d*) = p*. Table 4.1 describes the 
conditional probability assignments for P(Ei | PDi). Recall from Section 3.2.2 that PC uses expert 
knowledge to obtain P(Ei | PDi) in this conditional probability table. The UBH algorithm takes 
into account the uncertainty of the expert’s estimates and models these probabilities as random 
variables. See Section 4.1 for a detailed description of how to model p0, pk, and p* in the non-
outbreak disease model, in the disease-specific model, and in the unknown-disease model, 
respectively. 
Table 4.1 The conditional probability table for P(Ei | PDi) 
cough state (Ei) ED & d0  ED & dk  ED & d* noED 
ED & cough p0 pk p* 0 
ED & no cough 1 – p0 1 – pk 1 – p* 0 
unknown 0 0 0 1 
4.2.3 Inference 
This section describes how to perform inference on the example Bayesian network model in 
Figure 4.1. The objective of inference is to derive the posterior probability of an outbreak 
occurring given the observed evidence. That is, we wish to derive P(O = OB | E = e), where e 
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denotes the status of the symptom cough for every person in the population. I assume the status 
is either cough or no cough for people who have come to the ED, and that it was unknown for 
people who have not. I derive P(O = OB | E = e) by deriving P(E = e | O = OB) and P(E = e | O = 
NOB), assessing P(O = OB), and applying Bayes’ rule.  
Note that P(O = OB | E = e) represents the posterior probability of an outbreak due to any 
outbreak disease. Recall that the BH detection algorithm models 13 CDC-A+ diseases and 
unknown diseases. If we want to know the posterior probability of a particular disease outbreak 
occurring or an unknown disease outbreak occurring, we then derive P(OD | E = e), where OD = 
dk (for 1 ≤ k ≤ K) represents a specific outbreak disease, and OD = d* represents an unknown 
outbreak disease. In this dissertation, the BH algorithm aims to detect disease outbreaks due to 
any outbreak disease, i.e., deriving P(O = OB | E = e), but does not characterize the outbreak to 
determine whether it is due to dk or d*. 
Computing the posterior probability P(O = OB | E = e) involves computing the 
likelihoods P(E = e | O = OB) and P(E = e | O = NOB), and specifying the prior probability P(O 
= OB), as shown below:  
( ) ( ) ( )( ) ( ) ( ) ( )NOBPNOBOeEPOBPOBOeEP
OBPOBOeEPeEOBOP
==+==
==
===
||
|| .           (4.4) 
As described in Section 4.2.2, I derive the likelihood ratio LR as Equation 4.5 to avoid 
specifying the prior probability P(O = OB), which can be difficult to assess with confidence. 
( )
( )NOBOeEP
OBOeEPLR
==
==
=
|
| .                                                 (4.5) 
We can derive LR from Equation 4.4 and 4.5, as follows: 
( )
( )( ) ( )OBOPeEOBOP
NOBOPLR
=−==
=
=
1|/1
. 
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Thus, given the prior probabilities P(O = OB) and P(O = NOB), LR is an increasing function of 
the posterior probability P(O = OB | E = e).  
The proposed evaluation method described in this dissertation (Chapter 5) determines the 
expected detection time (at a specific false alert rate) based on the relative order of the 
probabilistic outputs. Since LR is an increasing function of the posterior probability P(O = OB | 
E = e), computing LR rather than  P(O = OB | E = e) does not affect the detection performance of 
the BH algorithm when using this evaluation method. Moreover, the values of the prior 
probabilities P(O = OB) and P(O = NOB) do not affect this relative order. Thus these prior 
probabilities do not affect the detection performance of the BH algorithm reported in Chapter 5, 
but do affect the magnitude of the outputs LR of the BH algorithm. 
In order to derive the likelihood ratio LR, I first compute the likelihood P(E = e | O = OB) 
as follows: 
( ) ( )
( ) ( ). ||
|,|
0
0
∑
∑
≠
≠
===
=====
dOD
dOD
OBOODPODeEP
OBOODeEPOBOeEP
                               (4.6) 
The second equality of the above equation holds because E and OB are conditionally 
independent given OD being an outbreak disease, given the Bayesian network model in Figure 
4.1. 
I then compute the likelihood P(E = e | O = NOB) using the equation below, because O = 
NOB, OD = none, and OD = d0 are equivalent events. 
( ) ( ). || 0dODeEPNOBOeEP =====                                        (4.7) 
Now the inference problem turns out to be computing the likelihood P(E = e | OD = dk) 
(for 1 ≤ k ≤ K) and P(E = e | OD = d*) in Equation 4.6 and computing the likelihood P(E = e | 
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OD = d0) in Equation 4.7. For the remainder of this section, let dw represent any member of {d0, 
d1, …, dK, d*}, because they are all involved in the same inference procedure. 
We can derive P(E = e | OD = dw) by performing inference on the Bayesian network in 
Figure 4.1. Inference is complicated by the fact that we have distributions over P(Ei = ei | PDi), 
as described in Sections 4.1; thus, inference includes integrating over these distributions. I 
assume that the values of the fraction node in Figure 4.1 are distributed over some discrete set of 
values that are independent of OD. Thus we are able to derive P(E = e | OD = dw) as follows: 
( ) ( ) ( ).,|| ∑ =======
f
ww fFPfFdODeEPdODeEP                             (4.8) 
By assuming that the N cases in the population are independent, we are able to derive P(E 
= e | OD = dw, F = f) as follows: 
( ) ( ) ( ) ,,,|,|
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i
PPwiiw dBBgBfFdODeEPfFdODeEP            (4.9) 
where BP is a vector whose values denote the conditional probability assignments associated with 
P(Ei = ei | PDi), and g(BP) is the probability distribution over BP. Note that BP is p0 when OD = 
d0, BP = p0 and pk when OD = dk (for 1 ≤ k ≤ K), and BP = p0 and p* when OD = d*. 
Since PDi is hidden, in computing Equation 4.9 we had to sum out all the combinations 
of PDi, as follows: 
( ) ( ) ( ) .,,|,,|
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P iB
P
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i
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PD
Pwiiiw dBBgBfFdODPDeEPfFdODeEP       (4.10) 
From the network structure in Figure 4.1, the person_i cough state node (Ei) and the 
outbreak disease in population node (OD) are conditionally independent given the person_i 
disease node (PDi); a similar independence holds between the person_i cough state node and the 
fraction node. We can write Equation 4.10 as follows: 
 77 
( )
( ) ( ) ( ) .,|,|
,|
1
∫∏∑
=
====
===
P iB
P
N
i
P
PD
wiPiii
w
dBBgfFdODPDPBPDeEP
fFdODeEP
                  (4.11) 
We then rearrange the sum in Equation 4.11 to obtain Equation 4.12. In this equation, 
P(PDi | OD = dw, F = f) is calculated as described Section 4.2.1. P(E = e| PDi, BP) is the 
probability associated with Table 4.1. 
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              (4.12) 
Recall that when OD ≠ none, PDi is hidden for the ith person who comes to the ED. Let 
NED be the number of people who came to the ED. The sums in Equation 4.12 were taken over 
every possible value of the hidden variable PDi for every possible person i who came to the ED, 
which resulted in a complexity exponential in NED. 
In order to compute the likelihood efficiently, I adapted the inference method given in 
(Cooper 1995), which performs Bayesian inference using grouping and factorization. I thus call 
this method the Bayesian grouping and factorization method or the BGF method. In this method, 
the population is aggregated into groups by their cough status. The example application 
described in Section 4.2.1 contained three groups, namely ED & cough, ED & no cough, and 
unknown. I call these three groups Gc, Gn, and Gu respectively. Note that for the people in Gu, 
their disease status is not hidden because their disease status is assigned to be noED as described 
in Section 3.2.1. Let uED be the number of the groups excluding Gu, namely uED = 2. To compute 
P(E | OD, f), the inference method used a factored approach to efficiently sum over every 
possible value of the hidden variable PDi for every possible person i in Gc and in Gn, with a time 
complexity that is ( )EDuEDNO  = ( )2EDNO  (Cooper 1992; Cooper 1995). 
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4.3 THE MULTIVARIATE BAYESIAN HYBRID DETECTION ALGORITHM 
If an outbreak due to disease d occurs in the population, patients infected with disease d are often 
expected to exhibit several disease symptoms of disease d. Although many evidential features 
may be predictive of an outbreak, detection algorithms generally monitor each evidential feature 
separately (as described in Section 4.2), which limits the surveillance system’s detection 
capabilities. This section describes a multivariate Bayesian hybrid (MBH) detection algorithm 
that takes as input multiple disease symptoms, such as cough, fever, and headache, of every 
person in the population for the last 24 hours. 
4.3.1 The multivariate entity-based disease model 
The MBH algorithm extends the UBH algorithm to model multiple clinical findings for every 
patient in the ED. However, extracting specific clinical findings from electronic ED patient 
reports continues to be a major challenge (McDonald 1997), although steady progress is being 
made (Chapman 2004; Chapman 2005; Chu 2007). This dissertation assumes that we will obtain 
a set of clinical findings for each patient in the ED in the foreseeable future. Thus, the 
multivariate disease model uses such evidence rather than assuming we only will have a single 
patient chief complaint, which is information that is already readily available. 
When J evidential features of every person are available, the disease model of the MBH 
algorithm models them as being conditionally independent, as described below. This disease 
model is different from the PC model in that PC models a patient chief complaint (one per 
patient) while the MBH algorithm models multiple disease symptoms per patient.   
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Recall from Section 4.2.1 that Ei is a variable that represents an evidential feature for 
person i. When Ei contains J symptoms, Ei1, …, EiJ, I apply the naïve Bayes model (Mitchell 
1997), as shown in Figure 4.2, where every conditional symptom state of person i (Eij, for 1 ≤ j ≤ 
J) is modeled using a Bernoulli distribution. Thus, we obtain the Bayesian network model shown 
in Figure 4.3 for the MBH algorithm, where every subnetwork that models the symptoms of an 
individual assumes conditional independence. As described in Section 2.6.4, the conditional 
independence model in Figure 4.2 can be represented using plate notation, as shown in Figure 
4.4. Thus, we obtain a multivariate disease model for the MBH algorithm using plate notation, as 
shown in Figure 4.5. 
 
person_i disease 
(PDi) 
person_i evidence 1 
( ) 
person_i evidence 2 
( ) 
person_i evidence J 
( ) 
… 
Figure 4.2 A naïve Bayes model representing J evidential features for a specific person i in the population. 
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J 
person_i disease 
(PDi) 
person_i evidence j 
(Ei
j) 
disease outbreak status 
(O) 
outbreak disease in population 
(OD) 
fraction 
(F) 
person_1 disease 
(PD1) 
person_N disease 
(PDN) 
… 
… 
person_1 
evidence 1 
( ) 
person_1 
evidence J 
( ) 
person_N 
evidence 1 
( ) 
person_N 
evidence J 
( ) 
… … 
Figure 4.3 Bayesian network showing the MBH disease model where every person’s disease state and evidence 
states are modeled using a naïve Bayes model. 
Figure 4.4 Plate notation of the naïve Bayes model shown in Figure 4.2, where J in the corner represents the total J 
evidential features modeled for person i. 
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4.3.2 The conditional probability tables 
In Figure 4.3, nodes O, OD, F, and PD1, … PDN have the same conditional probability tables as 
those in Figure 4.1. This section will focus on deriving the conditional probability tables for the 
multivariate evidential features Ei1, …, EiJ, for a specific person i in the population. 
As shown in Figure 4.3, a naïve Bayes model assumes that Ei1, …, EiJ are conditionally 
independent given the disease state of that person (PDi). Recall that every conditional symptom 
 
 
 
 
 
 
 
 
 
 
N 
 
 
 
 
J 
disease outbreak status 
(O) 
outbreak disease in population 
(OD) 
fraction 
(F) 
person_i disease 
(PDi) 
person_i 
evidence j 
( ) 
Figure 4.5 Plate notation of the Bayesian network model shown in Figure 4.3, where J on the inner plate represents 
the total J evidential features modeled for person i, and N on the outer plate represents the total number of 
population being monitored in the region. 
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state of person i (Eij, for 1 ≤ j ≤ J) is modeled using an independent Bernoulli distribution. For a 
person who came to the ED in the last 24 hours, his (or her) evidence state Eij is modeled as 
having symptom j (eij) or not having symptom j (~eij). Table 4.2 describes the conditional 
probability assignments for P(Eij | PDi), where p0j, pkj, and p*j are modeled using the methods 
described in Section 4.1. 
Table 4.2 The conditional probability table for P(Eij | PDi) 
evidence state ED & d0 ED & dk ED & d* noED 
ED & eij p0j pkj p*j 0 
ED & ~eij 1 – p0j 1 – pkj 1 – p*j 0 
unknown 0 0 0 1 
4.3.3 Inference 
As described in Section 4.2.3, we wish to derive the likelihood ratio LR =                                 
P(E = e | O = OB) / P(E = e | O = NOB). Computing this likelihood ratio involves deriving     
P(E = e | OD = dw), where dw is a disease that represents any member of {d0, d1, …, dK, d*}. We 
would like to derive P(E = e | OD = dw) by performing exact inference on the Bayesian network 
in Figure 4.3.  
Recall from Section 4.2.3 that computing P(E = e | OD = dw) involves the following 
inference procedure. 
( ) ( ) ( ) , ,|| ∑ =======
f
ww fFPfFdODeEPdODeEP                       (4.13) 
and P(E = e | OD = dw, F = f) can be derived as follows, as described in Section 4.2.3: 
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where MP is a matrix that contains probabilities that are described below, and we assume that our 
belief about the distributions of these probability parameters are independent, namely, parameter 
independence. 
In the multivariate version, Ei contains multivariate evidential features Ei1, …, EiJ. Recall 
that we had distributions over P(Eij = eij | PDi = du), as described in Sections 4.3.2. Let puj =   
P(Eij = eij | PDi = du). Let MP represent a matrix that contains every puj, where j is the row index 
and 1 ≤ j ≤ J, and u is the column index and { },*,,1,0 Ku ∈ . Let BPj be a vector that represents 
the jth row in MP, i.e., BPj = (p0j, p1j, …, pKj, p*j). According to the conditional independence 
assumption of a naïve Bayes model and the assumption of parameter independence described 
above, P(Ei | PDi, MP) and h(MP) can thus be represented as follows: 
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By combining Equation 4.14, 4.15, and 4.16, we derive P(E = e | OD = dw, F = f) as 
follows: 
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By combining Equation 4.13 and Equation 4.17, we can derive P(E = e | OD = dw) and 
finally compute the likelihood ratio as described above. 
Recall from Section 4.2.2 that when OD ≠ none the disease state PDi is hidden for the ith 
person who came to the ED. Let NED be the number of people who came to the ED in the most 
recent 24 hours. If we solve Equation 4.17 using a brute-force method, we have to sum over 
every possible combination of values of hidden variables PDi for every possible person i who 
came to the ED. The time complexity is thus exponential in NED, as described in Section 4.2.3.  
Another option is to apply the relatively more efficient exact inference method, the BGF 
method, described in Section 4.2.3 (that uses grouping and factorization) for the univariate BH 
algorithm (Cooper 1995). However, when multiple disease symptoms are modeled, this inference 
method often turns out to be computationally intractable as well. Recall that each person is 
modeled having J symptoms in this multivariate version, and each symptom state of person i is 
modeled as being true or false using a Bernoulli distribution. For example, a person who came to 
the ED could have symptom states as being cough = true, fever = true, and diarrhea = false. If 
we use the BGF method, in the worst case, there will be a total number of u
ED
 = 2J groups. With 
this method the time required to compute P(E | OD, f) is ( )EDuEDNO , which is not 
computationally feasible when J and therefore u
ED
 is large. In this dissertation, I applied 
stochastic methods to approximate Equation 4.18, which is equivalent to Equation 4.17.  
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   (4.18) 
Recall that for PDi ≠ noED we had distributions over P(Eij = eij | PDi) represented as 
g(BPj) in Equation 4.18. Since current techniques allow directly sampling from g(BPj), which is a 
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Beta distribution, I investigated using Monte Carlo integration (Wasserman 2004) to 
approximate Equation 4.18. Monte Carlo integration is a method of approximating an 
expectation by the sample mean of a function of sampled random variables. Using sampling 
methods makes it easy to generalize the patient model (shown in Figure 4.2) beyond the naïve 
Bayes model. 
For each symptom j and each disease that person i could have, I sample M times from the 
Beta distribution of g(BPj) to get a total number of M sampled values. For each sample, I used the 
sampled value as the value of P(Eij = eij | PDi). Given a value of P(Eij = eij | PDi), as for example 
P(Eij = eij | PDi) = pj,d(m), we can use exact inference to efficiently compute P(E = e | OD = dw, F 
= f, pj,d(m)) from the Bayesian network in Figure 4.3 using Equation 4.19, where pj,d(m) is a 
sampled value for the probability of a patient with symptom j given that the patient has disease d.  
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 (4.19) 
In Equation 4.19, when OD = d0, PDi = d0; when OD = dk (or d*), PDi can take two 
values as PDi = d0 or dk (or PDi = d0 or d*). Thus, the summation in this equation takes O(J) 
time, where J is the total number of symptoms. Thus, computing Equation 4.19 requires O(J·N) 
time, where N is the total number of people in the population being monitored; thus, computing it 
is efficient. 
Using Monte Carlo integration over the statistic given by Equation 4.19, we can compute 
P(E = e | OD = dw, F = f), as shown in Equation 4.20, which requires a time complexity of 
O(J·N·M). 
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However, Monte Carlo integration might fail to converge, thus not giving an accurate 
approximation. Thus, I also investigated using importance sampling (Wasserman 2004) to 
approximate the integral in Equation 4.18.  
Importance sampling chooses a proposal distribution q from which to simulate a set of 
random variables, as opposed to directly sampling from the target distribution. A main reason for 
using importance sampling is the potential to reduce the variance of the approximation by an 
appropriate choice of the proposal distribution q, as samples from q may be more "important" for 
the estimation of the integral in the sense of having greater probability mass. Wasserman 
(Wasserman 2004) suggests using a proposal distribution that has a larger tail relative to the 
target distribution. I used a uniform distribution over [0, 1] as a proposal distribution and 
compared the simulation results with those using the basic Monte Carlo integration. I found that 
Monte Carlo integration converged well for solving the problem in this dissertation, and I think it 
is mainly because this problem contains relatively thicker-tailed target distributions (Beta 
distributions). 
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5.0  EXPERIMENTAL EVALUATION 
This chapter describes an experimental evaluation of the Bayesian hybrid detection algorithm. 
Section 5.1 describes the outbreak diseases and symptoms that were used for creating semi-
synthetic datasets. Section 5.2 describes how the experimental data were simulated using the 
selected diseases and symptoms.  
Recall from Chapter 1 that the hypothesis proposed is that modeling both known and 
unknown outbreak diseases in a hybrid system can lead to better expected disease outbreak 
detection performance than modeling known outbreak diseases only. Therefore, to test this 
hypothesis, I constructed a detection system that only models known outbreak diseases, which I 
call a disease-specific detector, and a hybrid detector that models both known and unknown 
outbreak diseases. The experimental evaluation compares the disease-specific detector and the 
hybrid detector in order to evaluate the hypothesis. Section 5.3 describes the experimental 
methodology, and Section 5.4 provides a detailed, technical statement of the dissertation 
hypothesis. Section 5.5 presents an overview of the representative experimental results. 
Section 5.6 contains results from using a uniform prior over the appearance of outbreak 
diseases being modeled. In particular, that section contains a statistical analysis for assessing 
whether the disease-specific detector and the hybrid detector perform significantly differently in 
terms of expected detection performance, and Section 5.7 contains a decision analysis that 
investigates the circumstances in which the hybrid detector has a greater expected utility than the 
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disease-specific detector in monitoring for a disease outbreak. Finally, Section 5.8 describes a 
sensitivity analysis over the prior probability of the appearance of an unknown disease d* or a 
partially-known disease d*p being modeled. 
5.1 CHOICES OF DISEASES AND SYMPTOMS 
Recall from Chapter 4 that there are 13 CDC-A+ diseases and 54 possible disease symptoms that 
we model. In this dissertation research, I chose three diseases from the 13 CDC-A+ diseases for 
use in the experiments described below. The three diseases are cryptosporidiosis, early stage 
anthrax, and inhalation tularemia. For each of the three diseases, I model three disease 
symptoms cough, headache, and abdominal pain. I selected the three diseases and the three 
symptoms because these diseases and their symptoms contain a wide variety of distributional 
patterns (over probability of a person’s symptom state given that person has a specific outbreak 
disease) among the 13 total CDC-A+ diseases as described below. 
Let pkj represent the probability of a person having the jth symptom, given that person has 
disease dk, where 1 ≤ j ≤ 3 and 1 ≤ k ≤ 3. The distributions over pkj were estimated by using 
expert assessment as described in Section 4.1.2. Recall from Section 4.3.2 that P(Eij | PDi = dk) 
also is denoted pkj for a specific person i. Figure 5.1a-c plot the distributions over P(Eij = 
abdominal pain | PDi = dk), P(Eij = cough | PDi = dk), and P(Eij = headache | PDi = dk), 
respectively, where dk is either cryptosporidiosis, early stage anthrax, or inhalation tularemia. 
That is, as discussed in Chapter 3, we do not assume that these probabilities are known precisely, 
but rather, there is a distribution over them. 
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The following sections describe how I use these three diseases and their symptoms to 
create datasets and set up the experiments. 
 
 
5.2 CREATING DATASETS 
I created datasets by using information from real ED events along with simulated outbreak cases 
produced by a linear outbreak simulator called the FLOO simulator (Neill 2005), which is 
Figure 5.1 The probability density functions of each symptom probability given each disease. 
 90 
described in detail below. A time series of real ED cases was used to generate the number of 
patients who came to the ED in the previous 24-hour period. 
I obtained real ED cases for 2004 and 2005 from several hospitals in Allegheny County, 
Pennsylvania, of which I selected the largest hospital to obtain information for use in my 
dissertation experiments. The mean number of patients who visited the ED of this hospital per 
day was about 130, and the population size that is covered by this hospital is approximately 
60,000. The time series of real ED cases of the hospital was used to determine the number of 
people who came to the ED on a given day without any disease outbreak. 
The MBH algorithm takes as input evidence from every person in the population from the 
most recent 24-hour period, where each person has three symptom states (cough, headache, and 
abdominal pain) that can each either be present or absent, as described in Section 5.1. Every 
dataset is generated by overlaying the simulated outbreak cases onto a time series of background 
cases. Recall that the three symptom states are modeled as conditionally independent. Thus, 
assuming this state of independence, I simulate the symptom states of background cases and 
outbreak cases. The background time series was generated using the time series of real ED cases, 
where I use n0 to represent the number of ED cases for a specific day. On any given day (on or 
after midnight that day and before midnight the next day), I sampled from Beta(α0j, β0j) to 
determine the probability (p0j) of a person having symptom j, given that person had disease d0 as 
described in the non-outbreak disease model in Section 4.1.1, where 1 ≤ j ≤ 3. I then sampled 
from Beta(n0, p0j) to determine the number of people having that symptom when there was no 
disease outbreak in the population on that day, where n0 is the number of people who in reality 
came to the ED on that day. I did this for each of the three symptoms I selected. Thus, for 
example, a possible ED patient case that might be generated by this process is (cough = present, 
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headache = absent, abdominal pain = absent). A total of n0 such cases would be generated for the 
current day. These generated cases with simulated symptom states are called background cases 
for that day. Note that I only created a single time series of background cases for all the 
experiments described below. Every dataset (outbreak scenario) was created by overlaying the 
simulated outbreak cases (as described below) onto this time series of background cases. 
From among the three outbreak diseases (cryptosporidiosis, early stage anthrax, and 
inhalation tularemia) being used in the evaluation, dk represents the specific outbreak disease 
that is occurring. The simulated outbreak cases with disease dk were generated using the 
“Fictional Linear Onset Outbreak” (or “FLOO”) simulator described in (Neill 2005), where dk 
(for 1 ≤ k ≤ 3) represents a specific outbreak disease out of the three diseases I selected. A 
simulated FLOO(Δ,T) outbreak has duration T. It generates tΔ cases on day t of the outbreak (0 < 
t ≤ T/2), and then generates TΔ/2 cases per day for the remainder of the outbreak. Figure 5.2 
shows an example of outbreak cases generated using FLOO(1, 10), in which the maximum 
number of outbreak cases generated is calculated as TΔ/2 = 10 × 1 / 2 = 5, as shown in this 
figure. 
Let nk be the simulated outbreak cases generated by FLOO(Δ,T) per day. I sampled from 
the Beta distribution, Beta(αkj, βkj), to determine the probability (pkj) of a person having symptom 
j, given that person had disease dk, as described in the disease-specific model in Section 4.1.2. I 
then sampled from Beta(nk, pkj) to determine the number of the outbreak cases having disease dk 
with symptom j, where 1 ≤ k ≤ 3 and 1 ≤ j ≤ 3. Thus, for example, a possible outbreak patient 
case having disease dk that might be generated by this process is (cough = present, headache = 
present, abdominal pain = absent). A total of nk such cases would be generated for the current 
day. 
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I applied the method described in (Cooper 2004) to randomly generate the onset dates of 
the simulated outbreak due to disease dk. That is, I randomly selected 8 dates from each of the 12 
consecutive months in 2005 as the starting dates in which simulated outbreaks due to disease dk 
were created. I created one dataset by overlaying the simulated outbreak cases produced by 
FLOO(Δ,T) onto the background ED cases starting from the onset date to T-1 days thereafter. I 
thus created 8 × 12 = 96 datasets (scenarios) of outbreaks due to disease dk.  
In order to evaluate the BH algorithm’s detection performance using different scales of 
disease-outbreak scenarios, I generated outbreak cases using three sets of FLOO parameters. To 
specify the FLOO parameters, I first estimated the standard deviation (σ0) of the number of ED 
patients per day from real ED data for 2004; σ0 ≈ 8. I then created three disease-outbreak 
scenarios, FLOO(1, 10), FLOO(2, 14) and FLOO(4, 14), in which the maximum outbreak cases 
overlaid per day correspond to approximately 0.6σ0 (low severity), 1.8σ0 (medium severity) and 
3.5σ0 (high severity), respectively. Using each of these three FLOO parameter settings, I 
Figure 5.2 An example showing outbreak cases generated using FLOO(1,10), in which 1, 2, 3, 4 outbreak cases 
were generated on day 1 to day 4, respectively, and 5 outbreak cases were generated per day for day 5 to day 10. 
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generated 96 outbreak scenarios for a specific disease and three evidential features. The outbreak 
cases in each of these outbreak scenarios were overlaid onto the single time series of ED 
background cases to generate a complete scenario. 
Recall that the three diseases in the experiments are cryptosporidiosis, early stage 
anthrax, and inhalation tularemia. As mentioned above, for each disease I used three different 
FLOO(Δ,T) settings to inject cases. A total of 3 (FLOO setting possibilities) × 3 (disease 
possibilities) × 96 (outbreak scenarios) = 864 datasets were created, with each containing three 
evidential features per patient case (cough, headache, and abdominal pain) that could each be 
either present or absent. 
Discussion of noise effects of the datasets 
Recall from Section 4.1 that the frequency of a symptom state in the individuals with the non-
outbreak disease d0 is assumed to have a Beta distribution, as for example the frequency of 
cough in the individuals with d0. Using this example, the simulated cough cases with d0 were 
generated using a Beta-Binomial model. The remainder of this section shows that the variance of 
the number of cough cases generated from the Beta-Binomial model is greater than the variance 
of cases that would be generated by the Beta model (except when the total number of ED cases 
for a specific day is one, in which the two variances are equal). Thus, by design the data contain 
considerable noise, which arguably makes it more realistic than having less noisy data. 
Let n be the total number of ED cases for a specific day; Appendix B contains the actual 
number of cases used in the experiments. For each of the n cases, I determined its cough status 
by simulating from the Beta model. Let pi be a random sample for the ith ED case drawn from 
the Beta model of disease d0, then pi represents the probability that the ith ED case is a cough 
case.  Let Ii be an indicator of the event that the ith ED case is a cough case. Then Ii takes values 
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0 and 1, and the probability of Ii equals 1 is pi. Let X be a random variable that represents the 
number of cough cases generated from the Beta model. Then X is the sum of Ii for i from 1 to n, 
and I1,…, In are independent. Thus, we derive the variance of X as  
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Alternatively, let us consider that the number of cough cases with disease d0 is 
determined by sampling from the Beta-Binomial model. Let Y be a random variable that 
represents the number of cough cases generated from the Beta-Binomial model. Let p be a 
random variable that represents the probability of cough and follows a Beta distribution. Thus, 
by law of total variance (Bertsekas 2002), we can derive the variance of Y as follows: 
( ) ( )( ) ( )( )pZpZY |EVar|VarEVar += , 
where Z is a random variable of the Binomial model with parameter p. Then we have Var(Z | p) 
= np(1 – p) and E(Z) = np. By definition, p has the same distribution as p1. Thus,  
( ) ( )[ ] ( ) [ ] ( )1211 VarEVar1EVar npppnnppnpY +−=+−= . 
Given ( ) ( ) ( ) ( )( )[ ]21212121 EEVarVar ppnpnnp −== , we can further write Var(Y) as 
( ) ( ) ( ) ( ) ( )( )[ ]
( ) ( ) ( ) ( )( )[ ]
( ) ( )( )[ ]. EE
EEEE
EEEEVar
2
11
2
1
2
1
2
11
2
1
2
1
22
11
ppn
ppnpnpn
ppnpnpnY
−=
−+−≥
−+−=
, since n ≥ 1. The equality holds when n = 1. 
The above two equations show that when more than one patient case present to the ED, 
the number of cough cases generated from the Beta-Binomial model has a greater variance than 
those generated from the Beta model. Thus, besides the general noise (random) effects associated 
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with random symptom-state-sampling, there is another level of noise effects that result from 
sampling from using the Beta-Binomial model, which results in a greater variance than sampling 
from the Beta model. 
5.3 EVALUATION METHODS 
In order to evaluate the disease-specific model (DSM), the unknown disease model (UDM), and 
the partially-known disease model (PDM) described in Section 4.1, I first constructed outbreak 
detection systems using each of these models in the framework of the univariate BH (UBH) 
algorithm and the multivariate BH (MBH) algorithm, respectively, and then evaluated the 
detection performance of these algorithms, as described below.  
5.3.1 Experimental design 
Recall from Section 1.2 that the hypothesis of this dissertation is that modeling both known and 
unknown outbreak diseases in a hybrid system can lead to better expected disease outbreak 
detection performance than modeling known outbreak diseases only. In order to evaluate this 
hypothesis, I constructed two experiments in which an outbreak is occurring due to some disease 
du with the characteristics: (1) disease du is known to us and has been modeled in DSM, and (2) 
disease du is unexpected and not explicitly modeled in DSM. 
I first describe an example of a disease outbreak due to early stage anthrax, namely du = 
early stage anthrax. I construct two experiments, as described above, which are denoted as Exp. 
1 and Exp. 2, respectively. In Exp. 1, we assume that early stage anthrax is modeled in DSM. In 
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UDM, we not only model early stage anthrax but also model an unknown disease d*. Similarly in 
PDM, we model early stage anthrax and a partially-known disease d*p. Since early stage anthrax 
is known to us in Exp. 1, the partially-known disease is modeled using a mixture of prior 
distributions that is composed of a uniform prior distribution and the three selected outbreak 
diseases cryptosporidiosis, early stage anthrax, and inhalation tularemia. In Exp. 1, d* in UDM 
(d*p in PDM) is an extra disease that is not actually occurring in the experiment. An extra disease 
increases the number of false alert disease possibilities. Thus, detection performance might 
degrade relative to DSM, which only is modeling the actual outbreak disease in Exp. 1. 
Nonetheless, I conjecture that modeling d* (d*p) will not significantly degrade detection 
performance because d* and d*p are able to model du. Exp. 1 investigates the extent to which this 
conjecture holds. 
In Exp. 2, we assume that we do not know the outbreak disease that is causing an 
ongoing disease outbreak. In Exp. 2, suppose DSM models only cryptosporidiosis as a possible 
outbreak disease. Suppose also that in addition cryptosporidiosis, UDM also models an unknown 
disease d*, and PDM models a partially-known disease d*p using a mixture of prior distributions 
that is composed of a uniform prior distribution and the priors of two of the three selected 
outbreak diseases that we know about and have modeled, namely, cryptosporidiosis and 
inhalation tularemia. Suppose that the simulated outbreak is due to early stage anthrax. Since 
DSM does not model early stage anthrax, it may be difficult for it to detect it. In contrast, UDM 
contains the “catch all” disease d* that can match a wide variety of disease presentations, 
including early stage anthrax. Thus, UDM’s detection performance might surpass that of DSM. 
By similar reasoning, PDM’s detection performance might surpass that of DSM as well. Exp. 2 
investigates whether these results occur. 
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Table 5.1 summarizes the two experiments constructed for DSM, UDM, and PDM, in 
which the two experiments are denoted as Exp. 1 and Exp. 2, respectively. In this table, both 
experiments have simulated outbreaks due to disease du, which is one of the three selected 
diseases (cryptosporidiosis, early stage anthrax, and inhalation tularemia) and is determined 
using leave-one-out experiments as described below. Disease du is being modeled in DSM, 
PDM, and UDM in Exp. 1. In contrast in Exp. 2 du is not being modeled in any of these three. 
DSM models disease du in Exp. 1, while it models another (known) disease dv in Exp. 2, where 
dv ≠ du. In each of the two experiments, UDM models an unknown disease d* using the method 
described in Section 4.1.3, and PDM models a partially-known disease d*p using the method 
described in Section 4.1.4. 
See Section 4.1 for the general methods for modeling non-outbreak diseases and for 
modeling outbreak diseases that are known, unknown, and partially-known. In the remainder of 
this section, I describe how I model these diseases in the specific experiments summarized by 
Table 5.1. 
Table 5.1 A 2 × 3 table that summarizes the two experiments that each involves the use of a disease-specific model 
(DSM), an unknown disease model (UDM), and a partially-known disease model (PDM). 
 DSM UDM PDM 
Exp. 1 
Model d0, du. 
Simulate outbreak cases 
from du. 
Model d0, du, d*. 
Simulate outbreak cases 
from du. 
Model d0, du, d*p. 
Simulate outbreak cases 
from du. 
 
Exp. 2 
Model d0, dv. 
Simulate outbreak cases 
from du. 
Model d0, dv, d*. 
Simulate outbreak cases 
from du. 
Model d0, dv, d*p. 
Simulate outbreak cases 
from du. 
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In each model (DSM, UDM, and PDM) of Exp. 1 and Exp. 2, we model a non-outbreak 
disease d0 using past ED data that are assumed to contain no disease outbreaks. We also need to 
model a specific known outbreak disease du (or dv), which is modeled using expert judgment. See 
Section 4.1.1 and Section 4.1.2 for a detailed description of modeling of d0 and du (or dv), 
respectively. 
UDM in Exp. 1 and Exp. 2 needs to model an unknown outbreak disease d* using a non-
informative prior distribution, for which I use a uniform distribution. See Section 4.1.3 for a 
detailed description of the modeling of the d* disease. 
Recall from Section 4.1.4 that I use a mixture of priors to model a partially-known 
disease d*p in terms of symptom j in the PDM models, and M represents the number of known 
diseases that have been modeled in the mixture. Using the three selected diseases 
(cryptosporidiosis, early stage anthrax, and inhalation tularemia) I carry out leave-one-out 
experiments, in which the disease that is left out is the disease du that will be simulated to cause 
an outbreak in Exp. 1 and in Exp. 2. Exp. 1 simulates a scenario in which the ongoing outbreak is 
caused by a disease that we know about and have modeled, thus we have M = 3 in Exp. 1; Exp. 2 
simulates a scenario in which the ongoing outbreak is due to an unknown disease du, therefore, 
we have M = 3 – 1 = 2 in Exp. 2.  
Thus there are 3 + 1 = 4 components in the mixture model in Exp. 1 and 2 + 1 = 3 
components in the mixture model in Exp. 2. In each experiment, the additional component 
represents the condition that we know little about (d*p regarding symptom j), and we use a 
uniform distribution on [0, 1] to model this component of the mixture. Recall from Section 4.1.4 
that each component in the mixture model has a prior that represents possible similarities in 
distribution between disease d*p and any disease of the four components. I assume a uniform 
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prior probability over these components. Thus, the symptom j of the partially-known disease d*p 
is modeled as follows: 
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where ( )jkjkk pf θ;  is a Beta distribution, which is an informative prior derived for the kth disease, 
as described in Section 4.1.2, U[0,1] represents a uniform prior distribution, M = 3 in Exp.1, and 
M = 2 in Exp. 2. 
5.3.2 Experimental procedures 
In each of the 2 × 3 = 6 detection systems constructed in Exp. 1 and Exp. 2 in Table 5.1, I 
compute the likelihood ratio LR = P(E = e | O = OB) / P(E = e | O = NOB) using the following 
equation, as described in Section 4.2.3.  
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In the UDM model in Exp. 1, the sum in Equation 5.2 is taken over du and d*, and in the 
UDM model in Exp. 2, the sum in Equation 5.2 is taken over dv and d*; in contrast, in the DSM 
model in Exp. 1, the sum of OD consists only of the term du, and in the DSM model in Exp. 2, 
the sum of OD consists only of dv. The PDM model applies the same strategy as the UDM model 
when using Equation 5.2, but sums over d*p and du in Exp. 1 (or d*p and dv in Exp. 2). 
I performed sensitivity analysis and used a sequence of probability values for P(OD = d* | 
O = OB) and P(OD = d*p | O = OB). Section 5.8 contains a detailed description of this analysis. 
To convey the basic approach, I restrict this chapter to an example that uses a single prior 
probability for P(OD = d* | O = OB). For any given outbreak disease du (or dv) being modeled, I 
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assume a uniform prior over the specific disease du (or dv) and d*, which yields that P(OD = du | 
O = OB) = P(OD = d* | O = OB) = 0.5 or P(OD = dv | O = OB) = P(OD = d* | O = OB) = 0.5. 
Similarly, this uniform prior was applied to the specific disease du (or dv) and d*p for the PDM 
model described in this chapter. 
Recall from Section 4.2.3 and Section 4.3.3 that there is a fraction node that needs to be 
involved in computing the likelihood ratio in Equation 5.2. I constructed the fraction node in 
Figure 4.1 (for the UBH algorithm) and in Figure 4.3 (for the MBH algorithm) using a sequence 
of uniformly distributed values as f = i/N for i = 1 to 10, where N is the total number of people in 
the population. Recall that the standard deviation (σ0) of the mean number of ED patients per day 
from real ED data for 2004 is approximately σ0  = 8. By recognizing a small number of outbreak 
cases (from one case to 1σ0 cases, namely 1, 2, …, 8), the detection system can detect disease 
outbreaks early. For each value f among the ten, I compute P(E = e | OD = du, F = f) and P(E = e 
| OD = dv, F = f) as shown in Equation 4.9. I then compute P(E = e | OD = du), P(E = e | OD = 
dv), and P(E = e | OD = d0) for the UBH algorithm, as described in Section 4.2.3 and compute the 
above probabilities for the MBH algorithm, as described in Section 4.3.3. I finally compute the 
likelihood ratio using Equation 5.2. 
 I ran the UBH algorithm and the MBH algorithm using the 2 × 3 experimental setup 
given in Table 5.1, as described next. 
UBH algorithm: I ran the UBH algorithm on the datasets described in Section 5.2 
assuming a given dataset only contains a single evidential feature that is either abdominal pain, 
cough, or headache. In a given dataset, a simulated patient who came to the ED could either have 
that symptom or not. The UBH algorithm took as input such data during the most recent 24-
hours of simulated time. 
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 Using the three selected diseases that are described in Section 5.1, I did leave-one-out 
experiments. The disease that is left out is the disease du that will be simulated to cause an 
outbreak in Exp. 1 and in Exp. 2. Recall from Section 5.1 that I also selected three symptoms 
(abdominal pain, cough, or headache) to be the evidential features, and the UBH algorithm is 
run on one feature (out of the three features) at a time. I created 96 semi-synthetic datasets using 
each FLOO(Δ,T) setting, of which there are three parameter settings for Δ and T, as described in 
Section 5.2. In Exp. 1, I thus created 3 (disease possibilities for du) × 3 (symptom possibilities) × 
3 (FLOO setting possibilities) = 27 experimental configurations. I then ran the UBH algorithm a 
total of 3 (disease models: DSM, UDM, and PDM) × 27 (experimental configurations) = 81 
times, and there are 96 outbreak scenarios to run each time. In Exp. 2, I created 3 (disease 
possibilities for du) × 2 (disease possibilities for dv) × 3 (symptom possibilities) × 3 (FLOO 
setting possibilities) = 54 experimental configurations and ran the UBH algorithm a total of 3 
(disease models: DSM, UDM, and PDM) × 54 (experimental configurations) = 162 times, and 
there are 96 outbreak scenarios to run each time.  
MBH algorithm: I ran the MBH algorithm on the multivariate datasets described in 
Section 5.2. Given the three diseases, I did leave-one-out experiments as described above. As 
opposed to the UBH algorithm, the MBH algorithm takes as input the three evidential features 
(abdominal pain, cough, or headache) for each patient case during the most recent 24-hours of 
simulated time. In Exp. 1, I thus created 3 (disease possibilities for du) × 3 (FLOO setting 
possibilities) = 9 experimental configurations and ran the MBH algorithm a total of 3 (disease 
models: DSM, UDM, and PDM) × 9 (experimental configurations) = 27 times, and there are 96 
outbreak scenarios to run each time. In Exp. 2, I created 3 (disease possibilities for du) × 2 
(disease possibilities for dv) × 3 (FLOO setting possibilities) = 18 experimental configurations 
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and ran the MBH algorithm a total of 3 (disease models: DSM, UDM, and PDM) × 18 
(experimental configurations) = 54 times, and there are 96 outbreak scenarios to run each time.  
Thus, for a specific experimental configuration described above, there are 96 outbreak 
scenarios to run for a specific disease model (DSM, UDM, or PDM) of a specific detection 
algorithm (UBH or MBH).  
Given the output of the likelihood ratio of one outbreak scenario, I determined its 
detection time and false alert rate for various detection-ratio thresholds. The detection time is the 
time from the simulated release until the detection-ratio threshold r was exceeded. If a detection 
threshold has never been exceeded using the output likelihood ratios, the detection time was 
taken as the maximum duration time of the outbreak. For example, if this happens in an outbreak 
scenario created using FLOO(1,10), then the detection time is taken to be 10 days. The false alert 
rate is derived as FP / M, where FP is the number of false alerts that occurred using threshold r 
when each experiment monitored the time series of simulated ED cases (12 months) in which 
there is no (simulated) outbreak, and M is length in months in that time series, namely, M = 12. 
For each algorithm (UBH and MBH), I applied this process to the 96 outbreak scenarios, 
computed the expected detection time over the 96 outbreak scenarios, and plotted AMOC curves 
(Fawcett 1999) for DSM, UDM, and PDM in Exp. 1 and for DSM, UDM, and PDM in Exp. 2. 
As described above, I thus plotted 27, 54, 9, and 18 sets of AMOC curves for the UBH algorithm 
in Exp. 1, the UBH algorithm in Exp. 2, the MBH algorithm in Exp. 1, and the MBH algorithm 
in Exp. 2, respectively, where each set contains three AMOC curves that correspond to DSM, 
UDM, and PDM, respectively.  
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5.4 TECHNICAL STATEMENT OF THE HYPOTHESIS 
Chapter 1 provided the following qualitative statement of the dissertation hypothesis: 
Modeling both known and unknown outbreak diseases in a hybrid system can lead to 
better expected disease outbreak detection performance than modeling known outbreak 
diseases only. 
The chapters and sections since Chapter 1 have provided significant detail related to how to 
evaluate the above hypothesis. Given that detail, it is now possible in the current section to 
provide a more technical statement of the dissertation hypothesis.  
Let event G denote the following event: Given that an outbreak is occurring, the outbreak 
disease is not explicitly being modeled in the detection system. According to Table 5.1, G is true 
in Exp. 2 and is false in Exp. 1. Let q be the probability that G is true. Recall that we wish to 
evaluate whether modeling an unknown or a partially-known disease (in the form of d* or d*p) 
yields a net gain in detecting disease outbreaks. This evaluation is relative to q. If q = 1, then 
modeling d* or d*p will likely be helpful. If q = 0, however, modeling d* or d*p will be useless 
and possibly harmful by allowing more chances for a false alert alert. At the end of this chapter, 
based on the experimental results that follow, I describe a decision analysis that derives range of 
values of q for which modeling d* or d*p yields a net expected gain in detection performance. 
I represent models DSM, UDM, and PDM in Exp. 1 as DSM1, UDM1, and PDM1, 
respectively, and likewise represent models DSM, UDM, and PDM in Exp. 2 as DSM2, UDM2, 
and PDM2. Let EDSM1 be the average detection time of DSM1 over all the experiments 
constructed for the UBH algorithm described in Section 5.1-5.3 at a false alert rate of one per 
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month11
The dissertation hypothesis can now be stated more precisely as follows: 
. Let EDSM2 be the average detection time of DSM2 over all the experiments constructed 
for the UBH algorithm described in Section 5.1-5.3 at a false alert rate of one per month. Let 
EDSM = (1 - q) × EDSM1 + q × EDSM2. Define EUDM and EPDM analogously. 
There exists a q < 1 such that EPDM <EUDM < EDSM. 
If the experimental results support the above hypothesis, they will also support the qualitative 
hypothesis described at the beginning of this section. 
5.5 OVERVIEW OF REPRESENTATIVE RESULTS 
This section presents the AMOC curves of a selection of representative experimental 
configurations out of all those described in Section 5.3.2. In this section, for brevity I describe an 
experimental configuration using the following notation: du, FLOO(∆,T), and the symptom. An 
example is du = inhalation tularemia, FLOO(∆, T) = FLOO(4,14), and symptom = cough. This 
example represents an experimental configuration with 96 simulated outbreak scenarios due to 
disease inhalation tularemia, with simulated inhalation tularemia cases generated using FLOO 
simulator with parameter ∆ = 4 and T = 14, and with each outbreak case being observed present 
or absent for the symptom cough.  
If a symptom is specified in an experimental configuration, such as the symptom cough, 
then the univariate BH algorithm (UBH) using a specific model (DSM, UDM, or PDM) is run 
under that experimental configuration; if a symptom is specified as multivariate, then the 
                                                 
11 A directly analogous hypothesis exists and will be tested for UBH at zero false alerts per month, for 
MBH at one false alert per month, and for MBH at zero false alerts per month as well, but for brevity these are not 
described here explicitly.  
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multivariate BH algorithm (MBH) using a specific model (DSM, UDM, or PDM) is run, and the 
model used is specified in the legend of each figure. For example, an experimental configuration 
of du = inhalation tularemia, FLOO(∆,T) = FLOO(4,14), and symptom = multivariate represents 
running the MBH algorithm on 96 simulated outbreak scenarios of inhalation tularemia, with 
simulated inhalation tularemia cases generated using FLOO(4,14), and with each case symptoms 
abdominal pain, cough, and headache with a value of present or absent. 
5.5.1 AMOC curves of the UBH algorithm 
Figure 5.3 shows three sets of AMOC curves for the UBH algorithm when the simulated 
outbreak is due to inhalation tularemia and the symptom being modeled is cough. The figure 
caption explains additional details. 
Figure 5.3a shows the AMOC curves for Exp. 1 using the above experimental 
configuration, where the simulated outbreak is due to disease inhalation tularemia, which is 
being modeled. As shown, DSM performs slightly better than UDM and PDM. In particular, at 
one false alert per month, which is frequently cited as an upper bound of a tolerable rate, UDM 
has an expected detection time of approximately 3.6 days while DSM and PDM each has an 
expected detection time of approximately 2.9 days. Thus, DSM and PDM detect a simulated 
inhalation tularemia outbreak about 0.7 days earlier than UDM. At zero false alerts per month, 
the three models take approximately the same time to detect the disease outbreak. This result 
supports that when an existing outbreak disease is being modeled (in this situation it is inhalation 
tularemia), then also modeling d* in UDM (or d*p in PDM) does worsen the performance 
somewhat, but not dramatically. 
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Figure 5.3 (a) shows the AMOC curves of Exp. 1, and (b)-(c) show the AMOC curves of Exp. 2 with dv = 
cryptosporidiosis in (b) and dv = early stage anthrax in (c). 
 
Figure 5.3b and 5.3c show the AMOC curves for Exp. 2, where the outbreak disease 
inhalation tularemia is not being explicitly modeled. In contrast, only cryptosporidiosis is 
explicitly modeled in the experiment that has the results shown in Figure 5.3b. Similarly, only 
early stage anthrax is explicitly modeled in the experiment shown in Figure 5.3c. In Figure 5.3b, 
at one false alert per month, DSM has an expected detection time of 7.5 days, and PDM has an 
Experimental configuration: 
du = inhalation tularemia, FLOO setting = FLOO(4,14), and symptom = cough 
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expected detection time of 5.6 days. UDM, however, has an expected detection time of only 4.8 
days, which is 2.7 days earlier than DSM and 0.8 days earlier than PDM. In Figure 5.3c, the gain 
in detection time of UDM over DSM is not as large as that in Figure 5.3b, due to the fact that the 
distribution of the probability of the cough symptom of inhalation tularemia and that of early 
stage anthrax are similar, as shown previously in Figure 5.1. The results in Figure 5.3b and 5.3c 
support that when the ongoing outbreak disease is not being explicitly modeled, then modeling 
d* or d*p can be quite helpful in detecting the unmodeled disease. While Figure 5.3 shows a set of 
experimental results that support the dissertation hypothesis, there are some exceptions, as shown 
below. 
Figure 5.4a shows the AMOC curves for Exp. 2 using an experimental configuration of 
du = cryptosporidiosis, FLOO(2,14), and abdominal pain, where an ongoing outbreak is caused 
by cryptosporidiosis, which is not modeled in the detection model, while just disease inhalation 
tularemia is modeled in DSM, UDM, and PDM. The dissertation hypothesis predicts that 
modeling an unknown disease d* in UDM and d*p in PDM would help detect the disease 
outbreak. That is, UDM and PDM are expected to have better expected detection performance 
than DSM. However, as shown in Figure 5.4a, DSM has a slightly shorter expected detection 
time than UDM and PDM at the false alert rates of zero and one per month.  
Figure 5.4b provides the AMOC curves for Exp. 2 using an experimental configuration of 
du = inhalation tularemia, FLOO(2,14), and abdominal pain, where an ongoing outbreak is 
caused by inhalation tularemia, which is not modeled in the detection model, while just disease 
cryptosporidiosis is modeled in DSM, UDM, and PDM. As described above, it is expected that 
UDM and PDM would have better expected detection performance than DSM. However, the 
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results again show that DSM has modestly better expected detection performance than UDM and 
PDM. 
A possible reason for the results in Figure 5.4a and 5.4b is that cryptosporidiosis and 
inhalation tularemia have a similar distribution of the symptom abdominal pain (as shown in 
Figure 5.1a). Thus, even when an ongoing outbreak is due to cryptosporidiosis, modeling 
inhalation tularemia only in DSM would lead to a better expected detection performance than 
modeling it in UDM and PDM. An analogous explanation exists for the exception shown in 
Figure 5.4b. 
Experimental configuration:  
du = cryptosporidiosis, FLOO setting = 
FLOO(2,14), and symptom = abdominal pain 
 
Experimental configuration:  
du = inhalation tularemia, FLOO setting = 
FLOO(2,14), and symptom = abdominal pain 
 
Figure 5.4 AMOC curves of two experimental configurations for Exp. 2. 
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Figure 5.5a shows the AMOC curves for Exp. 1 in an experimental configuration of du = 
early stage anthrax, FLOO(1,10), and abdominal pain, where DSM is expected to outperform 
UDM and PDM. However, the three models have similar expected detection performance. In 
particular, at zero false alerts per month, each of the three models has an expected detection time 
at approximately 10 days, which means the three models barely detect the ongoing outbreak in 
most of the 96 outbreak scenarios. Using FLOO(1,10), the maximum number of early stage 
anthrax cases overlaid onto the background cases is 1 × 10 / 2 = 5, which is less than one 
standard deviation (σ0 = 8) of the background time series. It appears that the outbreak signal in 
this experimental configuration is too weak for any disease model to perform detection well, thus 
making all three disease models perform equally poorly.  
I then overlaid more early stage anthrax cases onto the background cases using 
FLOO(4,14) while keeping other parameters in the experimental configuration the same as those 
in Figure 5.5a. Using FLOO(4,14) makes the maximum number of early stage anthrax cases 
Experimental configuration:  
du = early stage anthrax, FLOO setting = 
FLOO(1,10), and symptom = abdominal pain 
 
Experimental configuration:  
du = early stage anthrax, FLOO setting = 
FLOO(4,14), and symptom = abdominal pain 
 
Figure 5.5 AMOC curves of two experimental configurations for Exp. 1. 
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equal to 4 × 14 / 2 = 28, which is 4 cases more than three standard deviations of the background 
time series. Figure 5.5b shows the AMOC curves for this new experimental configuration, where 
DSM outperforms UDM and PDM, as expected. In particular, at one false alert per month, UDM 
has an expected detection time of 6.7 days while DSM has an expected detection time of 6 days, 
which is 0.7 days faster. 
Figure 5.6a also shows an exception in Exp. 1, where DSM has detection performance 
similar to UDM and PDM. However, it was expected that DSM would outperform UDM and 
PDM in this experimental configuration because an ongoing outbreak is due to cryptosporidiosis, 
which is known to us and explicitly modeled in DSM. When a stronger outbreak signal is 
injected in the experiment constructed in Figure 5.6b, DSM detects the outbreak 1.8 days faster 
than UDM at zero false alerts per month and 1.2 hours faster than UDM at one false alert per 
month. 
Experimental configuration:  
du = cryptosporidiosis, FLOO setting = 
FLOO(1,10), and symptom = cough 
 
Experimental configuration:  
du = cryptosporidiosis, FLOO setting = 
FLOO(4,14), and symptom = cough 
 
Figure 5.6 AMOC curves of two experimental configurations for Exp. 1. 
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It is somewhat surprising that UDM performs no worse than PDM in Exp. 2 in some 
outbreak scenarios, as for example the scenario shown in Figure 5.4a-b at one false alert per 
month. We now discuss a rationale for these results. In Exp. 2, a mixture of priors is used for 
implicitly modeling disease du, which is the cause of the ongoing outbreak. PDM computes a 
likelihood using a mixture of priors that is composed of three components: a uniform distribution 
and the prior distribution for each of the two diseases other than du. If each of these two diseases 
has a probability distribution of its symptom state that is quite different than that of disease du, 
then it is not surprising that the proposed mixture of priors is not as effective as the uniform prior 
in modeling unknown disease. For example, as shown Figure 5.1b, the three selected outbreak 
diseases have little overlap in their probability distributions for cough. Whichever among the 
three diseases has been selected as disease du that causes the ongoing outbreak, the mixture of 
priors that contains the other two diseases is expected to not be as effective as the uniform prior 
in modeling disease du. Figure 5.7 shows such an example where the ongoing outbreak is due to 
disease early stage anthrax, namely du = early stage anthrax. The uniform distribution shown in 
this graph will get a greater likelihood than the mixture distribution if the cough states of early 
stage anthrax cases were obtained by simulating P(cough | du) with du = early stage anthrax. 
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5.5.2 AMOC curves of the MBH algorithm 
Recall from the experiments associated with Figure 5.6a that each of the DSM, UDM, and PDM 
models barely detected the outbreak in the 96 outbreak scenarios using the UBH algorithm. In 
particular, the expected detection time at zero false alerts per month is approximately 10 days. 
Figure 5.8a-c show the experimental configurations of du = cryptosporidiosis and FLOO(1,10) of 
Exp. 1 and Exp. 2 using the MBH algorithm. As opposed to the UBH algorithm, the MBH 
algorithm has an expected detection time (at zero false alerts per month) of 9.1 days for each of 
the DSM, UDM, and PDM models, which is 0.9 days faster than using the UBH algorithm. 
These results suggest that the MBH algorithm performs better than the UBH algorithm in 
outbreak detection. As with the case of comparing the performance of the three disease models, 
it was expected that DSM would outperform UDM and PDM in 5.8a, and UDM and PDM would 
Figure 5.7 Probability density functions of the probability of cough given outbreak disease early stage anthrax, the 
unknown disease d*, and the partially-known disease d*p. The mixture distribution is composed of a mixture of a 
uniform distribution, the distribution for cryptosporidiosis, and the distribution for inhalation tularemia. 
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outperform DSM in 5.8b-c. However, the performance of DSM, UDM, and PDM are at 
approximately the same level in the experimental configurations in 5.8a-c. I conjecture that the 
outbreak signal in this experimental configuration is not strong enough for the three disease 
models to be differentiated, in a way similar to what was seen in the UBH results above. 
I then injected more outbreak cases using FLOO(4,14) while keeping other parameters in 
the experimental configuration the same as those in Figure 5.8a-c. Figure 5.8d-f show the 
AMOC curves for Exp. 1 and Exp. 2 using these stronger outbreaks. In particular, as shown in 
Figure 5.8d, DSM detects the outbreak 1.2 days faster than UDM and 0.3 days faster than PDM 
at one false alert per month, as expected. As shown in Figure 5.8e, UDM has an expected 
detection time that is 1.8 days shorter than DSM, and PDM has an expected detection time that is 
one day shorter than DSM at one false alert per month, as expected. The results in Figure 5.8f 
also show that UDM and PDM perform slightly better than DSM in detecting the ongoing 
disease outbreak due to cryptosporidiosis. The results in Figure 5.8d-f support the hypothesis 
that DSM would outperform UDM and PDM in Exp. 1, and UDM (and PDM) outperform DSM 
in Exp. 2. 
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Experimental configuration:  
du = cryptosporidiosis, FLOO setting = 
FLOO(1,10), and symptom = multivariate 
 
Experimental configuration:  
du = cryptosporidiosis, FLOO setting = 
FLOO(4,14), and symptom = multivariate 
 
Figure 5.8 (a) and (d) shows the AMOC curves for Exp. 1, and (b), (c), (e), (f) show the AMOC curves for Exp. 2 
with dv = early stage anthrax in (b) and (e), and dv = inhalation tularemia in (c) and (f). The plots in (d)-(f) are 
different from those in (a)-(c) only in that FLOO(∆,T) = FLOO(4,14), and thus, the simulated outbreaks are stronger. 
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5.6  STATISTICAL ANALYSIS 
The results presented in Section 5.5 are representative of the complete set of results I obtained in 
the experiments, but nonetheless they do not give a complete analysis of all the results. This 
section describes an analysis of all the results. In particular, I performed statistical analyses to 
evaluate the probabilistic outputs from the UBH algorithm and the MBH algorithm. The outputs 
from the UBH algorithm and from the MBH algorithm were evaluated separately. Next, I 
describe an example procedure for performing a statistical analysis using the UBH algorithm. 
The results of the statistical analysis are presented for both the UBH algorithm and the MBH 
algorithm at the end of this section. 
Recall from Section 5.3.4 that EDSM, EUDM, and EPDM are continuous linear functions in q. 
Then if EPDM < EUDM < EDSM holds under q = 1, then by continuity of EDSM, EUDM, and EPDM, 
there must be a q < 1 such that EPDM < EUDM < EDSM holds. When q = 1, it is easy to see that 
EDSM = EDSM2, EUDM = EUDM2, and EPDM = EPDM2. Thus the problem is reduced to testing whether 
EPDM2 < EUDM2 < EDSM2 holds. 
To perform a statistical analysis, I ran the UBH algorithm for models DSM, UDM, and 
PDM on the background time series of ED cases of 2005 that are assumed to contain no disease 
outbreaks in order to determine their false alert rates under various detection-ratio thresholds. I 
first select a threshold r that is used for obtaining a rate of one false alert per month12
                                                 
12 A statistical analysis was performed on a rate of zero false alerts per month as well using a directly 
analogous procedure. 
, since one 
false alert per month is frequently cited as an upper bound of a tolerable rate. Then threshold r is 
applied on the output likelihood ratios of an outbreak scenario of a specific experimental 
configuration to determine its detection time under one false alert per month.  
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Using this procedure, I obtained the detection time of all the three disease models (DSM, 
UDM, and PDM) over all proposed experimental configurations, where 96 outbreak scenarios 
were created using each experimental configuration. Using the UBH algorithm in Exp. 1, there 
are three factors (FLOO(Δ,T), du, and symptom) that affect the detection time (at one false alert 
per month) from the three disease models, thus creating a total of 3 (FLOO setting possibilities) 
× 3 (disease possibilities for du) × 3 (symptom possibilities: abdominal pain, cough, and 
headache) = 27 experimental configurations. Similarly, The UBH algorithm in Exp. 2 results in a 
total of 3 (FLOO setting possibilities) × 3 (disease possibilities for du) × 2 (disease possibilities 
for dv) × 3 (symptom possibilities: abdominal pain, cough, and headache) = 54 experimental 
configurations because there are four factors (FLOO(Δ,T), du, dv and symptom) that are involved 
in Exp. 2. 
Table 5.2 shows the detection times that were obtained for the three disease models in 
Exp. 1 over the 27 experimental configurations and the 96 simulated outbreak scenarios. For 
example, cell(1,1) constructs a single scenario of an outbreak due to a known disease 
cryptosporidiosis with an outbreak generator setting of  FLOO(1,10), and it contains the 
detection times for this scenario for models DSM1, UDM1, PDM1, where DSM1 models 
cryptosporidiosis, UDM2 models cryptosporidiosis and an unknown disease d*, and PDM2 
models cryptosporidiosis and a partially-known disease d*p.  
Table 5.3 shows the detection times that were obtained for the three disease models in 
Exp. 2 over the 54 experimental configurations and the 96 simulated outbreak scenarios. For 
example, cell(1,1) contains the detection times for a single scenario for models DSM2, UDM2, 
PDM2, where DSM2 models early stage anthrax, UDM2 models early stage anthrax and an 
unknown disease d*, and PDM2 models early stage anthrax and a partially-known disease d*p, 
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yet the actual outbreak disease is cryptosporidiosis with an outbreak generator setting of  
FLOO(1,10). 
 
Table 5.2 Detection times that were obtained for models DSM1, UDM1, and PDM1 (in Exp. 1) over 27 
experimental configurations × 96 outbreak scenarios. 
Outbreak 
scenarios 
1 2 … 27 
FLOO(1,10) 
du = cryptosporidiosis, 
symptom = abdominal 
pain 
FLOO(1,10) 
du = cryptosporidiosis, 
symptom = cough 
… 
FLOO(4,14) 
du = inhalation 
tularemia, 
symptom = headache 
1 
Detection times (at one 
false alert per month) 
of models DSM1, 
UDM1, PDM1 
Detection times (at 
one false alert per 
month) of models 
DSM1, UDM1, PDM1 
… 
Detection times (at one 
false alert per month) 
of models DSM1, 
UDM1, PDM1 
2 … … … … 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
96 … … … … 
 
Table 5.3 Detection times that were obtained for models DSM2, UDM2, and PDM2 (in Exp. 2) over 54 
experimental configurations × 96 outbreak scenarios. 
Outbreak 
scenarios 
1 2 … 54 
FLOO(1,10) 
du = cryptosporidiosis, 
dv = early stage anthrax, 
symptom = abdominal 
pain 
FLOO(1,10) 
du = cryptosporidiosis, 
dv = early stage anthrax, 
symptom = cough 
… 
FLOO(4,14) 
du = inhalation 
tularemia, 
dv = early stage anthrax, 
symptom = headache 
1 
Detection times (at one 
false alert per month) of 
models DSM2, UDM2, 
PDM2 
Detection times (at one 
false alert per month) 
of models DSM2, 
UDM2, PDM2 
… 
Detection times (at 
one false alert per 
month) of models 
DSM2, UDM2, 
PDM2 
2 … … … … 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
96 … … … … 
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To perform statistical analysis using the results that were obtained in form shown in 
Table 5.213
As shown in Table 5.2, for each experimental configuration (out of the total 27 
configurations), there are 96 outbreak scenarios which were created by overlaying the simulated 
outbreak cases onto a background dataset with randomly selected outbreak onset dates. Thus, for 
a given configuration I assume that the 96 scenarios are independent. However, the total 96 × 27 
scenarios over all 27 configurations are not independent. For example, in Table 5.2, outbreak 
scenario 1 for the 1st experimental configuration and outbreak scenario 1 for the 2nd experimental 
configuration are highly correlated in terms of the background data, the number of outbreak 
cases (created by using FLOO(1,10)) that were overlaid onto the background cases, and the 
disease (cryptosporidiosis) that causes the ongoing outbreak. Thus, the 27 outbreak results in any 
given row in Table 5.2 are correlated due to overlapping experimental configurations. The results 
are also correlated due to using the same background data in generating the scenarios in that row. 
The data shown in Table 5.2 suggests a hierarchical analysis that is clustered according to the 
factor outbreak scenario. Each row in Table 5.2 can be considered as a group categorized using 
the same outbreak scenario. An analysis that is based on individual observations without taking 
this clustering into account is likely to over-estimate the statistical significance of any observed 
effect. Thus, I did not apply traditional MANOVA analysis to test the proposed hypothesis. I 
instead adopted a linear mixed effects model (Davidian 2007) that takes into account (1) the 
, I evaluated the following null hypothesis Ho: EPDM2 = EUDM2 = EDSM2 versus the 
alternative hypothesis Ha: at least two models have different mean detection times. 
                                                 
13 A statistical analysis was performed on the results obtained in form shown in Table 5.3 using an 
analogous procedure as did for Table 5.2, and the results of statistical analysis are presented at the end of this 
section. 
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variation between and within groups and (2) the correlations between factors FLOO(Δ,T), du, and 
symptom. 
I assigned the three factors (FLOO(Δ,T), du, and symptom) as fixed effects. The random 
effect in this application is the factor outbreak scenario, because the outbreak scenarios under a 
specific experimental configuration (such as a configuration of FLOO(1,10), du = 
cryptosporidiosis, and symptom = abdominal pain) are assumed to be independently created 
using randomly generated outbreak onset dates. 
After fitting the data in Table 5.2 using a linear mixed effects model, I further examined 
the fitted model and made certain that the underlying distributional assumptions appear valid for 
the data. According to (Pinheiro 2000), we should examine the fitted model both graphically and 
numerically.  
The plot of the standardized residuals versus the fitted values from the model, shown in 
Figure 5.9, does not indicate a violation of the assumption of constant variance. In addition, the 
normal plot in Figure 5.10 indicates that the assumption of normality for the within-group errors 
is plausible.  
I then examined a set of confidence intervals on the model parameters using the intervals 
function in R. Since this dissertation does not focus on the linear mixed effects model per se, I 
just present a summary of the analysis using it. Details regarding how to interpret the results are 
in (Pinheiro 2000). A summary of the confidence intervals on the parameters of the fitted model 
is presented as below, which shows that the parameters were estimated relatively precisely. 
> intervals(mydata.lme) 
Approximate 95% confidence intervals 
 
 Fixed effects: 
                                                          lower        est.       upper 
(Intercept)                          9.06640249  9.40235983  9.73831716 
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FLOOT14D2                      -0.48473402 -0.40711806 -0.32950209 
FLOOT14D4                      -2.55022399 -2.47260802 -2.39499206 
symptomcough                 0.05659594  0.14621914  0.23584233 
symptomheadache         -0.28046681 -0.19084362 -0.10122043 
duearly_anthrax              -0.77996936 -0.70235340 -0.62473743 
duinhalation_tularemia -2.31748865 -2.23987269 -2.16225672 
dvearly_anthrax              -0.33697167 -0.25935571 -0.18173975 
dvinhalation_tularemia -1.18322939 -1.10561343 -1.02799746 
modelPDM                       -0.12227260 -0.04465664  0.03295933 
modelUDM                      -0.13375022 -0.05613426  0.02148170 
attr(,"label") 
[1] "Fixed effects:" 
 
 Random Effects: 
  Level: scenario  
                                        lower     est.    upper 
sd((Intercept))    1.376677 1.587236 1.829999 
 
 Within-group standard error: 
         lower     est.    upper  
 2.828784 2.851140 2.873672 
Figure 5.9 Scatter plot of the standardized within-group residuals versus the within-group fitted values for the fitted 
model. 
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I then performed pairwise comparisons to look for inequalities between pairs of models. I 
applied Tukey’s method (Toothaker 1993) to adjust for multiple comparisons. Table 5.4 shows 
the results of pairwise comparisons using the outputs from the UBH algorithm. It contains p-
values of comparing DSM, UDM, and PDM in a pairwise fashion over all 96 × 27 experiments 
in Exp. 1 and over all 96 × 54 experiments in Exp. 2. The results support that DSM is at least as 
good as UDM and PDM in Exp. 1. A one-sided test was used for comparing DSM vs. UDM and 
DSM vs. PDM. Since the direction of the difference between PDM and UDM is not clear, I used 
a two-sided test for comparing them. Similarly, one-sided tests were used for UDM vs. DSM and 
PDM vs. DSM in Exp. 2, and a two-sided test was used for PDM vs. UDM in Exp. 2. All these 
tests used a significant level of 0.05. 
Table 5.4 shows the p-values of pairwise comparisons of DSM, UDM, and PDM for the 
UBH algorithm. As shown in this table, UDM and DSM are statistically significantly different in 
Figure 5.10 Normal plot of within-group standardized residuals for the fitted model. 
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disease detection performance in all circumstances; PDM and DSM are statistically significantly 
different in circumstances except in Exp. 2 at zero false alerts per month, in which the p-value is 
close to being statistically significantly different; PDM and UDM had no significant difference 
in the performance of disease outbreak detection using two-sided tests. 
 
Table 5.4 p-values of three pairwise comparisons at zero and one false alert per month, respectively, when using the 
UBH algorithm. 
 
Number of 
false alerts 
per month 
Pairwise comparison 
Ho: EUDM = EDSM Ho: EPDM = EDSM Ho: EPDM = EUDM 
Ha: EUDM > EDSM Ha: EPDM > EDSM Ha: EPDM ≠ EUDM 
Exp. 1 
0 0.030 0.036 0.044 
1 0.041 0.042 0.052 
 
 Ha: EUDM < EDSM Ha: EPDM < EDSM Ha: EPDM ≠ EUDM 
Exp. 2 
0 0.025 0.054 0.047 
1 0.019 0.020 0.034 
 
Table 5.5 p-values of three pairwise comparisons at zero and one false alert per month, respectively, from using the 
MBH algorithm. 
 
Number of 
false alerts 
per month 
Pairwise comparison 
Ho: EUDM = EDSM Ho: EPDM = EDSM Ho: EPDM = EUDM 
Ha: EUDM > EDSM Ha: EPDM > EDSM Ha: EPDM ≠ EUDM 
Exp. 1 
0 0.021 0.033 0.058 
1 0.032 0.031 0.022 
 
 Ha: EUDM < EDSM Ha: EPDM < EDSM Ha: EPDM ≠ EUDM 
Exp. 2 
0 0.012 0.016 0.052 
1 0.008 0.011 0.048 
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Table 5.5 shows the p-values of pairwise comparisons of DSM, UDM, and PDM for the 
MBH algorithm. As shown in this table, DSM performed significantly differently from UDM 
and PDM in all circumstances. As for the detection performance of UDM vs. PDM, PDM and 
UDM had significantly different detection performance in Exp. 1 at one false alert per month and 
had no significantly different detection performance in other circumstances. 
5.7 DECISION ANALYSIS 
As described in Section 5.6, if in Exp. 2 EPDM2 < EUDM2 < EDSM2 holds, then there must exists a q 
< 1 such that EPDM < EUDM < EDSM holds. This section describes how to determine values of q 
(for q < 1) such that EPDM < EUDM < EDSM using the UBH algorithm. The same decision analysis 
was also performed on the MBH algorithm using an analogous procedure, and the results of both 
algorithms are presented in this section14
Recall that in Exp. 1 there are 3 (FLOO setting possibilities) × 3 (disease possibilities for 
du) × 3 (symptom possibilities) = 27 experimental configurations and for each configuration 
there are 96 outbreak scenarios created, thus there are a total of 96 × 27 outbreak scenarios. I 
assume that each of the 96 × 27 outbreak scenarios in Exp. 1 is equally likely to occur. If so, we 
can calculate EDSM1 as the average detection time over the 96 × 27 outbreak scenarios for DSM1; 
EUDM1 and EPDM1 can each be calculated analogously. Similarly, in Exp. 2, there are a total of 96 
× 54 outbreak scenarios. Thus EDSM2 can be calculated as the average detection time over the 96 
× 54 outbreak scenarios for DSM2, and EUDM2 and EPDM2 can each be calculated analogously. 
. 
                                                 
14 Section 5.8 contains a sensitivity analysis over the prior probability of the unknown (partially-known) 
disease being modeled and a related decision analysis is presented in that section as well. 
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Using this procedure, I obtained the mean detection time (in days) of all six models over all the 
experiments at a false alert rate of zero and one per month, as shown in Table 5.6. 
In Exp. 1, DSM has a slightly better expected detection performance than UDM and 
PDM at both zero and one false alert per month, which is qualitatively expected. In Exp. 2, UDM 
detects the ongoing outbreak 0.76 days faster than DSM, and PDM detects the ongoing outbreak 
0.57 days faster than DSM at one false alert per month as expected. At zero false alerts per 
month in Exp. 2, UDM and PDM also have a slightly better disease outbreak detection 
performance than DSM. 
Table 5.6 Mean detection time (in days) at a false alert rate of zero and one per month of all six models over all the 
experiments when using the UBH algorithm 
 
Number of 
false alerts 
per month 
DSM UDM PDM 
Exp. 1 
0 9.70 9.99 9.90 
1 6.05 6.18 6.18 
 
Exp. 2 
0 10.59 10.30 10.37 
1 7.14 6.38 6.57 
 
 
Using a similar procedure as described above, I also obtained the mean detection time (in 
days) at a false alert rate of zero and one per month from using the MBH algorithm. Table 5.7 
summarizes those results. At zero false alerts per month, DSM detects the ongoing outbreak 0.75 
days faster than UDM and 0.68 days faster than PDM in Exp. 1. In Exp. 2, UDM detects the 
outbreak 1.21 days faster than DSM, and PDM detects the outbreak 1.08 days faster than DSM; 
at one false alert per month in Exp. 2, the net gain in the expected detection time of UDM 
relative to DSM is 1.36 days and of PDM relative to DSM is 1.16 days. 
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Table 5.7 Mean detection time (in days) at a false alert rate of zero and one per month of all six models over all the 
experiments when using the MBH algorithm 
 
Number of 
false alerts 
per month 
DSM UDM PDM 
Exp. 1 
0 5.62 6.37 6.30 
1 3.06 3.25 3.11 
 
Exp. 2 
0 7.73 6.52 6.65 
1 4.91 3.55 3.75 
 
From the results shown in Table 5.6 and 5.7, we can see that PDM performs better than 
UDM in Exp. 1 of both UBH and MBH algorithms but performs worse than UDM in Exp. 2 of 
both algorithms. This makes sense because the partially-known disease d*p in PDM in Exp. 1 is 
modeled using a mixture of priors that includes the known outbreak disease du that causes the 
ongoing disease outbreak, whereas the unknown disease d* in UDM in Exp. 1 is just modeled 
using a uniform prior distribution. In contrast, disease du is not known to us in Exp. 2, and thus 
d*p in PDM in Exp. 2 is modeled using a mixture of priors that does not include disease du. I 
conjecture that in Exp. 2, the uniform prior employed by UDM might be better in modeling the 
outbreak data that were constructed by simulating from disease du than the mixture of priors 
employed by PDM. 
We can determine the value range of q such that modeling an unknown disease d* (using 
UDM) or a partially-known disease d*p (using PDM) yields an expected decrease in detection 
time. I first do so for a false alert rate of one per month for the UBH algorithm, and thus, we will 
use the results in Table 5.6 that relates to one false alert per month. Based on deriving such an 
estimate of q, we can then determine whether to construct a DSM or an UDM model in a 
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detection system. Figure 5.11 shows such a decision analysis. Let q* be the probability such that 
the equation below holds: 
(1 – q)EUDM1 + qEUDM2 = (1 – q)EDSM1 + qEDSM2                                   (5.3)                                 
Then q* is the threshold such that any probability greater than q* renders modeling d* 
helpful, given the conditions and assumptions of the evaluation. Solving Equation 5.3 using the 
values in Tables 5.6, yields q* = 0.15. If q = 0.15 then modeling d* is expected to be neither 
helpful nor harmful. Moreover, if q > 0.15, then including d* in the model is expected to decrease 
the detection time at a false alert rate of one per month. 
 
I also assessed the uncertainty for estimating q by calculating its standard error. I 
performed random sampling of scenarios with replacement and obtained 100 scenarios at a time 
from the total 96 × 27 scenarios in Exp. 1 and 100 scenarios at a time from the total 96 × 54 
scenarios in Exp. 2. I repeated this sampling procedure 1000 times. For each sampled 100 
scenarios in Exp. 1 and Exp. 2, I calculated EDSM1, EDSM2, EUDM1, and EUDM2, and then calculated 
a q value that satisfies Equation 5.3. I thus obtained 1000 sets of q values. Let  q*(s) be a specific 
DSM 
Exp. 1 (1 – q)  EDSM1 
Exp. 2 (q)  EDSM2 
UDM 
Exp. 1 (1 – q)  
Exp. 2 (q)  
EUDM1 
EUDM2 
 
Figure 5.11 A decision tree showing the decision analysis on selecting DSM vs. UDM 
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q value that was obtained out of the total 1000, where 1 ≤ s ≤ 1000. I estimated the standard error 
(SE) of q using 
( )
( )( )
11000
1000
1
2
**
−
−
=
∑ =s s qqqSE , 
where q*  = 0.15 as described above. 
I also applied the same procedure, as described above, for the mean detection times of 
DSM1, UDM1, DSM2, and UDM2 that were obtained from using the UBH algorithm at zero 
false alerts per month. Similarly, we can apply this procedure for the mean detection times of 
DSM1, PDM1, DSM2, and PDM2 to determine a value of  q*p with which modeling d*p is 
neither helpful nor harmful. Table 5.8 summarizes the results of q*, q*p, and their standard errors 
at a false alert rate of zero and one per month from using the UBH algorithm and the MBH 
algorithm, respectively. 
Table 5.8 A summary of the decision analysis results 
Algorithm Number of false alerts per month 
q* 
SE(q*) 
q*p 
SE(q*p) 
UBH 
0 0.49 0.19 
0.48 
0.18 
1 0.15 0.11 
0.19 
0.13 
 
MBH 
0 0.38 0.13 
0.39 
0.12 
1 0.12 0.10 
0.039 
0.08 
 
Under the assumptions introduced, this result indicates that if the probability is greater 
than 0.19 of an outbreak being due to a partially-known disease d*p, then including d*p in the 
model of the UBH algorithm is expected to decrease the detection time at a false alert rate of one 
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per month. As discussed above, if the probability is greater than 0.15 of an outbreak being due to 
an unknown disease, then including d* in the model of the UBH algorithm is expected to 
decrease the detection time at one false alert per month. Table 5.8 also shows analogous results 
when the false alert rate is zero when using the UBH algorithm. In that case, the probability of an 
unknown disease is about 0.49 and the probability of a partially-known disease is about 0.48, 
which is higher than for an alert rate of one. 
As for the results of the MBH algorithm, the probabilities of an unknown disease and a 
partially-known disease are all smaller than those of the UBH algorithm at both zero false alerts 
per month and one false alert per month, which supports that the hybrid detection system 
constructed in MBH performs better than UBH in detecting new disease outbreaks. The lowest 
probability 0.039 was obtained from using the MBH algorithm that includes a PDM model, and a 
probability 0.12 was obtained from using the MBH algorithm that includes a UDM model. 
It seems plausible that there are disease-outbreak monitoring situations in which if there 
is an outbreak then the expected probability exceeds 0.12 of it being due to an unknown disease 
and 0.039 if it being due to an partially-known disease. The Olympics provide one possible 
scenario, where a bioterrorist might attempt to use a new infectious disease agent to maximize 
terror. In such situations, modeling an unknown disease d* or a partially-known disease d*p could 
be beneficial. 
5.8 SENSITIVITY ANALYSIS 
Recall that Section 5.7 only reports experimental results for disease-specific model (DSM), 
unknown-disease model (UDM), and partially-known disease model (PDM) of the UBH and 
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MBH algorithm when using a uniform prior over the appearance of the outbreak diseases being 
modeled. Let w represent the prior probability of an outbreak due to an unknown disease d* or a 
partially-known disease d*p given that an outbreak is occurring, namely w = P(d* | OB) or P(d*p | 
OB). This section describes a sensitivity analysis regarding w, for which a sequence of 
probability values 0.01, 0.02, … 0.09, 0.1, 0.2, …, 0.9, 0.91, 0.92, …, 0.99 was used for UDM 
and PDM, where the prior probability P(d* | OB) and P(d*p | OB) will be applied to UDM and 
PDM, respectively, to obtain the likelihood ratio results.  
For each prior probability value w in the sequence described above, I applied the same 
experimental methods described in Section 5.3 to obtain the mean detection time (over all the 
experiments) at zero and one false alert per month for the UBH algorithm and the MBH 
algorithm that includes a DSM model, an UDM model, and a PDM model, respectively. For 
example, when w = 0.1, by running the UBH algorithm, we obtain experimental results for UDM 
in Exp. 1 from using prior probability P(d* | OB) = 0.1 and P(du | OB) = 0.9, and for PDM in 
Exp. 1 from using prior probability P(d*p | OB) = 0.1 and P(du | OB) = 0.9. Note that when w = 0, 
DSM, UDM, and PDM have the same mean detection time in Exp. 1 and Exp. 2. Section 5.8.1 
and 5.8.2 describe the experimental results of the sensitivity analysis using the UBH algorithm 
and the MBH algorithm, respectively. Each section contains experimental results that were 
obtained at a false alert rate of zero and one per month. 
5.8.1 Results of the UBH algorithm 
Figure 5.12 shows the mean detection time of DSM1, UDM1, and PDM1 (in Exp. 1) at one false 
alert per month when using a sequence of prior probability values w. Note that DSM does not 
model disease d* or  d*p , thus the mean detection time of DSM does not change relative to w (w 
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= P(d* | OB) or  P(d*p | OB)), as shown in Figure 5.12 as a horizontal line at EDSM1 = 6.05 days, 
and DSM1 has a faster mean detection time than UDM and PDM at every value of w. UDM1 
and PDM 1 both have the fastest mean detection time at a prior probability w = 0.01 with EUDM1 
= EPDM1 = 6.06 days. The overall trend of UDM1 is that the mean detection time of UDM1 
increases relative to w. 
Figure 5.13 shows the mean detection time of DSM2, UDM2, and PDM2 (in Exp. 2) at 
one false alert per month when using a sequence of prior probability values w. UDM2 and PDM2 
outperform DSM2 at any probability value w in the sequence, as expected. The mean detection 
time of UDM2 decreases as w increases, which implies that the higher the prior probability 
assigned to disease d*, the better the mean detection performance of UDM2 in detecting the 
ongoing disease outbreak that is caused by an unknown disease. PDM2 also has a similar trend 
as UDM2, as expected. However, PDM2 performs no better than UDM2 at any value of w. 
Figure 5.14 shows the decision analysis results (q* and q*p) relative to w at one false alert 
per month for the UBH algorithm. For example, when w = 0.5, q* is 0.15, as shown in this figure. 
This example indicates that given a prior probability of 0.5 for d* (conditioned on there being an 
outbreak), modeling d* will decrease the expected outbreak-detection time if the actual frequency 
of d* (conditioned on there being an outbreak) is a 0.15 or greater. As shown in this figure, the 
maximum value of q* is 0.18 at w = 0.01. When w = 0.6, q*p also has the maximum value of 
0.22. Probability q* and q*p have the minimum value of 0.08 at w = 0.08 and w = 0.2, 
respectively. 
Figure 5.15 shows the mean detection time of DSM1, UDM1, and PDM1 (in Exp. 1) at 
zero false alerts per month when using a sequence of prior probability values w. It is expected 
that DSM1 detects the known ongoing disease outbreak faster than UDM1 and PDM1. However, 
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when the prior probability w falls into the range such that 0.01 ≤ w ≤ 0.09 for UDM1 and 0.03 ≤ 
w ≤ 0.1 for PDM1, UDM1 and PDM1 have slightly faster mean detection time than DSM1 as 
shown in this figure, with the maximum mean detection time gain of UDM1 over DSM1 as 0.02 
days and PDM1 over DSM1 as 0.02 days. The result using Tukey’s method shows that there is 
no statistically significantly difference in the mean detection time of DSM1, UDM1, and PDM1 
when w is in these ranges. Thus, I conjectured that the slight net gain in mean detection time of 
UDM1 (or PDM1) relative to DSM1 is due to noise. When w > 0.1, the results in this figure 
show that DSM1 outperforms UDM1 and PDM1, and the mean detection time of UDM1 and 
PDM1 increases, as w increases. 
Figure 5.16 shows the mean detection time of DSM2, UDM2, and PDM2 (in Exp. 2) at 
zero false alerts per month when using a sequence of prior probability values w. UDM2 and 
PDM2 outperforms DSM2 at any value of w in the sequence, as expected. As w increases, the 
mean detection times of UDM2 and PDM2 decrease, as expected. PDM2 has a mean detection 
time that is no worse than UDM2.  
Figure 5.17 shows the decision analysis results (q* and q*p) relative to w at zero false 
alerts per month using the UBH algorithm. Since UDM1 and PDM1 have faster mean times than 
DSM1 when 0.01 ≤ w ≤ 0.09 for UDM1 and 0.03 ≤ w ≤ 0.1 for PDM1 (as shown in Figure 5.15), 
and UDM2 and PDM2 outperform DSM2 (as shown in Figure 5.16), it is not surprising that the 
value of q* and q*p is smaller than zero at this range of w using Equation 5.3. In this 
circumstance, I set q* and q*p to be zero in the plot of q* and q*p relative to w. Recall that q is 
used to represent the actual frequency with which the Exp. 2 scenario occurs. Under the 
assumptions introduced, this result indicates that including d* (or d*p) in the model will decrease 
the detection time at a false alert rate of zero alerts per month when d* (or d*p) occurs at a 
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frequency q for 0.01 ≤ q ≤ 0.09 for UDM1 and 0.03 ≤ q ≤ 0.1 for PDM1. When w ≥ 0.02, the 
value of q* and q*p increases as w increases. 
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Figure 5.12 Mean detection time (days) at one false alert per month for DSM, UDM, and PDM in Exp. 1 using the 
UBH algorithm 
Figure 5.13 Mean detection time (days) at one false alert per month for DSM, UDM, and PDM in Exp. 2 using the 
UBH algorithm 
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Figure 5.14 Probability value q* and q*p relative to the prior probability of the appearance of the unknown (partially-
known) disease at one false alert per month using the UBH algorithm 
Figure 5.15 Mean detection time (days) at zero false alerts per month for DSM, UDM, and PDM in Exp. 1 using the 
UBH algorithm 
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Figure 5.16 Mean detection time (days) at zero false alerts per month for DSM, UDM, and PDM in Exp. 2 using the 
UBH algorithm 
Figure 5.17 Probability value q* and q*p relative to the prior probability of the appearance of the unknown (partially-
known) disease at zero false alerts per month using the UBH algorithm 
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5.8.2 Results of the MBH algorithm 
Figure 5.18 shows the mean detection time of DSM1, UDM1, and PDM1 (in Exp. 1) at one false 
alert per month when using a sequence of prior probability values w. The mean detection of 
DSM1 is approximately 3.06 days, and DSM1 has a faster mean detection time than UDM1 and 
PDM1 at w ≥ 0.08 and w ≥ 0.4, respectively. UDM1 has the fastest mean detection time at a 
prior probability w = 0.01 with EUDM1 = 3.04 days, and PDM1 has the fastest mean detection 
time at w = 0.3 with EPDM1 = 3.04 days. When w = 0.99, both UDM1 and PDM1 have the slowest 
mean detection time of 3.55 and 3.18 days, respectively, which are 2.51 and 2.88 days faster than 
the fastest mean detection time of UDM1 and PDM1 that were obtained using the UBH 
algorithm, as shown in Figure 5.12. 
Figure 5.19 shows the mean detection time of DSM2, UDM2, and PDM2 (in Exp. 2) at 
one false alert per month when using a sequence of prior probability values w. UDM2 and PDM2 
outperform DSM2 at any probability value w in the sequence, as expected. UDM2 performs 
slightly better than PDM2 at a probability range of 0.2 ≤ w ≤ 0.5. The MBH algorithm has a 
better mean detection performance than the UBH algorithm (shown in Figure 5.13) regarding the 
absolute magnitude of the mean detection time of DSM2, UDM2, and PDM2, and the net profit 
gain of UDM2 over DSM2 and PDM2 over DSM2. 
Figure 5.20 shows the decision analysis results (q* and q*p) relative to w at one false alert 
per month using the MBH algorithm. When 0.01 ≤ w ≤ 0.07, the value of q* that is calculated 
using Equation 5.3 is negative due to EDSM1 > EUDM1 and EDSM2 > EUDM2. I set the value of q* to 
be zero at this range of w, as shown in this figure. It indicates that when our prior belief about an 
unknown-disease outbreak is smaller than 0.07, modeling d* will definitely be helpful no matter 
what the actual frequency of an unknown-disease outbreak is. This is because that UDM 
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surprisingly had better detection performance than DSM in Exp. 1 while it is expected DSM 
outperformed UDM in this experiment; when w = 0.08, 0.09, 0.1, and 0.3, q*p also has been set 
to zero as described above, which indicates that including disease d*p will improve the disease 
detection performance when the actual frequency of the appearance of d*p falls into this range. 
Figure 5.21 shows the mean detection time of DSM1, UDM1, and PDM1 (in Exp. 1) at 
zero false alerts per month when using a sequence of prior probability values w. The mean 
detection of DSM1 is approximately 5.62 days, and DSM1 has a faster mean detection time than 
UDM1 and PDM1 at w ≥ 0.05 and w ≥ 0.3, respectively. UDM1 has the fastest mean detection 
time at a prior probability w = 0.01 with EUDM1 = 5.56 days, and PDM1 has the fastest mean 
detection time at w = 0.1 with EPDM1 = 5.41 days. When w = 0.99, both UDM1 and PDM1 have 
the slowest mean detection time of 6.44 and 6.48 days, respectively, which are 3.24 and 3.20 
days faster than the fastest mean detection time of UDM1 and PDM1 that were obtained using 
the UBH algorithm, as shown in Figure 5.15. 
Figure 5.22 shows the mean detection time of DSM2, UDM2, and PDM2 (in Exp. 2) at 
zero false alerts per month when using a sequence of prior probability values w. UDM2 and 
PDM2 outperform DSM2 at any probability value w in the sequence, as expected, and UDM2 
performs slightly better than PDM2. The MBH algorithm has a better mean detection 
performance than the UBH algorithm (shown in Figure 5.16) regarding the absolute magnitude 
of the mean detection time of DSM2, UDM2, and PDM2, and the net profit gain of UDM2 over 
DSM2 and PDM2 over DSM2. 
Figure 5.23 shows the decision analysis results (q* and q*p) relative to w at zero false 
alerts per month when using the MBH algorithm. As shown in this figure, when 0.01 ≤ w ≤ 0.04, 
the value of q* has been set to zero; when 0.01 ≤ w ≤ 0.2, q*p has been set to zero due to the 
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reason described above. This result also indicates that including d* will improve the disease 
detection performance of the detection system when d* occurs at a frequency q for 0.01 ≤ q ≤ 
0.04. A similar conclusion holds for including disease d*p for 0.01 ≤ q ≤ 0.2. 
It is interesting to notice that the overall trend of q* relative to w is that when w increases, 
q* increases as well, such as Figure 5.20 and Figure 5.23. This trend indicates that the more prior 
belief we think that the ongoing outbreak is due to an unknown disease, the higher the actual 
frequency of the unknown-disease outbreak needs to be in order for modeling d* to be helpful. 
This trend seems to be contradictory to our expectation. However, our prior belief about the 
probability of an unknown-disease outbreak might not be realistic. In particular, in the 
experiments constructed in Exp. 1 and Exp. 2, there is 1/3 chance that the outbreak is being 
caused by an unknown disease because three outbreak diseases were selected for performing 
leave-one-out experiments, as described in Section 5.3. 
Section 5.8.1 and 5.8.2 provides support that including unknown and partially-known 
diseases in the model can improve the disease detection performance of the detection system. In 
addition, modeling unknown and partially-known diseases will yield more net profit when using 
the MBH algorithm than using the UBH algorithm. 
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Figure 5.18 Mean detection time (days) at one false alert per month for DSM, UDM, and PDM in Exp. 1 using the 
MBH algorithm 
Figure 5.19 Mean detection time (days) at one false alert per month for DSM, UDM, and PDM in Exp. 2 using the 
MBH algorithm 
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Figure 5.20 Probability value q* and q*p relative to the prior probability of the appearance of the unknown (partially-
known) disease at one false alert per month using the MBH algorithm 
Figure 5.21 Mean detection time (days) at zero false alerts per month for DSM, UDM, and PDM in Exp. 1 using the 
MBH algorithm 
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Figure 5.22 Mean detection time (days) at zero false alerts per month for DSM, UDM, and PDM in Exp. 2 using the 
MBH algorithm 
Figure 5.23 Probability value q* and q*p relative to the prior probability of the appearance of the unknown (partially-
known) disease at zero false alerts per month using the MBH algorithm 
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6.0  CONCLUSION AND FUTURE WORK 
This dissertation investigates Bayesian modeling of unknown causes in the context of disease-
outbreak detection. It introduces a Bayesian method for disease-outbreak detection that combines 
models of known diseases and unknown (or partially-known) diseases. In particular, I model the 
known non-outbreak disease d0 using an informative prior estimated from past ED data, and 
model a known outbreak disease dk (for k > 0) using informative priors that were assessed from 
an infectious disease expert. The unknown-disease model uses a non-informative prior to model 
some unknown disease d*. This dissertation also investigated modeling of a partially-known 
disease d*p, for which a mixture of informative and non-informative priors is used.  
In order to evaluate the hypothesis proposed in Chapter 1, I constructed several versions 
of detection systems that include a known outbreak disease dk (for k > 0), an unknown-disease 
d*, and a partially-known disease d*p, respectively.  
The results presented in this dissertation provide support for the hypothesis that modeling 
both known and unknown outbreak diseases in a hybrid system can lead to better expected 
disease outbreak detection performance than modeling known outbreak diseases only. 
The remainder of this chapter first summarizes the contributions of this dissertation 
research and then presents areas for future research. 
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6.1 CONTRIBUTIONS 
6.1.1 Disease modeling 
I investigated a continuous disease-modeling space, from disease-specific modeling to partially-
known disease modeling to unknown disease modeling using the following methods: 
• I used expert judgment for modeling a specific outbreak disease dk, for which an 
informative prior distribution was derived using expert assessment on the mean and 
variance of the frequency of some symptom state in the people having dk in the 
population, where k ≥ 1. 
• A non-informative prior was proposed for modeling an unknown outbreak disease d* 
about which we almost completely lack knowledge. In particular, I used a uniform 
distribution on the interval of [0,1] to model the probability of a symptom state, as for 
example cough, given a person having disease d*. 
• I also proposed a mixture of informative and non-informative priors for modeling a 
partially-known disease d*p. In particular, an informative prior in the mixture model 
represents the prior distribution of a known outbreak disease dk that we conjecture to 
share some similar characteristics, such as the frequency of the cough symptom in the 
population that have dk, with the partially-known disease d*p; The non-informative prior 
in the mixture model represents the condition that we know little about d*p. The mixture 
of priors I proposed is semi-informative in the sense that it combines prior distributions 
that are informative and non-informative in a mixture model. 
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6.1.2 A unifying framework in a hybrid disease detection system 
I used a Bayesian framework that combines models of known outbreak diseases and an unknown 
outbreak disease to construct a hybrid outbreak detection system. This unifying framework 
allows us to model any number of known and unknown diseases and also provides a way to 
specify arbitrary prior probabilities for models of known and unknown diseases. 
6.2 FUTURE WORK 
This section describes future work and some open problems related to the dissertation research. 
As mentioned, the Bayesian approach I describe for modeling unknown diseases is based on 
specifying non-informative priors. There are numerous ways of specifying such non-
informativeness, and it would be worthwhile to explore approaches beyond just using uniform 
distributions. One such approach is to use semi-informative priors, in which some constraints are 
placed on the parameters of a disease model (e.g., the symptom cough has an increased rate of 
occurrence above some specified level), but otherwise the parameter distributions are uniform 
(Shen 2009). I believe the investigation of non-informative and semi-informative priors holds 
significant promise in artificial intelligence in general and biomedical informatics applications in 
particular, where causes of events may often be unknown. 
Recall that the MBH algorithm models the binary state of every evidential feature, as for 
example, cough vs. no cough, and headache vs. no headache, by assuming the evidential features 
are conditionally independent given the disease state of an individual in the population. 
Assuming independence between evidential features makes it easier to convey the basic 
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approach in this dissertation. However, modeling independence among evidential features may 
ignore possible dependencies between them, and thus may affect the likelihood ratio output of 
the MBH algorithm. We could model dependent symptoms using Dirichlet-multinomial 
hierarchical model. However, it may be difficult to assess from experts the parameters of the 
Dirichlet distribution. Note that the inference method employed in this dissertation does not limit 
us from using any non-independence model because I used a simulation method to perform 
inference on the Bayesian network that models multivariate independent evidential features, as 
described in Section 4.3.3. 
Besides detecting possible disease outbreaks, it would be useful for the BH algorithm to 
characterize the ongoing disease outbreak, as for example by computing the posterior probability 
P(person_i_cough_state = present | outbreak_disease_in_population = d*, evidence). Such an 
analysis gives the user some insight into how unknown disease d* is presenting.  To compute this 
posterior probability, we can perform inference on the Bayesian network model shown in Figure 
4.1. 
Recall that the BH algorithm was evaluated on the simulated outbreak scenarios, in which 
the number of outbreak cases was generated using the linear FLOO simulator, and the simulated 
symptom state of each patient case was generated by sampling from the Beta-Binomial model. 
The sampling method itself brings random effects into the outbreak scenarios to be tested. In 
addition, as described in Section 5.2, the probability of a symptom state in a disease was 
assumed to have a Beta distribution, while the data were simulated using the Beta-Binomial 
model, as described above.  Thus, the simulated data contains another level of random effects. In 
the future, it would still be useful to evaluate the BH algorithm on datasets that are generated 
using simulators other than FLOO and that also contain additional sources of noise. 
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It would also be useful to evaluate the BH algorithm using real data, as for example 
evaluating the univariate version of the BH algorithm (UBH) using real ED chief complaints. By 
doing this, we could compare the detection performance of the UBH algorithm with other 
outbreak-detection algorithm, such as PC. 
In the future, we could also apply the UDM and PDM model to the spatio-temporal 
version of MD-PANDA (Jiang 2008) and investigate whether including d* and d*p can improve 
the disease detection performance when using a spatio-temporal model. However, we have to 
consider the computational issue of the spatio-temporal version of the MBH algorithm. Recall 
from Section 4.3.3 (for the current version of MBH) that I applied Monte Carlo integration to 
approximate the likelihood given by Equation 4.20, where the time complexity of Monte Carlo 
integration depends on the exact inference time of the non-spatial, non-temporal Bayesian 
network model shown in Figure 4.3. According to (Jiang 2008), a spatio-temporal version of PC 
(PCTS) requires inference time of approximately 5 minutes when running PCTS on ED data 
from the past five days. If we still use Monte Carlo integration to approximate the likelihood of 
the spatio-temporal version of MBH, we will need 5M minutes for inference, where M is the 
number of samples. Monte Carlo integration typically uses M > 1000 samples, which makes the 
inference time of the spatio-temporal version of MBH computationally expensive. One possible 
direction to future research is to develop an approximate inference method for PCTS that can 
more efficiently compute the likelihood (or posterior probability). 
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APPENDIX A 
A COMPLETE LIST OF PARAMETERS ESTIMATED FOR DISEASE MODELS 
Table A.1 shows the parameters (α, β) estimated for the non-outbreak disease model and the 
disease-specific models.  
Table A.1 Parameters (α, β) estimated for the non-outbreak disease model and the disease-specific models given the 
non-outbreak disease, three selected outbreak diseases, and three selected disease symptoms. 
Diseases abdominal pain cough headache 
non-outbreak 
disease (1218.5,38781.5) (463.77,39536.23) (974.83,39025.17) 
cryptosporidiosis (22.38,5.59) (9.91,485.77) (1.25,11.25) 
early stage anthrax (1.07,10.84) (6.84,13.90) (6.22,16.83) 
inhalation tularemia (8.83,3.79) (22.38,5.59) (5.67,1.42) 
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APPENDIX B 
A COMPLETE LIST OF THE NUMBER OF REAL EMERGENCY DEPARTMENT 
CASES USED IN THE EVALUATION 
Recall from Section 5.2 that I obtained real ED cases for 2004 and 2005 from a large hospital in 
Allegheny County, Pennsylvania. Table B.1 shows a complete list of the daily number of real ED 
cases for 2004 and 2005 from that hospital. This list is being provided for completeness in 
describing the experiments that I performed. 
Table B.1 A complete list of real ED cases for 2004 and 2005 from a large hospital in Allegheny County, 
Pennsylvania. 
Date Number of 
ED cases 
Date Number of 
ED cases 
Date Number of 
ED cases 
1/1/2004 122 9/1/2004 126 5/3/2005 141 
1/2/2004 141 9/2/2004 160 5/4/2005 150 
1/3/2004 151 9/3/2004 164 5/5/2005 119 
1/4/2004 118 9/4/2004 146 5/6/2005 133 
1/5/2004 145 9/5/2004 165 5/7/2005 135 
1/6/2004 114 9/6/2004 142 5/8/2005 122 
1/7/2004 127 9/7/2004 160 5/9/2005 140 
1/8/2004 122 9/8/2004 139 5/10/2005 124 
1/9/2004 121 9/9/2004 141 5/11/2005 150 
1/10/2004 122 9/10/2004 127 5/12/2005 108 
1/11/2004 124 9/11/2004 155 5/13/2005 147 
1/12/2004 123 9/12/2004 137 5/14/2005 133 
1/13/2004 119 9/13/2004 171 5/15/2005 139 
1/14/2004 112 9/14/2004 158 5/16/2005 150 
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1/15/2004 117 9/15/2004 138 5/17/2005 116 
1/16/2004 107 9/16/2004 137 5/18/2005 142 
1/17/2004 105 9/17/2004 127 5/19/2005 113 
1/18/2004 137 9/18/2004 156 5/20/2005 115 
1/19/2004 153 9/19/2004 131 5/21/2005 123 
1/20/2004 141 9/20/2004 158 5/22/2005 138 
1/21/2004 129 9/21/2004 151 5/23/2005 138 
1/22/2004 105 9/22/2004 152 5/24/2005 121 
1/23/2004 109 9/23/2004 142 5/25/2005 129 
1/24/2004 128 9/24/2004 158 5/26/2005 107 
1/25/2004 124 9/25/2004 150 5/27/2005 136 
1/26/2004 109 9/26/2004 139 5/28/2005 135 
1/27/2004 126 9/27/2004 141 5/29/2005 137 
1/28/2004 128 9/28/2004 143 5/30/2005 153 
1/29/2004 124 9/29/2004 143 5/31/2005 129 
1/30/2004 143 9/30/2004 136 6/1/2005 141 
1/31/2004 127 10/1/2004 142 6/2/2005 128 
2/1/2004 131 10/2/2004 137 6/3/2005 103 
2/2/2004 151 10/3/2004 138 6/4/2005 141 
2/3/2004 132 10/4/2004 151 6/5/2005 137 
2/4/2004 129 10/5/2004 141 6/6/2005 143 
2/5/2004 119 10/6/2004 108 6/7/2005 143 
2/6/2004 123 10/7/2004 115 6/8/2005 128 
2/7/2004 107 10/8/2004 135 6/9/2005 137 
2/8/2004 129 10/9/2004 157 6/10/2005 125 
2/9/2004 129 10/10/2004 148 6/11/2005 125 
2/10/2004 117 10/11/2004 159 6/12/2005 133 
2/11/2004 122 10/12/2004 127 6/13/2005 152 
2/12/2004 114 10/13/2004 111 6/14/2005 121 
2/13/2004 136 10/14/2004 146 6/15/2005 134 
2/14/2004 152 10/15/2004 128 6/16/2005 130 
2/15/2004 138 10/16/2004 123 6/17/2005 161 
2/16/2004 128 10/17/2004 140 6/18/2005 143 
2/17/2004 139 10/18/2004 130 6/19/2005 130 
2/18/2004 111 10/19/2004 145 6/20/2005 128 
2/19/2004 132 10/20/2004 147 6/21/2005 117 
2/20/2004 122 10/21/2004 144 6/22/2005 153 
2/21/2004 129 10/22/2004 140 6/23/2005 134 
2/22/2004 124 10/23/2004 162 6/24/2005 135 
2/23/2004 155 10/24/2004 128 6/25/2005 124 
2/24/2004 112 10/25/2004 142 6/26/2005 134 
2/25/2004 130 10/26/2004 135 6/27/2005 144 
2/26/2004 129 10/27/2004 128 6/28/2005 140 
 150 
2/27/2004 138 10/28/2004 118 6/29/2005 135 
2/28/2004 120 10/29/2004 130 6/30/2005 147 
2/29/2004 137 10/30/2004 162 7/1/2005 147 
3/1/2004 147 10/31/2004 135 7/2/2005 143 
3/2/2004 138 11/1/2004 125 7/3/2005 145 
3/3/2004 103 11/2/2004 116 7/4/2005 136 
3/4/2004 130 11/3/2004 144 7/5/2005 137 
3/5/2004 140 11/4/2004 125 7/6/2005 141 
3/6/2004 130 11/5/2004 143 7/7/2005 129 
3/7/2004 107 11/6/2004 135 7/8/2005 153 
3/8/2004 115 11/7/2004 135 7/9/2005 138 
3/9/2004 141 11/8/2004 140 7/10/2005 141 
3/10/2004 122 11/9/2004 134 7/11/2005 127 
3/11/2004 125 11/10/2004 134 7/12/2005 140 
3/12/2004 110 11/11/2004 132 7/13/2005 145 
3/13/2004 127 11/12/2004 134 7/14/2005 131 
3/14/2004 124 11/13/2004 118 7/15/2005 161 
3/15/2004 140 11/14/2004 135 7/16/2005 156 
3/16/2004 127 11/15/2004 134 7/17/2005 145 
3/17/2004 147 11/16/2004 129 7/18/2005 166 
3/18/2004 138 11/17/2004 139 7/19/2005 152 
3/19/2004 139 11/18/2004 122 7/20/2005 139 
3/20/2004 126 11/19/2004 117 7/21/2005 142 
3/21/2004 122 11/20/2004 138 7/22/2005 142 
3/22/2004 130 11/21/2004 139 7/23/2005 142 
3/23/2004 120 11/22/2004 159 7/24/2005 145 
3/24/2004 108 11/23/2004 108 7/25/2005 147 
3/25/2004 112 11/24/2004 128 7/26/2005 146 
3/26/2004 126 11/25/2004 86 7/27/2005 146 
3/27/2004 150 11/26/2004 145 7/28/2005 152 
3/28/2004 136 11/27/2004 126 7/29/2005 132 
3/29/2004 137 11/28/2004 126 7/30/2005 128 
3/30/2004 137 11/29/2004 129 7/31/2005 139 
3/31/2004 116 11/30/2004 117 8/1/2005 141 
4/1/2004 112 12/1/2004 112 8/2/2005 147 
4/2/2004 148 12/2/2004 118 8/3/2005 135 
4/3/2004 123 12/3/2004 111 8/4/2005 147 
4/4/2004 114 12/4/2004 134 8/5/2005 129 
4/5/2004 115 12/5/2004 118 8/6/2005 147 
4/6/2004 132 12/6/2004 124 8/7/2005 152 
4/7/2004 128 12/7/2004 106 8/8/2005 147 
4/8/2004 130 12/8/2004 145 8/9/2005 157 
4/9/2004 143 12/9/2004 115 8/10/2005 147 
 151 
4/10/2004 108 12/10/2004 138 8/11/2005 133 
4/11/2004 98 12/11/2004 137 8/12/2005 141 
4/12/2004 152 12/12/2004 120 8/13/2005 153 
4/13/2004 132 12/13/2004 127 8/14/2005 127 
4/14/2004 132 12/14/2004 107 8/15/2005 152 
4/15/2004 135 12/15/2004 118 8/16/2005 140 
4/16/2004 162 12/16/2004 116 8/17/2005 143 
4/17/2004 134 12/17/2004 125 8/18/2005 133 
4/18/2004 155 12/18/2004 111 8/19/2005 163 
4/19/2004 135 12/19/2004 111 8/20/2005 129 
4/20/2004 127 12/20/2004 129 8/21/2005 146 
4/21/2004 154 12/21/2004 137 8/22/2005 153 
4/22/2004 136 12/22/2004 107 8/23/2005 137 
4/23/2004 124 12/23/2004 94 8/24/2005 119 
4/24/2004 138 12/24/2004 98 8/25/2005 143 
4/25/2004 115 12/25/2004 98 8/26/2005 158 
4/26/2004 115 12/26/2004 122 8/27/2005 117 
4/27/2004 130 12/27/2004 152 8/28/2005 151 
4/28/2004 121 12/28/2004 137 8/29/2005 139 
4/29/2004 140 12/29/2004 152 8/30/2005 130 
4/30/2004 145 12/30/2004 124 8/31/2005 149 
5/1/2004 124 12/31/2004 115 9/1/2005 146 
5/2/2004 117 1/1/2005 138 9/2/2005 153 
5/3/2004 140 1/2/2005 143 9/3/2005 138 
5/4/2004 133 1/3/2005 142 9/4/2005 165 
5/5/2004 123 1/4/2005 144 9/5/2005 146 
5/6/2004 126 1/5/2005 131 9/6/2005 160 
5/7/2004 159 1/6/2005 157 9/7/2005 156 
5/8/2004 105 1/7/2005 152 9/8/2005 143 
5/9/2004 115 1/8/2005 148 9/9/2005 163 
5/10/2004 116 1/9/2005 145 9/10/2005 141 
5/11/2004 161 1/10/2005 153 9/11/2005 138 
5/12/2004 125 1/11/2005 123 9/12/2005 152 
5/13/2004 117 1/12/2005 157 9/13/2005 147 
5/14/2004 146 1/13/2005 116 9/14/2005 135 
5/15/2004 135 1/14/2005 105 9/15/2005 134 
5/16/2004 141 1/15/2005 130 9/16/2005 150 
5/17/2004 133 1/16/2005 109 9/17/2005 129 
5/18/2004 116 1/17/2005 137 9/18/2005 126 
5/19/2004 137 1/18/2005 126 9/19/2005 161 
5/20/2004 129 1/19/2005 114 9/20/2005 134 
5/21/2004 136 1/20/2005 140 9/21/2005 138 
5/22/2004 136 1/21/2005 120 9/22/2005 126 
 152 
5/23/2004 128 1/22/2005 101 9/23/2005 140 
5/24/2004 173 1/23/2005 108 9/24/2005 121 
5/25/2004 150 1/24/2005 156 9/25/2005 137 
5/26/2004 124 1/25/2005 158 9/26/2005 145 
5/27/2004 122 1/26/2005 161 9/27/2005 139 
5/28/2004 132 1/27/2005 146 9/28/2005 137 
5/29/2004 141 1/28/2005 136 9/29/2005 136 
5/30/2004 144 1/29/2005 133 9/30/2005 139 
5/31/2004 147 1/30/2005 126 10/1/2005 144 
6/1/2004 151 1/31/2005 151 10/2/2005 152 
6/2/2004 135 2/1/2005 146 10/3/2005 148 
6/3/2004 121 2/2/2005 139 10/4/2005 133 
6/4/2004 133 2/3/2005 137 10/5/2005 150 
6/5/2004 126 2/4/2005 143 10/6/2005 155 
6/6/2004 132 2/5/2005 132 10/7/2005 131 
6/7/2004 146 2/6/2005 138 10/8/2005 122 
6/8/2004 119 2/7/2005 167 10/9/2005 152 
6/9/2004 120 2/8/2005 139 10/10/2005 149 
6/10/2004 116 2/9/2005 143 10/11/2005 133 
6/11/2004 135 2/10/2005 127 10/12/2005 151 
6/12/2004 116 2/11/2005 175 10/13/2005 143 
6/13/2004 122 2/12/2005 144 10/14/2005 136 
6/14/2004 170 2/13/2005 142 10/15/2005 139 
6/15/2004 124 2/14/2005 149 10/16/2005 125 
6/16/2004 138 2/15/2005 146 10/17/2005 151 
6/17/2004 143 2/16/2005 155 10/18/2005 139 
6/18/2004 153 2/17/2005 141 10/19/2005 169 
6/19/2004 134 2/18/2005 141 10/20/2005 124 
6/20/2004 119 2/19/2005 161 10/21/2005 158 
6/21/2004 133 2/20/2005 117 10/22/2005 143 
6/22/2004 150 2/21/2005 145 10/23/2005 140 
6/23/2004 124 2/22/2005 142 10/24/2005 130 
6/24/2004 124 2/23/2005 152 10/25/2005 141 
6/25/2004 138 2/24/2005 113 10/26/2005 125 
6/26/2004 124 2/25/2005 147 10/27/2005 118 
6/27/2004 157 2/26/2005 126 10/28/2005 135 
6/28/2004 149 2/27/2005 138 10/29/2005 132 
6/29/2004 130 2/28/2005 132 10/30/2005 135 
6/30/2004 131 3/1/2005 119 10/31/2005 151 
7/1/2004 124 3/2/2005 135 11/1/2005 163 
7/2/2004 133 3/3/2005 119 11/2/2005 122 
7/3/2004 140 3/4/2005 131 11/3/2005 125 
7/4/2004 128 3/5/2005 116 11/4/2005 136 
 153 
7/5/2004 155 3/6/2005 138 11/5/2005 148 
7/6/2004 150 3/7/2005 139 11/6/2005 139 
7/7/2004 134 3/8/2005 131 11/7/2005 142 
7/8/2004 151 3/9/2005 133 11/8/2005 126 
7/9/2004 141 3/10/2005 149 11/9/2005 142 
7/10/2004 157 3/11/2005 146 11/10/2005 122 
7/11/2004 135 3/12/2005 157 11/11/2005 123 
7/12/2004 160 3/13/2005 165 11/12/2005 122 
7/13/2004 138 3/14/2005 145 11/13/2005 127 
7/14/2004 137 3/15/2005 156 11/14/2005 116 
7/15/2004 114 3/16/2005 121 11/15/2005 139 
7/16/2004 130 3/17/2005 125 11/16/2005 134 
7/17/2004 132 3/18/2005 151 11/17/2005 126 
7/18/2004 136 3/19/2005 128 11/18/2005 139 
7/19/2004 131 3/20/2005 132 11/19/2005 156 
7/20/2004 118 3/21/2005 145 11/20/2005 122 
7/21/2004 139 3/22/2005 141 11/21/2005 133 
7/22/2004 119 3/23/2005 140 11/22/2005 129 
7/23/2004 120 3/24/2005 147 11/23/2005 108 
7/24/2004 138 3/25/2005 158 11/24/2005 102 
7/25/2004 119 3/26/2005 126 11/25/2005 133 
7/26/2004 132 3/27/2005 112 11/26/2005 116 
7/27/2004 138 3/28/2005 164 11/27/2005 124 
7/28/2004 135 3/29/2005 148 11/28/2005 146 
7/29/2004 115 3/30/2005 139 11/29/2005 130 
7/30/2004 148 3/31/2005 147 11/30/2005 135 
7/31/2004 117 4/1/2005 118 12/1/2005 125 
8/1/2004 135 4/2/2005 137 12/2/2005 132 
8/2/2004 137 4/3/2005 134 12/3/2005 125 
8/3/2004 130 4/4/2005 138 12/4/2005 114 
8/4/2004 117 4/5/2005 155 12/5/2005 135 
8/5/2004 141 4/6/2005 145 12/6/2005 138 
8/6/2004 136 4/7/2005 151 12/7/2005 108 
8/7/2004 116 4/8/2005 177 12/8/2005 133 
8/8/2004 126 4/9/2005 151 12/9/2005 103 
8/9/2004 131 4/10/2005 141 12/10/2005 142 
8/10/2004 127 4/11/2005 142 12/11/2005 108 
8/11/2004 138 4/12/2005 147 12/12/2005 124 
8/12/2004 117 4/13/2005 134 12/13/2005 111 
8/13/2004 125 4/14/2005 132 12/14/2005 106 
8/14/2004 130 4/15/2005 152 12/15/2005 102 
8/15/2004 110 4/16/2005 152 12/16/2005 129 
8/16/2004 152 4/17/2005 153 12/17/2005 114 
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8/17/2004 133 4/18/2005 161 12/18/2005 111 
8/18/2004 144 4/19/2005 130 12/19/2005 106 
8/19/2004 125 4/20/2005 157 12/20/2005 107 
8/20/2004 142 4/21/2005 138 12/21/2005 110 
8/21/2004 127 4/22/2005 144 12/22/2005 128 
8/22/2004 132 4/23/2005 124 12/23/2005 102 
8/23/2004 131 4/24/2005 104 12/24/2005 89 
8/24/2004 170 4/25/2005 139 12/25/2005 99 
8/25/2004 118 4/26/2005 152 12/26/2005 157 
8/26/2004 131 4/27/2005 124 12/27/2005 135 
8/27/2004 150 4/28/2005 125 12/28/2005 132 
8/28/2004 146 4/29/2005 131 12/29/2005 148 
8/29/2004 128 4/30/2005 136 12/30/2005 133 
8/30/2004 158 5/1/2005 126 12/31/2005 93 
8/31/2004 128 5/2/2005 138   
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